TWI443116B - Wettable silicone hydrogel contact lenses and related compositions and methods - Google Patents
Wettable silicone hydrogel contact lenses and related compositions and methods Download PDFInfo
- Publication number
- TWI443116B TWI443116B TW96121939A TW96121939A TWI443116B TW I443116 B TWI443116 B TW I443116B TW 96121939 A TW96121939 A TW 96121939A TW 96121939 A TW96121939 A TW 96121939A TW I443116 B TWI443116 B TW I443116B
- Authority
- TW
- Taiwan
- Prior art keywords
- contact lens
- hydrogel contact
- poly
- precursor composition
- weight
- Prior art date
Links
Landscapes
- Eyeglasses (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Description
本發明尤其係針對矽氧水凝膠眼科裝置及相關組合物及方法。更特定言之,本發明係關於經模製之可濕性矽氧水凝膠隱形眼鏡及相關組合物及方法。In particular, the present invention is directed to a hydroxyl hydrogel ophthalmic device and related compositions and methods. More particularly, the present invention relates to molded wettable hydrogel hydrogel contact lenses and related compositions and methods.
矽氧水凝膠隱形眼鏡已普及,此係由於與非矽氧水凝膠隱形眼鏡相比,隱形眼鏡配戴者在其眼睛上配戴該等眼鏡持續更長時間的能力。舉例而言,視特定眼鏡而定,矽氧水凝膠隱形眼鏡可經每天配戴、每週配戴、雙週配戴或每月配戴而磨損或規定為每天配戴、每週配戴、雙週配戴或每月配戴。與矽氧水凝膠隱形眼鏡相關之對眼鏡配戴者之益處可至少部分歸因於隱形眼鏡之親水性組份與含矽聚合物質疏水特性的組合。Hydroxyl hydrogel contact lenses have become popular because of the ability of contact lens wearers to wear these glasses for longer periods of time than their non-oxygenated hydrogel contact lenses. For example, depending on the particular lens, the oxygenated hydrogel contact lens can be worn daily, worn weekly, bi-weekly or worn on a monthly basis or worn or worn every day. Wear it in two weeks or wear it every month. The benefits to the lens wearer associated with the hydrogel contact lenses can be attributed, at least in part, to the combination of the hydrophilic component of the contact lens and the hydrophobic character of the ruthenium containing polymer.
非矽氧水凝膠隱形眼鏡(諸如基於甲基丙烯酸2-羥乙酯(HEMA)之水凝膠隱形眼鏡)常在非極性樹脂隱形眼鏡模具(例如自聚烯烴基樹脂產生之隱形眼鏡模具)中產生。換言之,用於非矽氧水凝膠隱形眼鏡之眼鏡前驅體組合物在非極性樹脂隱形眼鏡模具中聚合以產生基於HEMA之聚合眼鏡產物。由於基於HEMA之隱形眼鏡之聚合組份的親水性質,即使儘管使用非極性樹脂模具產生,但基於HEMA之眼鏡在眼睛上仍相容且具有眼用可接受之表面可濕性。Non-oxygenated hydrogel contact lenses, such as 2-hydroxyethyl methacrylate (HEMA based hydrogel contact lenses), are often found in non-polar resin contact lens molds (eg, contact lens molds derived from polyolefin-based resins). Produced in. In other words, the lens precursor composition for non-oxygenated hydrogel contact lenses is polymerized in a non-polar resin contact lens mold to produce a HEMA-based polymeric lens product. Due to the hydrophilic nature of the polymeric components of HEMA-based contact lenses, HEMA-based glasses are compatible on the eye and have an ophthalmically acceptable surface wettability, even though produced using a non-polar resin mold.
相比之下,自非極性樹脂模具所獲得之現有矽氧水凝膠隱形眼鏡具有疏水性眼鏡表面。換言之,該等矽氧水凝膠隱形眼鏡之表面具有低可濕性,且因此在眼睛上不相容或為眼睛所不可接受。舉例而言,該等矽氧水凝膠隱形眼鏡可與增加之脂質沈積、蛋白質沈積、眼鏡與眼睛表面之結合及對眼鏡配戴者之普遍刺激相關。In contrast, existing oxygenated hydrogel contact lenses obtained from non-polar resin molds have hydrophobic eyeglass surfaces. In other words, the surfaces of the hydroxyl hydrogel contact lenses have low wettability and are therefore incompatible or unacceptable to the eye. For example, such helium-hydrogel contact lenses can be associated with increased lipid deposition, protein deposition, combination of spectacles with the surface of the eye, and general stimuli for lens wearers.
在努力克服此等問題中,已嘗試採用對該等矽氧水凝膠隱形眼鏡或眼鏡產物進行表面處理或表面改質以增加眼鏡表面之親水性及可濕性。矽氧水凝膠眼鏡之表面處理的實例包括塗佈眼鏡表面,將化學物質吸附至眼鏡表面上,且改變眼鏡表面上化學基團之化學性質或靜電電荷。已描述表面處理,其包括使用電漿氣體塗佈聚合眼鏡表面,或在隱形眼鏡模具表面上使用電漿氣體以在形成聚合眼鏡之前處理模具。不幸的是,若干缺點與此方法相關。與不使用表面處理或改質之製造方法相比,隱形眼鏡之表面處理需要更多機械及時間來產生隱形眼鏡。此外,當眼鏡由眼鏡配戴者配戴及/或觸摸時,經表面處理之矽氧水凝膠隱形眼鏡可展示減少之表面可濕性。舉例而言,增加對經表面處理之眼鏡的觸摸可導致親水性表面降解或磨損。In an effort to overcome these problems, attempts have been made to surface or surface modify the hydroxyl hydrogel contact lens or lens product to increase the hydrophilicity and wettability of the lens surface. Examples of surface treatments of silicone hydrogel lenses include coating the surface of the lens, adsorbing chemicals onto the surface of the lens, and altering the chemical nature or electrostatic charge of the chemical groups on the surface of the lens. Surface treatments have been described which include coating the surface of the polymeric eyeglasses with a plasma gas or using a plasma gas on the surface of the contact lens mold to treat the mold prior to forming the polymeric eyeglasses. Unfortunately, several drawbacks are associated with this approach. The surface treatment of contact lenses requires more mechanical and time to produce contact lenses than manufacturing methods that do not use surface treatment or modification. In addition, surface treated silicone hydrogel contact lenses can exhibit reduced surface wettability when the lenses are worn and/or touched by the lens wearer. For example, increasing the touch on surface treated glasses can result in degradation or wear of the hydrophilic surface.
另一種增加矽氧水凝膠眼鏡之可濕性及眼睛相容性的方法為在包含聚合濕潤劑(諸如聚乙烯吡咯啶酮(PVP))之第二組合物存在下聚合矽氧水凝膠隱形眼鏡前驅體組合物。該等類型之眼鏡在本文中稱為具有聚合內部濕潤劑之矽氧水凝膠隱形眼鏡,且通常包含包括高分子量聚合物(諸如PVP)之互穿聚合物網路(IPN)。如一般熟習此項技術者所瞭解,IPN係指兩種或兩種以上不同聚合物以網路形式之組合,其中至少一種聚合物在另一種聚合物存在下合成及/或交聯,兩者之間無任何共價鍵。IPN可由兩種形成兩個獨立但毗鄰或互穿之網路的鏈組成。IPN之實例包括分步IPN、同步IPN、半IPN及均IPN。雖然包括聚合濕潤劑IPN之矽氧水凝膠隱形眼鏡避免與表面處理相關之問題,但該等眼鏡歷時延長之時間可能無法保留其眼睛相容性,包括表面可濕性。舉例而言,由於內部濕潤劑未共價結合形成聚合眼鏡之其他組份,因此當由眼鏡配戴者配戴時,其可能自眼鏡浸出,且藉此隨時間推移導致表面可濕性降低及眼鏡配戴者之不適感增加。Another method of increasing the wettability and eye compatibility of the oxygenated hydrogel glasses is to polymerize the hydroxyl hydrogel in the presence of a second composition comprising a polymeric wetting agent such as polyvinylpyrrolidone (PVP). Contact lens precursor composition. Such types of eyeglasses are referred to herein as silicone hydrogel contact lenses having a polymeric internal wetting agent, and typically comprise an interpenetrating polymer network (IPN) comprising a high molecular weight polymer such as PVP. As is generally understood by those skilled in the art, IPN refers to a combination of two or more different polymers in a network form in which at least one polymer is synthesized and/or crosslinked in the presence of another polymer, both There are no covalent bonds between them. An IPN can consist of two chains that form two separate but adjacent or interpenetrating networks. Examples of IPNs include step-by-step IPN, synchronous IPN, half-IPN, and average IPN. While helium oxygen hydrogel contact lenses comprising a polymeric wetting agent IPN avoid problems associated with surface treatment, such lenses may not retain their eye compatibility over a prolonged period of time, including surface wettability. For example, since the internal humectant does not covalently combine to form other components of the polymeric spectacles, when worn by the spectacles wearer, it may leach from the spectacles and thereby cause surface wettability to decrease over time and The discomfort of the wearer of the glasses increases.
作為如上所述之表面處理或使用聚合濕潤劑IPN之替代方式,已發現可使用極性樹脂模具代替非極性樹脂模具來產生具有眼用可接受之表面可濕性的矽氧水凝膠隱形眼鏡。舉例而言,在乙烯-乙烯醇基或聚乙烯醇基模具中形成之矽氧水凝膠隱形眼鏡具有所需之表面可濕性。適用於製造用於產生無聚合濕潤劑IPN之未經表面處理的矽氧水凝膠隱形眼鏡之隱形眼鏡模具的極性樹脂之一種實例為乙烯-乙烯醇共聚物之樹脂,諸如由Nippon Gohsei,Ltd以商標名稱SOARLITETM 出售之乙烯-乙烯醇共聚物樹脂。除其極性之外,SOARLITETM 描述為具有以下特徵:極高機械強度、抗靜電性、當用於模製過程時的低收縮性、優良抗油性及抗溶劑性、小的熱膨脹係數及良好耐磨性。As an alternative to the surface treatment as described above or the use of a polymeric wetting agent IPN, it has been found that a polar resin mold can be used in place of a non-polar resin mold to produce a helium oxygen hydrogel contact lens having an ophthalmically acceptable surface wettability. For example, a helium oxygen hydrogel contact lens formed in an ethylene vinyl alcohol based or polyvinyl alcohol based mold has the desired surface wettability. An example of a polar resin suitable for use in the manufacture of contact lens molds for the production of non-polymerized wetting agent IPN without surface treatment of hydroxyl hydrogel contact lenses is a resin of ethylene-vinyl alcohol copolymer, such as by Nippon Gohsei, Ltd. ethylene sold by the trade name SOARLITE TM - vinyl alcohol copolymer resin. In addition to its polarity, SOARLITE TM described as having the following characteristics: high mechanical strength, antistatic properties, low contractility when used in molding processes when, excellent oil resistance and solvent resistance, small coefficient of thermal expansion and good resistance to Grinding.
雖然基於SOARLITETM 之模具對於在不使用表面處理或聚合濕潤劑IPN下產生眼睛上相容之矽氧水凝膠隱形眼鏡提供有利之替代方式,但SOARLITETM 模具與非極性樹脂模具(諸如聚丙烯模具)相比之可變形性或可撓性較小,且與非極性樹脂模具相比相對較難以工作。Although SOARLITE TM based on the on the mold surface is not used for the polymerization treatment or wetting agent IPN produce compatible silicone hydrogel contact lenses on the eye to provide alternative advantageous, but non-polar SOARLITE TM die mold resin (such as polypropylene The mold) is less deformable or flexible than the non-polar resin mold and is relatively difficult to work with.
根據上文,可見需要眼睛上相容之矽氧水凝膠隱形眼鏡,其與自SOARLITETM 隱形眼鏡模具獲得之矽氧水凝膠隱形眼鏡相比更易於產生,且無需表面處理或使用聚合濕潤劑IPN(包括PVP IPN)來達成眼睛相容性。此外,極為需要提供一種自非極性樹脂或聚烯烴基隱形眼鏡模具構件產生眼睛上相容之矽氧水凝膠隱形眼鏡(諸如具有眼睛上相容之表面可濕性的矽氧水凝膠隱形眼鏡)的方法,該方法克服現有方法之缺點。亦即,需要一種用於製備眼睛上相容之矽氧水凝膠隱形眼鏡之改良方法,其既無需表面處理所得隱形眼鏡產物,亦無需使用聚合濕潤劑IPN作為可聚合矽氧水凝膠隱形眼鏡前驅體組合物之部分。本發明滿足該等需要。According to the above, need to be seen compatible silicone hydrogel contact lenses on the eye, and the silicon which is obtained from SOARLITE TM hydrogel contact lens mold more prone compared and used without surface treatment or a polymeric wetting Agent IPN (including PVP IPN) to achieve eye compatibility. In addition, it is highly desirable to provide an ophthalmically compatible hydroxyl hydrogel contact lens from a non-polar or polyolefin-based contact lens mold member (such as an invisible hydrogel having an eye-compatible surface wettability). A method of spectacles that overcomes the shortcomings of prior methods. That is, there is a need for an improved method for preparing an ophthalmic compatible hydrogel contact lens that does not require surface treatment of the resulting contact lens product or the use of a polymeric wetting agent IPN as a polymerizable hydrogel. Part of the lens precursor composition. The present invention satisfies these needs.
本發明之隱形眼鏡、眼鏡產物、組合物及方法解決與現有矽氧水凝膠隱形眼鏡及其目前之生產方法相關的需要及問題。已驚人地發現,眼睛上相容之矽氧水凝膠隱形眼鏡可藉由在預萃取之聚合矽氧水凝膠隱形眼鏡產物中提供相對大量之可移除物質,接著將該產物萃取以移除該等可移除物質且水合以產生矽氧水凝膠隱形眼鏡而獲得。具有可移除組份(亦即一或多種可移除物質,包括可萃取物質及其類似物)之預萃取聚合矽氧水凝膠眼鏡產物通常含有至少約10重量%之可移除組份。接著將預萃取之聚合矽氧水凝膠眼鏡產物萃取(以藉此移除可萃取組份)且水合以形成如本文所述具有眼用可接受之表面可濕性的矽氧水凝膠隱形眼鏡。本發明之矽氧水凝膠隱形眼鏡具有允許患者眼睛上舒適配戴該眼鏡歷時延長之時間,諸如至少一天、至少一週、至少兩週或約一個月而無需自眼睛移除眼鏡之透氧性、表面可濕性、模數、水含量、離子流及設計。The contact lenses, lens products, compositions and methods of the present invention address the needs and problems associated with prior art oxygenated hydrogel contact lenses and their current methods of production. It has been surprisingly found that an eye-compatible, oxygenated hydrogel contact lens can be obtained by extracting a relatively large amount of removable material in a pre-extracted polymeric hydrogel hydrogel contact lens product. Obtained in addition to the removable materials and hydration to produce a helium oxygen hydrogel contact lens. Pre-extracted polymeric hydrogel lens products having a removable component (i.e., one or more removable materials, including extractable materials and the like) typically contain at least about 10% by weight of the removable component. . The pre-extracted polymeric hydrogel hydrogel lens product is then extracted (to thereby remove the extractable component) and hydrated to form an ophthalmic hydrogel invisible having an ophthalmically acceptable surface wettability as described herein. glasses. The oxygenated hydrogel contact lens of the present invention has a time that allows the patient to comfortably wear the lens for a prolonged period of time, such as at least one day, at least one week, at least two weeks, or about one month without removing oxygen from the eye. , surface wettability, modulus, water content, ion current and design.
在一態樣中,本發明係針對可聚合矽氧水凝膠隱形眼鏡前驅體組合物。該等前驅體組合物有效形成矽氧水凝膠隱形眼鏡。聚合之後,前驅體調配物導致形成可萃取之可水合隱形眼鏡預產物。前驅體組合物包含以下各物:(i)至少約20重量%之反應性含氟丙烯醯基矽氧大分子單體,(ii)至少約45重量%之不含矽之單體組合物,其包含親水性含乙烯基單體、丙烯酸單體及丙烯酸酯官能化之氧化乙烯寡聚物,及(iii)聚氧化烯矽氧可萃取組份。In one aspect, the invention is directed to a polymerizable silicone hydrogel contact lens precursor composition. The precursor compositions are effective to form a helium oxygen hydrogel contact lens. After polymerization, the precursor formulation results in the formation of an extractable hydratable contact lens preform. The precursor composition comprises the following: (i) at least about 20% by weight of a reactive fluoroacryloyloxyl macromonomer, and (ii) at least about 45% by weight of a monomer composition free of bismuth, It comprises a hydrophilic vinyl-containing monomer, an acrylic monomer and an acrylate functionalized ethylene oxide oligomer, and (iii) a polyoxyalkylene oxide extractable component.
在一實施例中,可聚合矽氧水凝膠隱形眼鏡前驅體組合物包含至少約25重量%,且較佳約25重量%至約35重量%之反應性含氟二甲基丙烯醯基矽氧大分子單體。本發明之例示性反應性含氟二甲基丙烯醯基矽氧大分子單體為α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)(在本文中亦稱為M3U,且CAS註冊號為697234-74-5)。In one embodiment, the polymerizable silicone hydrogel contact lens precursor composition comprises at least about 25% by weight, and preferably from about 25% to about 35% by weight, of reactive fluorine-containing dimethyl propylene fluorenyl hydrazine. Oxygen macromonomer. An exemplary reactive fluorine-containing dimethyl propylene fluorenyl oxime macromonomer of the present invention is α-ω-bis(methacryloxyethyliminocarboxycarbonylpropyl)-poly (two Methyl methoxyoxane)-poly(trifluoropropylmethyloxirane)-poly(ω-methoxy-poly(ethylene glycol) propylmethyl decane) (also referred to herein as M3U) And the CAS registration number is 697234-74-5).
在另一實施例中,本發明之可聚合矽氧水凝膠隱形眼鏡前驅體組合物包含約45-55重量%之不含矽之單體組合物。尤其較佳為包含N-乙烯基-N-甲基乙醯胺、甲基丙烯酸甲酯及二甲基丙烯酸三乙二醇酯之不含矽的親水性組份。In another embodiment, the polymerizable silicone hydrogel contact lens precursor compositions of the present invention comprise from about 45 to about 55% by weight of a monomer composition free of barium. Particularly preferred is a hydrazine-free hydrophilic component comprising N-vinyl-N-methylacetamide, methyl methacrylate and triethylene glycol dimethacrylate.
在另一實施例中,可聚合矽氧水凝膠隱形眼鏡前驅體組合物包含約10重量%至約30重量%之聚氧化烯矽氧可萃取組份。在甚至更特定之實施例中,聚氧化烯矽氧可萃取組份視情況包含約0.1至6份鏈轉移劑及約99.9至94份聚氧化烯矽氧。說明性聚氧化烯矽氧可萃取組份包括二甲基矽氧烷-氧化乙烯嵌段共聚物,諸如含有約75重量%氧化乙烯之二甲基矽氧烷-氧化乙烯嵌段共聚物。一種該二甲基矽氧烷-氧化乙烯嵌段共聚物為DBE 712(Gelest,Morrisville,PA)。In another embodiment, the polymerizable silicone hydrogel contact lens precursor composition comprises from about 10% to about 30% by weight of the polyoxyalkylene oxide extractable component. In an even more specific embodiment, the polyoxyalkylene oxime extractable component optionally comprises from about 0.1 to 6 parts chain transfer agent and from about 99.9 to 94 parts polyoxyalkylene oxime. Illustrative polyoxyalkylene oxime extractable components include dimethyl methoxyalkane-oxyethylene block copolymers such as dimethyl decane-ethylene oxide block copolymers containing about 75% by weight ethylene oxide. One such dimethyloxane-ethylene oxide block copolymer is DBE 712 (Gelest, Morrisville, PA).
本文所述之組合物、眼鏡及方法中所用之鏈轉移試劑包括硫醇、二硫醚、有機鹵化物、烯丙氧基醚及烯丙氧基醇。在尤其較佳之實施例中,鏈轉移試劑為烯丙氧基乙醇。Chain transfer agents for use in the compositions, lenses, and methods described herein include mercaptans, disulfides, organic halides, allyloxy ethers, and allyloxy alcohols. In a particularly preferred embodiment, the chain transfer reagent is allyloxyethanol.
在本發明之其他實施例中,可聚合矽氧水凝膠隱形眼鏡前驅體組合物亦可包含一或多個以下各物:紫外線吸收劑、著色劑或引發劑。紫外線吸收劑可例如為光可聚合羥基二苯甲酮,諸如2-羥基-4-丙烯醯氧基乙氧基二苯甲酮。本發明所用之著色劑可例如為酞菁顏料,諸如酞菁藍。此外,可聚合矽氧水凝膠隱形眼鏡前驅體調配物中所包含之引發劑可例如為熱引發劑,諸如2,2'-偶氮雙(2,4-二甲基戊腈)(VAZO-52)。In other embodiments of the invention, the polymerizable silicone hydrogel contact lens precursor composition may also comprise one or more of the following: a UV absorber, a colorant or an initiator. The ultraviolet absorber may, for example, be a photopolymerizable hydroxybenzophenone such as 2-hydroxy-4-propenyloxyethoxybenzophenone. The color former used in the present invention may be, for example, a phthalocyanine pigment such as phthalocyanine blue. In addition, the initiator included in the polymerizable silicone hydrogel contact lens precursor formulation can be, for example, a thermal initiator such as 2,2'-azobis(2,4-dimethylvaleronitrile) (VAZO) -52).
在更特定實施例中,本發明之可聚合矽氧水凝膠隱形眼鏡前驅體組合物包含α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)、N-乙烯基-N-甲基乙醯胺、甲基丙烯酸甲酯及二甲基丙烯酸三乙二醇酯。In a more specific embodiment, the polymerizable silicone hydrogel contact lens precursor composition of the present invention comprises alpha-omega-bis(methacryloxyethyliminocarboxycarbonylpropyl)-poly (dimethyloxane)-poly(trifluoropropylmethyloxirane)-poly(ω-methoxy-poly(ethylene glycol) propylmethyloxirane), N-vinyl- N-methylacetamide, methyl methacrylate and triethylene glycol dimethacrylate.
在一較佳實施例中,本發明之前驅體組合物包含α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)、N-乙烯基-N-甲基乙醯胺、甲基丙烯酸甲酯、二甲基丙烯酸三乙二醇酯及二甲基矽氧烷-氧化乙烯嵌段共聚物可萃取組份。In a preferred embodiment, the precursor composition of the present invention comprises α-ω-bis(methacryloxyethylethyleniminocarboxyethoxypropyl)-poly(dimethyloxane). - poly(trifluoropropylmethyl decane)-poly(ω-methoxy-poly(ethylene glycol) propylmethyl decane), N-vinyl-N-methyl acetamide, The component can be extracted by methyl methacrylate, triethylene glycol dimethacrylate and dimethyloxane-ethylene oxide block copolymer.
在另一實施例中,可萃取組份包含視情況含有烯丙氧基乙醇之DBE 712。In another embodiment, the extractable component comprises DBE 712, which optionally contains allyloxyethanol.
在可聚合矽氧水凝膠隱形眼鏡前驅體組合物之更特定實施例中,α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)與N-乙烯基-N-甲基乙醯胺、甲基丙烯酸甲酯及二甲基丙烯酸三乙二醇酯之組合的比率以重量比計在約0.50至約0.65之範圍內。In a more specific embodiment of the polymerizable silicone hydrogel contact lens precursor composition, alpha-omega-bis(methacryloxyethyliminocarboxycarbonylpropyl)-poly(dimethyl) Alkyl oxyalkylene)-poly(trifluoropropylmethyl decane)-poly(ω-methoxy-poly(ethylene glycol) propylmethyl decane) and N-vinyl-N- The ratio of the combination of acetalamine, methyl methacrylate and triethylene glycol dimethacrylate is in the range of from about 0.50 to about 0.65 by weight.
在一較佳實施例中,可聚合矽氧水凝膠隱形眼鏡前驅體組合物包含α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)、N-乙烯基-N-甲基乙醯胺、甲基丙烯酸甲酯、二甲基丙烯酸三乙二醇酯、2-羥基-4-丙烯醯氧基乙氧基二苯甲酮、酞菁藍、2,2'-偶氮雙(2,4-二甲基戊腈)及DBE 712(視情況與烯丙氧基乙醇組合)。In a preferred embodiment, the polymerizable hydrogel contact lens precursor composition comprises alpha-omega-bis(methacryloxyethyliminocarboxyethoxypropyl)-poly (two) Methyl methoxyoxane)-poly(trifluoropropylmethyloxirane)-poly(ω-methoxy-poly(ethylene glycol) propylmethyl decane), N-vinyl-N- Methylacetamide, methyl methacrylate, triethylene glycol dimethacrylate, 2-hydroxy-4-propenyloxyethoxybenzophenone, phthalocyanine blue, 2,2'-even Nitrogen bis(2,4-dimethylvaleronitrile) and DBE 712 (in combination with allyloxyethanol).
上述組份在例示性可聚合矽氧水凝膠隱形眼鏡前驅體組合物中之尤其較佳重量/重量百分比為約28%(重量比)α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)、約37%(重量比)N-乙烯基-N-甲基乙醯胺、約13.5%(重量比)甲基丙烯酸甲酯、約0.16%(重量比)二甲基丙烯酸三乙二醇酯、約0.7%(重量比)2-羥基-4-丙烯醯氧基乙氧基二苯甲酮、約0.1%(重量比)酞菁藍、約0.4%(重量比)2,2'-偶氮雙(2,4-二甲基戊腈)及約20% DBE 712(視情況與烯丙氧基乙醇組合)。Particularly preferred weight percent of the above components in the exemplary polymerizable silicone hydrogel contact lens precursor composition is about 28% by weight alpha-omega-bis(methacryloxyethyl) Imino-carboxy ethoxypropyl)-poly(dimethyloxane)-poly(trifluoropropylmethyloxirane)-poly(ω-methoxy-poly(ethylene glycol) propyl Methyl methoxyoxane), about 37% by weight of N-vinyl-N-methylacetamide, about 13.5% by weight of methyl methacrylate, about 0.16% by weight of dimethyl Triethylene glycol acrylate, about 0.7% by weight of 2-hydroxy-4-propenyloxyethoxybenzophenone, about 0.1% by weight of phthalocyanine blue, about 0.4% by weight 2,2'-azobis(2,4-dimethylvaleronitrile) and about 20% DBE 712 (in combination with allyloxyethanol).
根據另一態樣,本發明提供自上述可聚合之眼鏡前驅體組合物中之任一者所產生之矽氧水凝膠隱形眼鏡。According to another aspect, the present invention provides a helium oxygen hydrogel contact lens produced from any of the above polymerizable lens precursor compositions.
在另一態樣中,本發明提供自如本文所述之不存在可萃取組份之可聚合之眼鏡前驅體組合物反應所得之矽氧水凝膠隱形眼鏡。In another aspect, the invention provides a hydroxamed hydrogel contact lens obtained by reacting a polymerizable lens precursor composition as described herein in the absence of an extractable component.
根據另一態樣,本發明係針對藉由以下步驟所產生之矽氧水凝膠隱形眼鏡:聚合如本文所述之可聚合之眼鏡前驅體組合物以形成預萃取之聚合矽氧水凝膠隱形眼鏡,自預萃取之隱形眼鏡萃取可萃取之組份以形成經萃取之聚合眼鏡產物,且使經萃取之聚合眼鏡產物水合以形成矽氧水凝膠隱形眼鏡。所得經萃取之水合隱形眼鏡產物通常具有約40重量%至約48重量%範圍內之平衡水含量及約100-115 barrer範圍內之透氧性(Dk ×10-11 )。According to another aspect, the present invention is directed to a hydroxyl hydrogel contact lens produced by the following steps: polymerizing a polymerizable lens precursor composition as described herein to form a pre-extracted polymeric hemohydrate hydrogel Contact lenses, extractable components are extracted from pre-extracted contact lenses to form an extracted polymeric lens product, and the extracted polymeric lens product is hydrated to form a hydroxyl hydrogel contact lens. The resulting hydrated contact lens product typically extracted with an oxygen permeability within about 40 to about 48 wt.% Equilibrium water content in the range of wt% and a range of about 100-115 barrer (D k × 10 -11).
在本發明之此態樣的一實施例中,根據以上方法產生矽氧水凝膠隱形眼鏡,其中可聚合之眼鏡前驅體組合物包含熱引發劑,且聚合步驟進一步包含將可聚合之眼鏡前驅體組合物加熱至大於約50℃之溫度。In an embodiment of this aspect of the invention, a helium oxygen hydrogel contact lens is produced according to the above method, wherein the polymerizable lens precursor composition comprises a thermal initiator, and the polymerizing step further comprises polymerizing the lens precursor The body composition is heated to a temperature greater than about 50 °C.
在另一實施例中,藉由以下步驟產生矽氧水凝膠隱形眼鏡:聚合如上所述之可聚合之眼鏡前驅體組合物以形成預萃取之聚合矽氧水凝膠隱形眼鏡,其中DBE與烯丙氧基乙醇組合;自預萃取之聚合矽氧水凝膠隱形眼鏡萃取聚氧化烯矽氧可萃取組份以形成經萃取之聚合眼鏡產物,且使經萃取之聚合眼鏡產物水合以形成一批任一或多種以下特徵具有低可變性之矽氧水凝膠隱形眼鏡:平衡水含量、透氧性、靜態接觸角、動態接觸角、滯後、折射率、離子流、模數及抗張強度。例如,視眼鏡產物之特定特徵而定,任一或多種前述眼鏡特徵之可變性通常均小於約20%,且較佳小於約10%。在一或多個實施例中,眼鏡直徑、平衡水含量及/或離子流之任一或多者的可變性均為約5%或小於5%,更佳為約3%或小於3%,且甚至更佳為約2%或小於2%。In another embodiment, a helium oxygen hydrogel contact lens is produced by polymerizing a polymerizable lens precursor composition as described above to form a pre-extracted polymeric hemohydrogel contact lens, wherein DBE and a combination of allyloxyethanol; extracting the polyoxyalkylene oxide extractable component from a pre-extracted polymeric hydrogel contact lens to form an extracted polymeric lens product, and hydrating the extracted polymeric lens product to form a Batches of one or more of the following characteristics of low-variability helium hydrogel contact lenses: equilibrium water content, oxygen permeability, static contact angle, dynamic contact angle, hysteresis, refractive index, ion current, modulus and tensile strength . For example, depending on the particular characteristics of the lens product, the variability of any one or more of the aforementioned lens features is typically less than about 20%, and preferably less than about 10%. In one or more embodiments, the variability of any one or more of the spectacles diameter, the equilibrium water content, and/or the ion current is about 5% or less, more preferably about 3% or less than 3%. And even more preferably about 2% or less than 2%.
在另一態樣中,本發明提供一種平衡水含量為至少約40%、透氧性(Dk ×10-11 )為約90-120 barrer之矽氧水凝膠隱形眼鏡。In another aspect, the present invention provides a helium oxygen hydrogel contact lens having an equilibrium water content of at least about 40% and an oxygen permeability (D k x 10 -11 ) of from about 90 to 120 barrer.
在上述之一實施例中,本文提供進一步包含選自由以下各特徵組成之群的一或多個特徵之矽氧水凝膠隱形眼鏡:眼鏡表面前進接觸角為約70°至約75°,拉伸模數小於約0.7 MPa,且離子流為約1.5-5(×10-3 mm2 /min)。In one of the above embodiments, there is provided a hydroxyl hydrogel contact lens further comprising one or more features selected from the group consisting of: a surface contact angle of the lens of from about 70[deg.] to about 75[deg.], drawn The modulus of extension is less than about 0.7 MPa and the ion current is about 1.5-5 (x 10 -3 mm 2 /min).
在某些實施例中,本發明之矽氧水凝膠隱形眼鏡亦可具有圓形外周邊緣,或可為以下之一者:球面眼鏡、非球面眼鏡、單焦點眼鏡或旋轉穩定複曲面隱形眼鏡。In certain embodiments, the oxygenated hydrogel contact lenses of the present invention may also have a rounded peripheral edge, or may be one of: spherical, aspherical, monofocal, or rotationally stable toric contact lenses. .
在另一實施例中,本發明提供密封包裝之如本文所述之矽氧水凝膠隱形眼鏡。In another embodiment, the present invention provides a heralloy hydrogel contact lens as described herein in a sealed package.
在另一實施例中,本發明之矽氧水凝膠隱形眼鏡未經表面處理。In another embodiment, the oxygenated hydrogel contact lenses of the present invention are not surface treated.
在另一態樣中,本發明提供一種產生可聚合矽氧水凝膠隱形眼鏡前驅體組合物之方法。該方法包括組合以下各物:(i)至少約25重量%之反應性含氟二甲基丙烯醯基矽氧大分子單體、(ii)至少約45重量%之不含矽之大分子單體組合物及(iii)聚氧化烯矽氧可萃取組份,以藉此產生可聚合矽氧水凝膠隱形眼鏡前驅體組合物,其中不含矽之大分子單體組合物包含親水性含乙烯基單體、丙烯酸系單體及丙烯酸酯官能化之氧化乙烯寡聚物。In another aspect, the invention provides a method of producing a polymerizable silicone hydrogel contact lens precursor composition. The method comprises combining the following: (i) at least about 25% by weight of a reactive fluorine-containing dimethyl propylene fluorenyloxy macromonomer, and (ii) at least about 45% by weight of a macromonomer containing no hydrazine a body composition and (iii) a polyoxyalkylene oxime oxygen extractable component to thereby produce a polymerizable hydrogel hydrogel contact lens precursor composition, wherein the bismuth-free macromer monomer composition comprises a hydrophilic content Vinyl monomer, acrylic monomer and acrylate functionalized ethylene oxide oligomer.
在本發明之此態樣之一實施例中,以上方法進一步包含組合大分子單體、不含矽之單體組合物及可萃取組份、紫外線吸收劑及著色劑。例示性著色劑包括酞菁顏料,諸如酞菁藍。較佳紫外線吸收劑為光可聚合之羥基二苯甲酮,諸如2-羥基-4-丙烯醯氧基乙氧基二苯甲酮。In an embodiment of this aspect of the invention, the above method further comprises combining a macromonomer, a ruthenium-free monomer composition and an extractable component, an ultraviolet absorber, and a color former. Exemplary colorants include phthalocyanine pigments such as phthalocyanine blue. Preferred UV absorbers are photopolymerizable hydroxybenzophenones such as 2-hydroxy-4-propenyloxyethoxybenzophenone.
在該方法之一特定實施例中,該反應性含氟二甲基丙烯醯基矽氧大分子單體之量在約25重量%至約35重量%之範圍內。In a particular embodiment of the method, the amount of the reactive fluorine-containing dimethyl propylene fluorenyl oxy macromonomer is in the range of from about 25% by weight to about 35% by weight.
在該方法之另一實施例中,該不含矽之單體組合物之量在約45-55重量%之範圍內。In another embodiment of the method, the amount of the bismuth-free monomer composition is in the range of from about 45 to about 55% by weight.
在該方法之另一實施例中,聚氧化烯矽氧可萃取組份之量在約10重量%至約30重量%之範圍內。In another embodiment of the method, the polyoxyalkylene oxime oxygen extractable component is present in an amount ranging from about 10% by weight to about 30% by weight.
在該方法之一較佳實施例中,反應性含氟二甲基丙烯醯基矽氧大分子單體為α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)(M3U)。In a preferred embodiment of the method, the reactive fluorine-containing dimethyl propylene fluorenyl oxime macromonomer is α-ω-bis(methacryl oxiranylethylimino carboxy ethoxy propyl acrylate Base)-poly(dimethyloxane)-poly(trifluoropropylmethyloxirane)-poly(ω-methoxy-poly(ethylene glycol)propylmethyl decane) (M3U ).
在該方法之另一實施例中,不含矽之單體組份包含N-乙烯基-N-甲基乙醯胺、甲基丙烯酸甲酯及二甲基丙烯酸三乙二醇酯。In another embodiment of the method, the ruthenium-free monomer component comprises N-vinyl-N-methylacetamide, methyl methacrylate, and triethylene glycol dimethacrylate.
在該方法之另一實施例中,聚氧化烯矽氧可萃取組份進一步包含鏈轉移劑,諸如硫醇、二硫醚、有機鹵化物或烯丙氧基醇。在一尤其較佳之實施例中,鏈轉移試劑為烯丙氧基乙醇。In another embodiment of the method, the polyoxyalkylene oxime extractable component further comprises a chain transfer agent such as a thiol, disulfide, organic halide or allyloxy alcohol. In a particularly preferred embodiment, the chain transfer reagent is allyloxyethanol.
在該方法之一較佳實施例中,聚氧化烯矽氧可萃取組份包含約0.05重量%至約7重量%之烯丙氧基乙醇。一種說明性聚氧化烯矽氧可萃取組份為二甲基矽氧烷-氧化乙烯嵌段共聚物,例如含有75重量%之氧化乙烯的二甲基矽氧烷-氧化乙烯嵌段共聚物。尤其較佳用作聚氧化烯矽氧可萃取組份者為DBE 712。In a preferred embodiment of the method, the polyoxyalkylene oxime oxygen extractable component comprises from about 0.05% to about 7% by weight of allyloxyethanol. An illustrative polyoxyalkylene oxime extractable component is a dimethyl siloxane-ethylene oxide block copolymer, such as a dimethyl siloxane-ethylene oxide block copolymer containing 75% by weight of ethylene oxide. Particularly preferred as the polyoxyalkylene oxime oxygen extractable component is DBE 712.
在該方法之另一實施例中,組合步驟進一步包含將引發劑與其他組份組合。較佳為熱引發劑,諸如2,2'-偶氮雙(2,4-二甲基戊腈)(VAZO-52)。In another embodiment of the method, the combining step further comprises combining the initiator with the other components. A thermal initiator such as 2,2'-azobis(2,4-dimethylvaleronitrile) (VAZO-52) is preferred.
在另一態樣中,本文提供一種產生可聚合矽氧水凝膠隱形眼鏡前驅體組合物之方法。該方法包含將α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)、N-乙烯基-N-甲基乙醯胺、甲基丙烯酸甲酯及二甲基丙烯酸三乙二醇酯組合,以藉此產生可聚合矽氧水凝膠隱形眼鏡前驅體組合物。In another aspect, provided herein is a method of producing a polymerizable silicone hydrogel contact lens precursor composition. The method comprises α-ω-bis(methacryloxyethyl iminocarboxyethoxypropyl)-poly(dimethyloxane)-poly(trifluoropropylmethyloxane) )-Poly(ω-methoxy-poly(ethylene glycol) propylmethyl decane), N-vinyl-N-methylacetamide, methyl methacrylate and triethyl methacrylate The glycol esters are combined to thereby produce a polymerizable hydrogel hydrogel contact lens precursor composition.
在以上方法之一實施例中,組合步驟進一步包含將二甲基矽氧烷-氧化乙烯嵌段共聚物可萃取組份(例如DBE 712)與其他組份組合。In one embodiment of the above method, the combining step further comprises combining the dimethyloxane-ethylene oxide block copolymer extractable component (e.g., DBE 712) with the other components.
在上述方法之一實施例中,烯丙氧基乙醇與DBE 712之相對量在約0.1份至約5份烯丙氧基乙醇與約99.9份至約95份DBE 712之範圍內。In one embodiment of the above process, the relative amount of allyloxyethanol and DBE 712 is in the range of from about 0.1 parts to about 5 parts of allyloxyethanol and from about 99.9 parts to about 95 parts of DBE 712.
在前述方法之另一實施例中,組合步驟進一步包含將酞菁藍與其他組份組合。In another embodiment of the foregoing method, the combining step further comprises combining the phthalocyanine blue with the other components.
在另一實施例中,組合步驟進一步包含將2-羥基-4-丙烯醯氧基乙氧基二苯甲酮與其他組份組合。In another embodiment, the combining step further comprises combining 2-hydroxy-4-propenyloxyethoxybenzophenone with the other components.
在該方法之另一實施例中,組合步驟包含將2,2'-偶氮雙(2,4-二甲基戊腈)添加至組合中。In another embodiment of the method, the combining step comprises adding 2,2'-azobis(2,4-dimethylvaleronitrile) to the combination.
在前述方法之一較佳實施例中,α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)與N-乙烯基-N-甲基乙醯胺、甲基丙烯酸甲酯及二甲基丙烯酸三乙二醇酯之組合的比率以重量比計在約0.50至約0.65之範圍內。In a preferred embodiment of the foregoing process, α-ω-bis(methacryloxyethyl iminocarboxyethoxypropyl)-poly(dimethyloxane)-poly(trifluoro Propylmethyl decane)-poly(ω-methoxy-poly(ethylene glycol) propylmethyl decane) with N-vinyl-N-methylacetamide, methyl methacrylate The ratio of the combination of triethylene glycol dimethacrylate is in the range of from about 0.50 to about 0.65 by weight.
在另一態樣中,本文提供一種產生可聚合矽氧水凝膠隱形眼鏡前驅體組合物之方法,其中該方法包含將α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)、N-乙烯基-N-甲基乙醯胺、甲基丙烯酸甲酯、二甲基丙烯酸三乙二醇酯、2-羥基-4-丙烯醯氧基乙氧基二苯甲酮、酞菁藍、2,2'-偶氮雙(2,4-二甲基戊腈)與DBE 712(視情況包含烯丙氧基乙醇)組合,以藉此產生可聚合矽氧水凝膠隱形眼鏡前驅體組合物。In another aspect, provided herein is a method of producing a polymerizable silicone hydrogel contact lens precursor composition, wherein the method comprises alpha-omega-bis(methacryloxyethyliminocarboxyl) Ethoxypropyl)-poly(dimethyloxane)-poly(trifluoropropylmethyloxirane)-poly(ω-methoxy-poly(ethylene glycol)propylmethyloxime Alkyl), N-vinyl-N-methylacetamide, methyl methacrylate, triethylene glycol dimethacrylate, 2-hydroxy-4-propenyloxyethoxybenzophenone, Phthalocyanine blue, 2,2'-azobis(2,4-dimethylvaleronitrile) combined with DBE 712 (optionally containing allyloxyethanol) to thereby produce a polymerizable hydrogel hydrogel invisible A lens precursor composition.
在一實施例中,上述方法包括以下相對量之組份:約28%(重量比)α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷)、約37%(重量比)N-乙烯基-N-甲基乙醯胺、約13.5%(重量比)甲基丙烯酸甲酯、約0.16%(重量比)二甲基丙烯酸三乙二醇酯、約0.7%(重量比)2-羥基-4-丙烯醯氧基乙氧基二苯甲酮、約0.1%(重量比)酞菁藍、約0.4%(重量比)2,2'-偶氮雙(2,4-二甲基戊腈)及約20% DBE 712(視情況包含烯丙氧基乙醇)。In one embodiment, the above method comprises the following relative amounts of components: about 28% by weight of alpha-omega-bis(methacryloxyethyliminocarbomethoxypropyl)-poly( Dimethyl methoxyoxane)-poly(trifluoropropylmethyl decane)-poly(ω-methoxy-poly(ethylene glycol) propylmethyl decane), about 37% by weight N-vinyl-N-methylacetamide, about 13.5% by weight of methyl methacrylate, about 0.16% by weight of triethylene glycol dimethacrylate, about 0.7% by weight 2-hydroxy-4-propenyloxyethoxybenzophenone, about 0.1% by weight of phthalocyanine blue, about 0.4% by weight of 2,2'-azobis (2,4-) Dimethylvaleronitrile) and about 20% DBE 712 (including allyloxyethanol as appropriate).
在前述方法之另一實施例中,組合步驟導致組份組合之形成,且該方法進一步包含混合組份之組合以形成混合物。In another embodiment of the foregoing method, the combining step results in the formation of a combination of components, and the method further comprises combining the components to form a mixture.
在另一實施例中,該方法進一步包含過濾混合物。In another embodiment, the method further comprises filtering the mixture.
在另一實施例中,該方法包含聚合可聚合之眼鏡前驅體組合物以形成預萃取之聚合矽氧水凝膠隱形眼鏡。In another embodiment, the method comprises polymerizing a polymerizable lens precursor composition to form a pre-extracted polymeric hemohydrogel contact lens.
在另一實施例中,該方法進一步包含在聚合步驟之前將可聚合之眼鏡前驅體組合物置放於非極性樹脂隱形眼鏡模具中。In another embodiment, the method further comprises placing the polymerizable lens precursor composition in a non-polar resin contact lens mold prior to the polymerizing step.
在另一實施例中,前述方法包括萃取預萃取之聚合隱形眼鏡以形成不存在可萃取組份之經萃取聚合眼鏡產物,且使經萃取之聚合眼鏡產物水合以形成矽氧水凝膠隱形眼鏡。In another embodiment, the foregoing method comprises extracting a pre-extracted polymeric contact lens to form an extracted polymeric lens product in the absence of an extractable component, and hydrating the extracted polymeric lens product to form a helium oxygen hydrogel contact lens .
在另一態樣,本發明提供一種改良用於矽氧水凝膠隱形眼鏡製備中之二甲基矽氧烷-氧化乙烯嵌段共聚物的效能之方法。該方法包含將約0.1重量%至約10重量%之烯丙氧基乙醇添加至二甲基矽氧烷-氧化乙烯嵌段共聚物中之步驟以提供用於製備矽氧水凝膠隱形眼鏡產物之烯丙氧基乙醇-二甲基矽氧烷氧化乙烯嵌段共聚物。In another aspect, the present invention provides a method of improving the efficacy of a dimethyloxane-ethylene oxide block copolymer for use in the preparation of a hydrogel contact lens. The method comprises the step of adding from about 0.1% to about 10% by weight of allyloxyethanol to the dimethyloxane-ethylene oxide block copolymer to provide a product for preparing a hydroxyl hydrogel contact lens. Allyloxyethanol-dimethyloxane oxide ethylene block copolymer.
用於添加步驟中之烯丙氧基乙醇之量較佳有效產生膨脹係數在約0.90至約1.10(諸如約0.95至約1.05)之範圍內的經萃取水合矽氧水凝膠隱形眼鏡產物。在至少一實施例中,膨脹係數為約0.98至約1.02。The amount of allyloxyethanol used in the addition step is preferably effective to produce an extracted hydrated hydrogel hydrogel contact lens product having a coefficient of expansion in the range of from about 0.90 to about 1.10, such as from about 0.95 to about 1.05. In at least one embodiment, the coefficient of expansion is from about 0.98 to about 1.02.
本發明之眼鏡、眼鏡產物、組合物及方法之其他實施例由以下描述、圖示、實例及申請專利範圍顯而易見。如由以上及以下描述可瞭解,本文所述之各個及每一特徵及該等特徵中之兩者或兩者以上之各個及每一組合均包括在本發明之範疇內,其限制條件為該組合中所包括之特徵彼此一致。此外,任何特徵或特徵組合可特定排除在本發明之任何實施例之外。尤其當結合隨附實例及圖示考慮時,本發明之其他態樣及優勢在以下實施方式及申請專利範圍中闡明。Other embodiments of the spectacles, spectacles products, compositions, and methods of the present invention are apparent from the following description, illustration, examples, and claims. As will be understood from the above and the following description, each and every feature and each of the features described herein, and each or both of the features are included in the scope of the invention, the The features included in the combination are consistent with each other. In addition, any feature or combination of features may be specifically excluded from any embodiment of the invention. Other aspects and advantages of the present invention are set forth in the following embodiments and claims.
本發明現將在下文中更全面地描述。然而,本發明可以多種不同形式具體化,且不應理解為限於本文所提出之實施例;相反,提供該等實施例以使本揭示案詳盡且完整,且對熟習此項技術者完全傳達本發明之範疇。The invention will now be described more fully below. However, the present invention may be embodied in many different forms and should not be construed as being limited to the embodiments set forth herein; rather, the embodiments are provided so that this disclosure will be thorough and complete, and The scope of the invention.
須注意,除非上下文另外明確指示,否則如本說明書中所用之單數形式"一"及"該"包括複數指示物。因此,舉例而言,提及"隱形眼鏡"包括單一眼鏡以及兩個或兩個以上相同或不同之眼鏡,提及"前驅體組合物"係指單一組合物以及兩種或兩種以上相同或不同之組合物,及其類似物。It must be noted that, as used in the specification, the singular " Thus, for example, reference to "a contact lens" includes a single lens and two or more identical or different glasses, and reference to "precursor composition" refers to a single composition and two or more of the same or Different compositions, and the like.
在描述且主張本發明時,以下術語將根據下文所述之定義來使用。In describing and claiming the present invention, the following terms will be used in accordance with the definitions set forth below.
如本文所用之術語"水凝膠"係指通常為聚合物鏈網路或基質之能夠在水中膨脹或遇水膨脹之聚合物質。網路或基質可交聯或可不交聯。水凝膠係指遇水可膨脹或遇水膨脹之聚合物質,包括隱形眼鏡。因此,水凝膠可(i)未經水合且遇水可膨脹,或(ii)部分水合且遇水膨脹,或(iii)完全水合且遇水膨脹。The term "hydrogel" as used herein refers to a polymeric material that is typically a polymer chain network or matrix that is capable of swelling or swelling with water. The network or matrix may or may not be crosslinked. Hydrogel refers to a polymeric material that swells or swells when exposed to water, including contact lenses. Thus, the hydrogel can be (i) unhydrated and swellable with water, or (ii) partially hydrated and swelled with water, or (iii) fully hydrated and swelled with water.
如(例如)"經取代之烷基"中之術語"經取代"係指經一或多個非干擾取代基取代之部分(例如烷基),該等取代基諸如(但不限於)C3 -C8 環烷基(例如環丙基、環丁基及其類似物)、鹵基(例如氟基、氯基、溴基及碘基)、氰基、烷氧基、低碳苯基、經取代之苯基及其類似物。對於苯環上之取代而言,取代基可在任何方位上(亦即鄰、間或對)。Such as (e.g.) "of the substituted alkyl group" in the term "substituted" means substituted with one or more non-interfering substituents of moiety (e.g. an alkyl group), a substituted group such as (but not limited to) C 3 -C 8 cycloalkyl (e.g. cyclopropyl, cyclobutyl and the like), halo (e.g. fluoro, chloro, bromo and iodo), cyano, alkoxy, lower phenyl, Substituted phenyl and its analogs. For substitutions on the phenyl ring, the substituents can be in any orientation (i.e., ortho, in between, or in pairs).
術語"矽氧水凝膠"或"矽氧水凝膠物質"係指包括矽(Si)組份或矽氧組份之特定水凝膠。舉例而言,矽氧水凝膠通常係藉由將含矽物質與習知親水性水凝膠前驅體組合來製備。矽氧水凝膠隱形眼鏡為包含矽氧水凝膠物質之隱形眼鏡,包括矯正視力之隱形眼鏡。矽氧水凝膠隱形眼鏡之特性不同於習知之水凝膠基眼鏡。The term "hydrogenated hydrogel" or "hydroxyl hydrogel material" refers to a specific hydrogel comprising a cerium (Si) component or a cerium component. For example, hydroxyl hydrogels are typically prepared by combining a hydrazine-containing material with a conventional hydrophilic hydrogel precursor. Hydroxyl hydrogel contact lenses are contact lenses comprising a hydroxyl hydrogel material, including contact lenses that correct vision. The characteristics of the helium-hydrogel contact lenses are different from those of the conventional hydrogel-based glasses.
"含矽氧組份"為在單體、大分子單體或預聚物中含有至少一個[-Si-O-Si]鍵聯之組份,其中各矽原子視情況可具有一或多個可相同或不同之有機基團取代基(R1 、R2 )或經取代之有機基團取代基,例如-SiR1 R2 O-。The "oxygen-containing component" is a component containing at least one [-Si-O-Si] linkage in a monomer, a macromonomer or a prepolymer, wherein each of the ruthenium atoms may have one or more as the case may be. The same or different organic group substituents (R 1 , R 2 ) or substituted organic group substituents such as —SiR 1 R 2 O—.
本文所用之術語"鍵聯劑"係指用以鍵聯互連部分之原子或原子集合,諸如聚合物末端及重複單元嵌段。鍵聯劑部分可為水解穩定的或可包括生理學上可水解或可酶促降解之鍵聯。較佳鍵聯劑為水解穩定的。The term "bonding agent" as used herein refers to a collection of atoms or atoms used to bond interconnecting moieties, such as polymer ends and repeating unit blocks. The linker moiety can be hydrolytically stable or can include a linkage that is physiologically hydrolyzable or enzymatically degradable. Preferably, the linking agent is hydrolytically stable.
"可選"或"視情況"意謂隨後所述之事件可能發生或可能不發生,以使得此描述包括事件發生之情況及事件不發生之情況。"Optional" or "as appropriate" means that the events described below may or may not occur, such that the description includes instances in which the event occurred and instances in which the event did not occur.
例如在提及諸如鍵聯劑中具有特定原子長度(例如長度在2至50個原子範圍內)之原子集合時,術語"長度"係基於原子集合之最長鏈中的原子數目,而與取代基無關。舉例而言,由於氫原子為碳上之取代基且在鏈之近似總體長度中不考慮,因此認為-CH2 CH2 -具有兩個碳原子之長度,即使各亞甲基自身含有總共三個原子。類似地,認為鍵聯劑-O-C(O)-CH2 CH2 C(O)NH-具有由下劃線指示之6個原子的鏈長度。For example, when referring to a collection of atoms having a specific atomic length (eg, ranging from 2 to 50 atoms in length) in a linking agent, the term "length" is based on the number of atoms in the longest chain of the set of atoms, and the substituents. Nothing. For example, since a hydrogen atom is a substituent on carbon and is not considered in the approximate overall length of the chain, it is considered that -CH 2 CH 2 - has a length of two carbon atoms, even if each methylene group itself contains a total of three atom. Similarly, the linking agent -O-C(O)-CH 2 CH 2 C(O)NH- is considered to have a chain length of 6 atoms indicated by underlining.
在本發明聚合物之情形下的"分子質量"係指聚合物之標稱平均分子質量,通常藉由尺寸排阻層析法、光散射技術或在1,2,4-三氯苯中之內在速度測定法來測定。在聚合物情形下之分子量可表述為數量平均分子量或重量平均分子量,且在廠商供應之物質的情況下,將視供應商而定。若並非以封裝物質形式提供,則任何該等分子量測定之基礎均可易於由供應商提供。通常本文提及之大分子單體或聚合物之分子量在本文中係指重量平均分子量。數量平均分子量及重量平均分子量之分子量測定均可使用凝膠滲透層析技術或其他液相層析技術來量測。亦可使用其他量測分子量值之方法,諸如使用端基分析或量測依數性(例如凝固點下降、沸點升高或滲透壓)來測定數量平均分子量,或使用光散射技術、超速離心法或黏度測定法來測定重量平均分子量。"Molecular mass" in the context of a polymer of the invention means the nominal average molecular mass of the polymer, usually by size exclusion chromatography, light scattering techniques or in 1,2,4-trichlorobenzene. The internal velocity measurement method was used for measurement. The molecular weight in the case of a polymer can be expressed as a number average molecular weight or a weight average molecular weight, and in the case of a material supplied by a manufacturer, it will depend on the supplier. The basis for any such molecular weight determination can be readily provided by the supplier if not provided in the form of an encapsulating material. Generally, the molecular weight of a macromonomer or polymer referred to herein is referred to herein as a weight average molecular weight. The molecular weight determination of the number average molecular weight and the weight average molecular weight can be measured using gel permeation chromatography or other liquid chromatography techniques. Other methods of measuring molecular weight values may also be used, such as using end group analysis or measuring dependencies (eg, freezing point drop, boiling point increase, or osmotic pressure) to determine the number average molecular weight, or using light scattering techniques, ultracentrifugation, or Viscosity measurement to determine the weight average molecular weight.
親水性聚合物之"網路"或"基質"通常意謂在聚合物鏈之間由共價鍵或物理鍵(例如氫鍵)形成之交聯。The "network" or "matrix" of a hydrophilic polymer generally means a crosslink formed between covalent bonds or physical bonds (e.g., hydrogen bonds) between polymer chains.
"非干擾性取代基"為存在於分子中時通常與同一分子中所含之其他官能基不反應之彼等基團。"Non-interfering substituents" are those groups which, when present in a molecule, generally do not react with other functional groups contained in the same molecule.
"親水性"物質為喜水性物質。該等化合物對水具有親和力且常帶電或具有吸引水之極性側鏈基團。"Hydrophilic" substances are hi-water substances. The compounds have an affinity for water and are often charged or have polar side chain groups that attract water.
本發明之"親水性聚合物"定義為能夠在水中膨脹但無需在水中可溶之聚合物。The "hydrophilic polymer" of the present invention is defined as a polymer which is capable of swelling in water but does not need to be soluble in water.
"親水性組份"為可為或可不為聚合物之親水性物質。親水性組份包括在與剩餘反應性組份組合時能夠對所得水合眼鏡提供至少約20%(例如至少約25%)之水含量的彼等親水性組份。The "hydrophilic component" is a hydrophilic substance which may or may not be a polymer. The hydrophilic component comprises those hydrophilic components capable of providing at least about 20% (e.g., at least about 25%) water content to the resulting hydrated spectacles when combined with the remaining reactive components.
如本文所用之"眼睛上相容之矽氧水凝膠隱形眼鏡"係指可配戴於人眼上而人不經歷或報導實質性不適(包括眼睛刺激及類似不適)的矽氧水凝膠隱形眼鏡。眼睛上相容之矽氧水凝膠隱形眼鏡具有眼用可接受之表面可濕性,且通常不引起顯著角膜腫脹、角膜脫水("乾眼病")、上方角膜上皮弓狀病變("SEAL")或其他顯著不適或與該等病狀不相關。As used herein, "a compatible oxygenated hydrogel contact lens" refers to a hydroxyl hydrogel that can be worn on the human eye without human experience or substantial discomfort (including eye irritation and similar discomfort). Contact lenses. Eye-compatible, oxygenated hydrogel contact lenses have an ophthalmically acceptable surface wettability and generally do not cause significant corneal swelling, corneal dehydration ("dry eye"), or superior corneal epithelial arch lesion ("SEAL") Or other significant discomfort or unrelated to these conditions.
"實質上"或"基本上"或"約"意謂幾乎全部或完全,例如某一給定量之95%或95%以上。"Substantially" or "substantially" or "about" means almost all or completely, such as 95% or more of a given amount.
"烷基"係指長度通常在約1至20個原子範圍內之烴鏈。該等烴鏈較佳但並非必需飽和,且雖然通常直鏈較佳,但可為支鏈或直鏈。例示性烷基包括甲基、乙基、丙基、丁基、戊基、1-甲基丁基、1-乙基丙基、3-甲基戊基及類似烷基。當提及三個或三個以上碳原子時,如本文所用之"烷基"包括環烷基。"Alkyl" means a hydrocarbon chain generally having a length in the range of from about 1 to 20 atoms. The hydrocarbon chains are preferably, but not necessarily, saturated, and although generally straight chain is preferred, they may be branched or straight chain. Exemplary alkyl groups include methyl, ethyl, propyl, butyl, pentyl, 1-methylbutyl, 1-ethylpropyl, 3-methylpentyl, and the like. When referring to three or more carbon atoms, "alkyl" as used herein includes cycloalkyl.
"寡聚物"為由有限數目之單體亞單元組成之分子,且通常由約2至約8個單體亞單元組成。An "oligomer" is a molecule composed of a limited number of monomeric subunits and typically consists of from about 2 to about 8 monomeric subunits.
"低碳烷基"係指含有1至6個碳原子之烷基,且可為直鏈或支鏈,例如甲基、乙基、正丁基、異丁基、第三丁基。"Lower alkyl" means an alkyl group having from 1 to 6 carbon atoms and may be straight or branched, such as methyl, ethyl, n-butyl, isobutyl, tert-butyl.
認為如本文所用之特定批次聚氧化烯矽氧(例如矽油)之"效能"為其在給定濃度(且所有其他因數均相同)下提供具有所用隱形眼鏡模具直徑0.98至1.02倍範圍內之直徑的最終經萃取水合眼鏡產物之能力。最終眼鏡產物之眼鏡直徑減小愈大,則聚氧化烯矽氧之"效能"愈大。It is believed that the "potency" of a particular batch of polyoxyalkylene oxime (e.g., eucalyptus) as used herein provides a range of from 0.98 to 1.02 times the diameter of the contact lens mold used at a given concentration (and all other factors being the same). The ability of the final diameter to extract the hydrated lens product. The greater the reduction in the diameter of the final lens product, the greater the "efficiency" of the polyoxyalkylene.
如本文所用之術語"膨脹係數"係指水合矽氧水凝膠隱形眼鏡之外徑與用以形成隱形眼鏡模具之眼鏡形成表面的一部分隱形眼鏡模具插入物之外徑的比率。因此,當隱形眼鏡模具插入物具有14.2 mm之外徑且水合矽氧水凝膠隱形眼鏡具有14.2 mm之外徑時,隱形眼鏡之膨脹係數為1.00。The term "expansion coefficient" as used herein refers to the ratio of the outer diameter of a hydrated hydrogel hydrogel contact lens to the outer diameter of a portion of a contact lens mold insert used to form the lens forming surface of a contact lens mold. Thus, when the contact lens mold insert has an outer diameter of 14.2 mm and the hydrated hydrogenated hydrogel contact lens has an outer diameter of 14.2 mm, the coefficient of expansion of the contact lens is 1.00.
其他定義亦可見於以下部分中。Other definitions can also be found in the following sections.
如先前所論述,本文提供之本發明至少部分基於以下發現,即:可使用避免與極性樹脂模具相關之問題、避免對複雜且昂貴之聚合後程序之需要且解決與聚合濕潤劑IPN相關之問題的方法來製備眼睛上相容之矽氧水凝膠隱形眼鏡。令人驚奇地,已發現藉由將特定組份併入用以製造矽氧水凝膠隱形眼鏡之調配物中且接著自所得經模製之隱形眼鏡產物移除相同組份(與其他未反應之組份一起),藉此可產生眼睛上相容之隱形眼鏡產物。As previously discussed, the invention provided herein is based, at least in part, on the use of avoiding problems associated with polar resin molds, avoiding the need for complex and expensive post-polymerization procedures, and addressing issues associated with polymeric wetting agent IPNs. The method to prepare a compatible oxygenated hydrogel contact lens on the eye. Surprisingly, it has been found that by incorporating a particular component into a formulation for making a silicone hydrogel contact lens and then removing the same component from the resulting molded contact lens product (unreacted with the other components) The components are combined together to produce a compatible contact lens product on the eye.
特定言之,本發明者已發現一種藉由將相對大量之一或多種可移除物質併入可聚合矽氧隱形眼鏡前驅體組合物中來提供眼睛上相容之矽氧水凝膠隱形眼鏡的方法。雖然該等物質賦予所得最終隱形眼鏡產物所需之特徵,但其實際上係(例如)藉由萃取自其中移除以提供經萃取之隱形眼鏡產物,其接著經水合以產生具有眼用可接受之表面可濕性以及如本文所述之其他有益特徵之最終矽氧水凝膠隱形眼鏡產物。In particular, the inventors have discovered an eye-compatible oxygenated hydrogel contact lens by incorporating a relatively large amount of one or more removable materials into a polymerizable silicone contact lens precursor composition. Methods. While such materials impart the desired characteristics to the resulting final contact lens product, they are in fact removed, for example, by extraction to provide an extracted contact lens product, which is then hydrated to produce an ophthalmically acceptable The final hemohydrogel contact lens product of surface wettability and other beneficial characteristics as described herein.
在一相關態樣中,本文提供一種改良用於矽氧水凝膠隱形眼鏡製備中之二甲基矽氧烷-氧化乙烯嵌段共聚物效能的方法,其中該方法包含將約0.1重量%至約10重量%之烯丙氧基乙醇添加至二甲基矽氧烷-氧化乙烯嵌段共聚物中以提供用於製備矽氧水凝膠隱形眼鏡產物之烯丙氧基乙醇-二甲基矽氧烷氧化乙烯嵌段共聚物。已有利地發現,例如在與可聚合隱形眼鏡前驅體組合物之其他組份混合之前向二甲基矽氧烷-氧化乙烯嵌段共聚物中添加烯丙氧基乙醇有效使得自使用特定批次或貨號或類似之二甲基矽氧烷-氧化乙烯嵌段共聚物或其類似物所得之任何潛在不利作用"正規化",以藉此提供對一或多種眼鏡尺寸或各種物理特性變化具有可接受之耐受性的最終眼鏡產物。In a related aspect, there is provided a method of improving the efficacy of a dimethyloxane-ethylene oxide block copolymer for use in the preparation of a hydrogel contact lens, wherein the method comprises about 0.1% by weight to About 10% by weight of allyloxyethanol is added to the dimethyloxane-ethylene oxide block copolymer to provide allyloxyethanol-dimethylhydrazine for the preparation of the hydroxyl hydrogel contact lens product. Oxyalkylene oxide block copolymer. It has been advantageously found that the addition of allyloxyethanol to the dimethyloxane-ethylene oxide block copolymer is effective, for example, prior to mixing with the other components of the polymerizable contact lens precursor composition. Or any of the potential adverse effects of the article number or similar dimethyloxane-ethylene oxide block copolymer or analog thereof to "normalize" to thereby provide for one or more eyeglass sizes or variations in various physical properties. Accept the tolerated final lens product.
在以下部分詳細描述且例示本發明之此等及其他重要態樣。These and other important aspects of the invention are described and illustrated in detail in the following section.
本發明之矽氧水凝膠隱形眼鏡通常自本文稱為"可聚合矽氧水凝膠隱形眼鏡前驅體組合物"或"前驅體組合物"之物質而產生。前驅體組合物為用以製備矽氧水凝膠隱形眼鏡之各種試劑的混合物,亦即在反應(在本發明之狀況下為聚合反應)前之反應混合物。The hydroxyl hydrogel contact lenses of the present invention are typically produced from materials referred to herein as "polymerizable silicone hydrogel contact lens precursor compositions" or "precursor compositions." The precursor composition is a mixture of various reagents used to prepare the hydroxyl hydrogel contact lenses, i.e., the reaction mixture prior to the reaction (in the case of the present invention, polymerization).
本發明之前驅體組合物通常包含至少以下組份:(i)至少約25重量%之反應性含氟二甲基丙烯醯基矽氧大分子單體,且較佳約25重量%至約35重量%之該反應性含氟二甲基丙烯醯基矽氧大分子單體,(ii)至少約45重量%之不含矽之單體組合物,及(iii)聚氧化烯矽氧可萃取組份。不含矽之單體組合物包括親水性含乙烯基單體、丙烯酸系單體及丙烯酸酯官能化之氧化乙烯寡聚物。The precursor compositions of the present invention typically comprise at least the following components: (i) at least about 25% by weight of a reactive fluorine-containing dimethyl propylene fluorenyloxy macromonomer, and preferably from about 25% to about 35. % by weight of the reactive fluorine-containing dimethyl propylene fluorenyl siloxane macromonomer, (ii) at least about 45% by weight of a ruthenium-free monomer composition, and (iii) a polyoxyalkylene oxime extractable Component. The ruthenium-free monomer composition includes a hydrophilic vinyl-containing monomer, an acrylic monomer, and an acrylate-functionalized ethylene oxide oligomer.
如上所述,自包含反應性含氟丙烯醯基矽氧大分子單體之前驅體組合物製備本發明之矽氧隱形眼鏡。雖然並非必需,但大分子單體通常表示為矽氧烷嵌段共聚物或三嵌段聚合物,亦即由兩個或三個不同之矽氧烷聚合物“嵌段”或區段組成且在線性大分子單體之一個末端具有至少一個反應性丙烯醯基且較佳在兩末端均具有反應性丙烯醯基的大分子單體。As described above, the oxime contact lenses of the present invention are prepared from a precursor composition comprising a reactive fluoropropenyl fluorenyloxy macromonomer. Although not required, macromonomers are generally referred to as a oxoxane block copolymer or a triblock polymer, ie consisting of two or three different helium oxide polymer "blocks" or segments and A macromonomer having at least one reactive acrylonitrile group at one end of the linear macromonomer and preferably having a reactive acryl oxime group at both ends.
用於本發明之含氟矽氧大分子單體通常具有至少一個氟取代基。氟取代基較佳存在於嵌段聚合物之重複單元之一者上,以使得總體大分子單體具有一個以上氟原子。較佳之含氟大分子單體為具有約1重量%至約10重量%之氟且較佳具有約1重量%至約5重量%之氟的彼等大分子單體。The fluorine-containing fluorenyloxy macromonomer used in the present invention usually has at least one fluorine substituent. The fluorine substituent is preferably present on one of the repeating units of the block polymer such that the overall macromonomer has more than one fluorine atom. Preferred fluorine-containing macromonomers are those macromonomers having from about 1% to about 10% by weight fluorine and preferably from about 1% to about 5% by weight fluorine.
一般而言,共聚物或三嵌段聚合物之嵌段之至少一者具有重複單元-[Si(CH3 )2 O]-,而至少一個其他嵌段包含矽原子,其具有含氟取代基、較佳具有氟烷基取代基、最佳其中烷基為低碳烷基。在大分子單體為三嵌段聚合物之情況下,較佳一個嵌段具有重複單元-[Si(CH3 )2 O]-,第二嵌段為其中矽原子具有氟烷基取代基之嵌段,最佳其中烷基為低碳烷基,且第三嵌段具有經包含親水性組份(例如短聚乙二醇(PEG)鏈(CH2 CH2 O)p )之烷基取代之矽原子。以上提及之第三嵌段較佳包含經共價連接至聚乙二醇之伸烷基鍵聯劑取代之矽原子,其中PEG視情況經封端基團(諸如低碳烷基或苯甲基)封端且伸烷基鍵聯劑部分最接近矽原子。聚乙二醇區段通常具有約1至約25個亞單元,且更佳約2至約12個亞單元。PEG區段最佳具有約4至約10個亞單元。以上提及之三個矽氧烷嵌段可呈任何次序。In general, at least one of the blocks of the copolymer or triblock polymer has a repeating unit -[Si(CH 3 ) 2 O]-, and at least one other block comprises a halogen atom having a fluorine-containing substituent Preferably, the fluoroalkyl substituent is preferred, and wherein the alkyl group is a lower alkyl group. In the case where the macromonomer is a triblock polymer, preferably one block has a repeating unit -[Si(CH 3 ) 2 O]-, and the second block is wherein the germanium atom has a fluoroalkyl substituent. a block, preferably wherein the alkyl group is a lower alkyl group, and the third block has an alkyl group substituted with a hydrophilic component (eg, a short polyethylene glycol (PEG) chain (CH 2 CH 2 O) p ) After the atom. The third block mentioned above preferably comprises a ruthenium atom substituted with an alkylene linkage agent covalently bonded to polyethylene glycol, wherein the PEG is optionally blocked (such as a lower alkyl group or a benzene group) The base and the alkyl linker moiety are closest to the ruthenium atom. The polyethylene glycol segment typically has from about 1 to about 25 subunits, and more preferably from about 2 to about 12 subunits. The PEG segment preferably has from about 4 to about 10 subunits. The three oxoxane blocks mentioned above may be in any order.
上文之例示性矽氧大分子單體描述於美國專利第6,867,245號及國際專利公開案第WO 2006/026474號中,該兩專利之內容均以引用的方式併入本文中。其中所述之任一或多個矽大分子單體適用於本發明之組合物及隱形眼鏡中,且尤其是彼等含有(-SiO-)嵌段之矽大分子單體,其中矽原子具有一取代基,該取代基為經一或多個氟原子取代之伸烷基或其他烴鏈。The above-described exemplary oxime macromonomers are described in U.S. Patent No. 6,867, 245, the disclosure of which is incorporated herein by reference. Any one or more of the macromonomers described therein are suitable for use in the compositions and contact lenses of the present invention, and especially those having a (-SiO-) block, wherein the germanium atoms have A substituent which is an alkyl or other hydrocarbon chain substituted with one or more fluorine atoms.
舉例而言,代表性矽氧大分子單體包含以下三嵌段之重複單元:
在提及含氟丙烯醯基矽氧大分子單體時,大分子單體之Si-O-Si部分通常佔矽氧大分子單體組份之總分子量的約大於20重量%,例如大於30重量%。本發明之矽氧大分子單體包含丙烯醯基,且較佳具有兩個丙烯醯基,即每一末端一個,其中丙烯醯基部分之一或多個烯烴碳視情況經有機基團(諸如烷基)取代。When referring to a fluoropropenyl fluorenyloxy macromonomer, the Si-O-Si portion of the macromonomer typically comprises greater than about 20% by weight of the total molecular weight of the oxime macromonomer component, for example greater than 30. weight%. The oxime macromonomer of the present invention comprises an acrylonitrile group, and preferably has two propylene fluorenyl groups, that is, one at each end, wherein one or more olefin carbons of the propylene sulfhydryl moiety are optionally organic groups (such as Alkyl) substitution.
丙烯醯基部分為衍生自丙烯酸之部分,例如,其中在丙烯酸中,R7 、R8 及R9 各自為H。然而,根據本發明,丙烯醯基部分為其中在以上結構中R9 為H或烷基,較佳為低碳烷基,且R7 及R8 各自獨立地為H、烷基或羧基者,但其限制條件為R7 或R8 中僅一者可為羧基。W為氧或氮。在W為氮之情況下,相應丙烯醯基部分稱為丙烯醯胺。在一較佳實施例中,R7 及R8 各自為氫,且R9 為低碳烷基,例如甲基、乙基或丙基。R9 較佳為甲基,且以上提及之丙烯醯基部分係存在於線性大分子單體之兩末端上。在大分子單體所含之各丙烯醯基中,R7 、R8 及R9 之值係獨立的。亦即,對具有一個以上丙烯醯基之大分子單體而言,各丙烯醯基部分之R7 、R8 及R9 之值係經獨立選擇。然而,在一較佳實施例中,各丙烯醯基中各R7 、R8 及R9 之值相同,因而大分子單體被視為均雙官能基者-意謂末端之反應性基團相同。在末端之反應性基團不相同之情況下,該等大分子單體被視為雜雙官能基者。可存在於矽氧大分子單體末端上之說明性丙烯醯基可聚合官能基包括甲基丙烯酸酯基、丙烯醯胺基及甲基丙烯醯胺基。The acryl thiol moiety is a moiety derived from acrylic acid, for example Wherein in the acrylic acid, each of R 7 , R 8 and R 9 is H. However, according to the present invention, the fluorenyl moiety is wherein R 9 is H or an alkyl group, preferably a lower alkyl group, and R 7 and R 8 are each independently H, an alkyl group or a carboxyl group, However, it is limited that only one of R 7 or R 8 may be a carboxyl group. W is oxygen or nitrogen. In the case where W is nitrogen, the corresponding propylene sulfhydryl moiety is referred to as acrylamide. In a preferred embodiment, R 7 and R 8 are each hydrogen and R 9 is a lower alkyl group such as methyl, ethyl or propyl. R 9 is preferably a methyl group, and the above-mentioned acryl-based moiety is present on both ends of the linear macromonomer. In the respective acrylonitrile groups contained in the macromonomer, the values of R 7 , R 8 and R 9 are independent. That is, for a macromonomer having one or more acrylonitrile groups, the values of R 7 , R 8 and R 9 of each propylene fluorenyl moiety are independently selected. However, in a preferred embodiment, the values of each of R 7 , R 8 and R 9 in each propylene fluorenyl group are the same, and thus the macromonomer is considered to be a homobifunctional group - meaning a terminal reactive group the same. Where the reactive groups at the ends are different, the macromonomers are considered to be heterobifunctional. Illustrative acryl-based polymerizable functional groups that may be present at the end of the oxime macromonomer include methacrylate groups, acrylamide groups, and methacrylamide groups.
合適之含矽氧單體的其他實例為聚矽氧烷基烷基(甲基)丙烯酸單體,其包括(但不限於)經氟取代之甲基丙烯醯氧基丙基參(三甲基矽烷氧基)矽烷、甲基丙烯酸五甲基二矽氧烷基甲酯及甲基二(三甲基矽烷氧基)甲基丙烯醯氧基甲基矽烷。Other examples of suitable oxo-containing monomers are polydecyloxyalkyl (meth) acrylate monomers including, but not limited to, fluoro-substituted methacryloxypropyl propyl (trimethyl)矽 alkoxy) decane, pentamethyldimethoxymethyl methacrylate and methyl bis(trimethyldecyloxy)methacryloxymethyl decane.
一類適用之含矽氧組份為聚(有機矽氧烷)預聚物,諸如經氟取代之α,-雙甲基丙烯醯氧基-丙基聚二甲基矽氧烷。另一實例為經氟取代之mPDMS(經單甲基丙烯醯氧基丙基封端之單正丁基封端之聚二甲基矽氧烷)。One type of suitable helium-containing component is a poly(organosiloxane) prepolymer, such as a fluorine-substituted alpha, - bis methacryloxy-propyl polydimethyl decane. Another example is a fluorine-substituted mPDMS (mono-n-butyl-terminated polydimethyloxane terminated with monomethacryloxypropyl).
大分子單體之矽氧烷聚合物部分(亦即一或多個矽氧烷聚合物嵌段)通常藉由插入鍵聯劑鍵聯至丙烯醯基末端。各鍵聯劑通常具有約4個原子至約20個原子之長度,其中說明性鍵聯劑可包括以下之一或多者:-O-C(O)-、-C(O)-O-、-C(O)-NH-、-O-C(O)-NH-、-C(O)-O-(CH2 )a 、-C(O)-O-(CH2 )a NH-C(O)(O)-(CH2 )b -O-(CH2 )c -、-O-C(O)-O-(CH2 )a -、-O-C(O)-O-(CH2 )a NH-C(O)(O)-(CH2 )b 及其類似物,其中a、b及c各自獨立地在1至約10之範圍內。亦即,a、b及c各自獨立地選自1、2、3、4、5、6、7、8、9及10。鍵聯劑較佳為直鏈而非支鏈,且視情況含有一或多個雜原子O或N。因此,除包含一或多個伸烷基鏈區段以外,鍵聯劑視情況可含有一或多個選自(例如)羧基、醯胺基、胺基甲酸酯基及碳酸酯基之官能基。The hafnoxy polymer portion of the macromonomer (i.e., one or more of the decane polymer blocks) is typically bonded to the end of the acrylonitrile group by the insertion of a linking agent. Each of the linking agents typically has a length of from about 4 atoms to about 20 atoms, wherein the illustrative linking agent can include one or more of the following: -O-C(O)-, -C(O)-O- , -C(O)-NH-, -O-C(O)-NH-, -C(O)-O-(CH 2 ) a , -C(O)-O-(CH 2 ) a NH- C(O)(O)-(CH 2 ) b -O-(CH 2 ) c -, -O-C(O)-O-(CH 2 ) a -, -O-C(O)-O- (CH 2 ) a NH-C(O)(O)-(CH 2 ) b and analogs thereof, wherein a, b and c are each independently in the range of from 1 to about 10. That is, a, b, and c are each independently selected from 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10. The linking agent is preferably a straight chain rather than a branched chain, and optionally contains one or more heteroatoms O or N. Thus, in addition to comprising one or more alkylene chain segments, the linking agent may optionally contain one or more functionalities selected from, for example, a carboxyl group, a guanylamino group, a urethane group, and a carbonate group. base.
矽氧大分子單體組份之分子量通常在約8,000道爾頓(dalton)至約25,000道爾頓之範圍內,且較佳在約10,000道爾頓至約20,000道爾頓之範圍內。一種用於本發明之尤其較佳矽氧烷大分子單體具有約16,000道爾頓之分子量。The molecular weight of the oxime macromonomer component is typically in the range of from about 8,000 daltons to about 25,000 daltons, and preferably in the range of from about 10,000 daltons to about 20,000 daltons. A particularly preferred oxoxane macromer for use in the present invention has a molecular weight of about 16,000 Daltons.
一類尤其較佳之矽氧烷大分子單體為具有以下通式之三嵌段聚合物:
本文所提供之可聚合矽氧水凝膠前驅體組合物通常含有至少約20重量%之含氟丙烯醯基矽氧大分子單體,且較佳含有至少約25重量%之含氟丙烯醯基矽氧大分子單體。本發明之組合物較佳含有約25重量%至約40重量%之含氟丙烯醯基矽氧大分子單體,且更佳含有約25重量%至約35重量%之大分子單體。The polymerizable hydroxyl hydrogel precursor compositions provided herein typically comprise at least about 20% by weight of a fluoropropenyl fluorene macromonomer, and preferably at least about 25% by weight of a fluoropropenyl group. Oxygen macromonomer. The compositions of the present invention preferably comprise from about 25% to about 40% by weight of the fluoropropenylhydrazine macromonomer, and more preferably from about 25% to about 35% by weight of the macromonomer.
除矽氧大分子單體以外,本發明之眼鏡、眼鏡產物及組合物進一步包括由大量添加劑組成之無矽單體組份或組合物。不含矽之單體組合物通常包含一種以上親水性化合物。親水性組份包括在與其他前驅體調配物組份組合時能夠對所得水合眼鏡提供至少約20%(或甚至至少約25%)水含量之彼等組份。以各前驅體組合物組份之分子量計,無矽之單體組合物(意謂組成單體組合物之各化合物)一般組成至少約45重量%之眼鏡前驅體組合物。無矽之單體組合物較佳佔前驅體組合物之約45重量%至55重量%。本發明之無矽單體組合物排除含有一或多個矽原子之親水性化合物。因此,本發明之單體組合物在本文中稱為"不含矽之組合物"。In addition to the oxime macromonomer, the spectacles, lens products and compositions of the present invention further comprise a ruthenium free monomer component or composition comprised of a plurality of additives. The monomer composition containing no antimony usually contains more than one hydrophilic compound. The hydrophilic component comprises those components capable of providing at least about 20% (or even at least about 25%) water content to the resulting hydrated eyeglass when combined with other precursor formulation components. The fluorene-free monomer composition (meaning each compound constituting the monomer composition) generally constitutes at least about 45% by weight of the lens precursor composition, based on the molecular weight of each precursor composition component. The inert monomer composition preferably comprises from about 45% to about 55% by weight of the precursor composition. The flawless monomer composition of the present invention excludes a hydrophilic compound containing one or more deuterium atoms. Thus, the monomer composition of the present invention is referred to herein as "the composition containing no antimony".
可包括在無矽之單體組合物中之單體通常具有至少一個可聚合之雙鍵及至少一個親水性官能基。可聚合雙鍵之實例包括丙烯酸、甲基丙烯酸、乙烯基、O-乙烯基乙醯基及N-乙烯基內醯胺、N-乙烯基醯胺基雙鍵及其類似物。該等親水性單體可為但並非必需為交聯劑。認為作為如上所述之丙烯醯基部分之子集,"丙烯酸型"或"含丙烯酸"或含丙烯酸酯之單體為含有丙烯酸基團(CR'H=CRCOW)之單體,其中R為H或CH3 ,R'為H、烷基或羰基,且W為O或N。The monomers which may be included in the inert monomer composition typically have at least one polymerizable double bond and at least one hydrophilic functional group. Examples of the polymerizable double bond include acrylic acid, methacrylic acid, vinyl group, O-vinylacetamyl group and N-vinyl decylamine, N-vinylguanidinyl double bond, and the like. These hydrophilic monomers may be, but are not necessarily, crosslinkers. It is considered that as a subset of the acrylonitrile moiety as described above, the "acrylic" or "acrylic" or acrylate containing monomer is a monomer containing an acrylic group (CR'H=CRCOW), wherein R is H or CH 3 , R' is H, an alkyl group or a carbonyl group, and W is O or N.
本發明之親水性組份一般包含以下各不含矽之組份,其中一或多種組份為親水性的:含親水性乙烯基(CH2 =CH-)之單體、丙烯酸系單體及丙烯酸酯官能化之氧化乙烯(-(OCH2 CH2 )n )寡聚物。The hydrophilic component of the present invention generally comprises the following components which are free of bismuth, wherein one or more of the components are hydrophilic: a monomer containing a hydrophilic vinyl group (CH 2 =CH-), an acrylic monomer and An acrylate functionalized ethylene oxide (-(OCH 2 CH 2 ) n ) oligomer.
說明性丙烯酸系單體包括N,N-二甲基丙烯醯胺(DMA)、丙烯酸2-羥乙酯、甲基丙烯酸甘油酯、2-羥乙基甲基丙烯醯胺、甲基丙烯酸、丙烯酸、甲基丙烯酸甲酯(MMA)及其混合物。Illustrative acrylic monomers include N,N-dimethyl decylamine (DMA), 2-hydroxyethyl acrylate, glyceryl methacrylate, 2-hydroxyethyl methacrylamide, methacrylic acid, acrylic acid Methyl methacrylate (MMA) and mixtures thereof.
如上所述,包括所有個別親水性及非親水性組份之單體組合物包含至少約45重量%之前驅體組合物。因此,組成單體組合物之各組份的重量百分比將在此範圍內變化。單體組合物較佳佔前驅體組合物之約45重量%至約55重量%,且因此,其各組份之重量百分比自前驅體組合物之約0.05重量%至約40重量%或約0.05重量%至約50重量%之間變化,以達到前驅體組合物之所需總重量百分比。丙烯酸系單體組份較佳以佔用以製備矽氧眼鏡產物之前驅體組合物之約7重量%至約20重量%的量存在,且甚至更佳以佔前驅體組合物之約10重量%至約18重量%的量存在。以總前驅體調配物計,丙烯酸系單體之說明性重量百分比包括以下:約10%、11%、12%、13%、14%、15%、16%、17%或18%。As noted above, the monomer composition comprising all of the individual hydrophilic and non-hydrophilic components comprises at least about 45% by weight of the precursor composition. Therefore, the weight percentage of each component constituting the monomer composition will vary within this range. The monomer composition preferably comprises from about 45% to about 55% by weight of the precursor composition, and thus, the weight percent of each component is from about 0.05% to about 40% by weight or about 0.05% of the precursor composition. The change is between % by weight and about 50% by weight to achieve the desired total weight percentage of the precursor composition. The acrylic monomer component is preferably present in an amount of from about 7% by weight to about 20% by weight of the precursor composition of the precursor composition for the preparation of the hydrogen spectacles product, and even more preferably in an amount of about 10% by weight of the precursor composition. It is present in an amount of about 18% by weight. Illustrative weight percentages of acrylic monomers include the following: about 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, or 18%, based on the total precursor formulation.
如上所述,單體組合物亦包含親水性含乙烯基單體。可併入本發明之眼鏡物質中的親水性含乙烯基單體包括以下各物:N-乙烯基內醯胺(例如N-乙烯基吡咯啶酮(NVP))、N-乙烯基-N-甲基乙醯胺(VMA)、N-乙烯基-N-乙基乙醯胺、N-乙烯基-N-乙基甲醯胺、N-乙烯基甲醯胺、胺基甲酸N-2-羥乙基乙烯酯、N-羧基-β-丙胺酸N-乙烯酯。一種尤其較佳之含乙烯基單體為N-乙烯基-N-甲基乙醯胺(VMA)。VMA之結構對應於CH3 C(O)N(CH3 )-CH=CH2 。As stated above, the monomer composition also comprises a hydrophilic vinyl-containing monomer. Hydrophilic vinyl-containing monomers which may be incorporated into the spectacles of the present invention include the following: N-vinyl decylamine (e.g., N-vinylpyrrolidone (NVP)), N-vinyl-N- Methylacetamide (VMA), N-vinyl-N-ethylacetamide, N-vinyl-N-ethylformamide, N-vinylformamide, N-2-carbamate Hydroxyethyl vinyl ester, N-carboxy-β-alanine N-vinyl ester. A particularly preferred vinyl containing monomer is N-vinyl-N-methylacetamide (VMA). The structure of VMA corresponds to CH 3 C(O)N(CH 3 )-CH=CH 2 .
單體組合物之含乙烯基單體組份較佳以佔用以製備矽氧眼鏡產物之前驅體組合物約20重量%至約50重量%範圍內之量存在,且甚至更佳以佔前驅體組合物約25重量%至約42重量%範圍內之量存在。含乙烯基單體之代表性重量包括以下各重量:前驅體組合物之約25重量%、26重量%、27重量%、28重量%、29重量%、30重量%、31重量%、32重量%、33重量%、34重量%、35重量%、36重量%、37重量%、38重量%、39重量%、40重量%、41重量%或42重量%。The vinyl-containing monomer component of the monomer composition is preferably present in an amount ranging from about 20% by weight to about 50% by weight of the precursor composition prior to the preparation of the hydrogen-oxygen glasses product, and even more preferably in the precursor form. The composition is present in an amount ranging from about 25% to about 42% by weight. Representative weights of vinyl-containing monomers include the following weights: about 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32% by weight of the precursor composition %, 33% by weight, 34% by weight, 35% by weight, 36% by weight, 37% by weight, 38% by weight, 39% by weight, 40% by weight, 41% by weight or 42% by weight.
單體組合物額外包含丙烯酸酯官能化之氧化乙烯寡聚物,亦即具有約2至約8個連續氧化乙烯(CH2
CH2
O-)單體亞單元且末端經反應性基團(諸如丙烯酸酯基)官能化之氧化乙烯寡聚物。寡聚物之一或兩端可經丙烯酸酯基官能化。實例包括與一或多莫耳當量之能夠將一或多個反應性丙烯酸酯基引入寡聚物之一或兩個末端的試劑(例如甲基丙烯酸異氰酸酯基乙酯("IEM")、甲基丙烯酸酐、甲基丙烯醯基氯或其類似物)反應以產生在一或兩個末端上具有丙烯酸基之氧化乙烯寡聚物的氧化乙烯寡聚物。代表性寡聚物由以下通式描述:
較佳用於本發明之丙烯酸酯官能化氧化乙烯寡聚物包括寡-氧化乙烯單甲基丙烯酸酯及寡-氧化乙烯二甲基丙烯酸酯。較佳用於本發明之丙烯酸酯官能化氧化乙烯寡聚物為二甲基丙烯酸丙二醇酯。Preferred acrylate functionalized ethylene oxide oligomers for use in the present invention include oligo-ethylene oxide monomethacrylate and oligo-ethylene oxide dimethacrylate. Preferred acrylate functionalized ethylene oxide oligomers for use in the present invention are propylene glycol dimethacrylate.
丙烯酸酯官能化氧化乙烯寡聚物通常以相對小之量存在於前驅體組合物中。舉例而言,寡聚物以約0.05重量%至約10重量%範圍內,較佳約0.075重量%至約5重量%範圍內之量存在於前驅體組合物中。寡聚物組份之代表性量包括以下量:前驅體組合物之約0.1重量%、0.2重量%、0.3重量%、0.4重量%、0.5重量%、0.8重量%、0.9重量%、1重量%、2重量%、3重量%、4重量%或5重量%。The acrylate functionalized ethylene oxide oligomers are typically present in the precursor composition in relatively small amounts. For example, the oligomer is present in the precursor composition in an amount ranging from about 0.05% to about 10% by weight, preferably from about 0.075% to about 5% by weight. Representative amounts of the oligomer component include the following amounts: about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 0.8%, 0.9%, and 1% by weight of the precursor composition. 2% by weight, 3% by weight, 4% by weight or 5% by weight.
如先前所述,本發明之前驅體組合物特別包括聚氧化烯矽氧(PAOS)可移除或可萃取組份。(兩術語"可移除"及"可萃取"在本文中可互換使用,且係指在眼鏡前驅體組合物聚合後移除之組份)。本發明之PAOS可萃取組份表示為聚氧化烯矽氧,其中聚氧化烯可為聚乙二醇、聚丙二醇、乙二醇與丙二醇之共聚物、聚乙二醇與聚丙二醇之三聚物,包括嵌段共聚物及三嵌段聚合物。該等聚氧化烯矽氧在本文中有時可稱為矽油;如本文所用之術語"矽油"旨在涵蓋任何該等聚氧化烯矽氧。As previously stated, the precursor compositions of the present invention specifically include polyoxyalkylene oxide (PAOS) removable or extractable components. (The terms "removable" and "extractable" are used interchangeably herein and refer to a component that is removed after polymerization of the lens precursor composition). The PAOS extractable component of the present invention is represented by polyoxyalkylene oxime, wherein the polyoxyalkylene may be polyethylene glycol, polypropylene glycol, a copolymer of ethylene glycol and propylene glycol, and a terpolymer of polyethylene glycol and polypropylene glycol. Including block copolymers and triblock polymers. Such polyoxyalkylene oxides are sometimes referred to herein as eucalyptus oil; as used herein, the term "anthracene oil" is intended to encompass any such polyoxyalkylene oxime.
一般而言,聚氧化烯矽氧之特徵在於具有聚二甲基矽氧烷(PDMS)主鏈,其中一定百分比之甲基經如上所述之聚烯氧基置換。在一較佳實施例中,聚烯氧基經由間隔基共價連接至矽氧烷主鏈。該等間隔基長度一般為約2至約12個原子,且通常用以便於聚氧化烯鏈與矽氧烷主鏈之連接。例示性間隔基包括伸烷基鏈、經取代之伸烷基鏈、胺基酸及其類似物。較佳間隔基為低碳烷基,諸如乙基、丙基、丁基、戊基、己基等。或者,用於本文之聚氧化烯矽氧可為二甲基矽氧烷氧化乙烯嵌段共聚物,諸如購自Gelest(Morrisville,PA)之彼等。一般而言,本發明之聚氧化烯矽氧將含有至少約25重量%之聚氧化烯,且更通常將含有約30重量%至約90重量%之聚氧化烯。較佳之聚氧化烯矽氧含有約50重量%或50重量%以上之聚氧化烯。說明性聚氧化烯矽氧含有約25%(重量%)聚氧化烯、40重量%、50重量%、60重量%、70重量%、75重量%、80重量%或85重量%之聚氧化烯。一般而言,具有約55重量%或55重量%以上之氧化乙烯的物質為水溶性的。尤其較佳用於本發明者為其中聚氧化烯為聚乙二醇或氧化丙烯-氧化乙烯嵌段共聚物之聚氧化烯矽氧。In general, polyoxyalkylene oxime is characterized by having a polydimethyl methoxy alkane (PDMS) backbone wherein a certain percentage of methyl groups are replaced by a polyalkenyloxy group as described above. In a preferred embodiment, the polyalkenyloxy group is covalently attached to the oxane backbone via a spacer. The spacers are typically from about 2 to about 12 atoms in length and are typically used to facilitate attachment of the polyoxyalkylene chain to the siloxane backbone. Exemplary spacers include an alkyl chain, a substituted alkyl chain, an amino acid, and the like. Preferred spacers are lower alkyl such as ethyl, propyl, butyl, pentyl, hexyl and the like. Alternatively, the polyoxyalkylene oxide used herein may be a dimethyloxane oxyethylene block copolymer such as those available from Gelest (Morrisville, PA). In general, the polyoxyalkylene oxides of the present invention will contain at least about 25% by weight polyoxyalkylene, and more typically will comprise from about 30% to about 90% by weight polyoxyalkylene. Preferably, the polyoxyalkylene oxide contains about 50% by weight or more of the polyoxyalkylene. Illustrative polyoxyalkylene oxime contains about 25% by weight polyoxyalkylene, 40% by weight, 50% by weight, 60% by weight, 70% by weight, 75% by weight, 80% by weight or 85% by weight of polyoxyalkylene. . In general, materials having about 55% by weight or more by weight of ethylene oxide are water soluble. Particularly preferred for use in the present invention are polyoxyalkylene oxides in which the polyoxyalkylene is a polyethylene glycol or a propylene oxide-oxyethylene block copolymer.
例示性聚氧化烯矽氧可自Gelest(PA,USA)獲得。代表性聚氧化烯矽氧包括二甲基矽氧烷(75%氧化乙烯)嵌段共聚物(PDMS-共-PEG);二甲基矽氧烷[65-70%(60%氧化丙烯/40%氧化乙烯)]嵌段共聚物(PDMS-共-PPO-PEG);二甲基矽氧烷(25-30%氧化乙烯)嵌段共聚物(PDMS-共-PEG);二甲基矽氧烷[50-55%(60%氧化丙烯/40%氧化乙烯)]嵌段共聚物(PDMS-共-PPO-PEG);二甲基矽氧烷(50-55%氧化乙烯)嵌段共聚物(PDMS-共-PEG);二甲基矽氧烷(80-85%氧化乙烯)嵌段共聚物(PDMS-共-PPO-PEG)及二甲基矽氧烷(80%氧化乙烯)嵌段共聚物(PDMS-共-PEG)。上述聚氧化烯矽氧分別對應於以下縮寫(Gelest):DBE-712、DBP-732、DBE-224、DBP-534、DBE-621、DBE-821及DBE-814。較佳之聚氧化烯矽氧為二甲基矽氧烷(75%氧化乙烯)嵌段共聚物(DBE-712)。Exemplary polyoxyalkylene oxides are available from Gelest (PA, USA). Representative polyoxyalkylene oxides include dimethyloxane (75% ethylene oxide) block copolymer (PDMS-co-PEG); dimethyloxane [65-70% (60% propylene oxide/40) % ethylene oxide) block copolymer (PDMS-co-PPO-PEG); dimethyloxane (25-30% ethylene oxide) block copolymer (PDMS-co-PEG); dimethyloxoxime Alkane [50-55% (60% propylene oxide / 40% ethylene oxide)] block copolymer (PDMS-co-PPO-PEG); dimethyl methoxy alkane (50-55% ethylene oxide) block copolymer (PDMS-co-PEG); dimethyloxane (80-85% ethylene oxide) block copolymer (PDMS-co-PPO-PEG) and dimethyloxane (80% ethylene oxide) block Copolymer (PDMS-co-PEG). The above polyoxyalkylene oxime corresponds to the following abbreviations (Gelest): DBE-712, DBP-732, DBE-224, DBP-534, DBE-621, DBE-821, and DBE-814. A preferred polyoxyalkylene oxime is dimethyl methoxy alkane (75% ethylene oxide) block copolymer (DBE-712).
雖然PAOS可萃取組份可以任何量存在於前驅體組合物中,但較佳可萃取組份以約2重量%至約30重量%,較佳約10重量%至約30重量%範圍內之量存在。可萃取組份更佳以約10重量%至約28重量%範圍內之量存在。可萃取組份在前驅體組合物中之例示性量包括以下重量%:約10重量%、約12重量%、約15重量%、約20重量%、約25重量%、約29重量%或約30重量%。While the PAOS extractable component can be present in the precursor composition in any amount, it is preferred that the extractable component be present in an amount ranging from about 2% to about 30% by weight, preferably from about 10% to about 30% by weight. presence. The extractable component is preferably present in an amount ranging from about 10% by weight to about 28% by weight. Exemplary amounts of extractable components in the precursor composition include the following weight %: about 10% by weight, about 12% by weight, about 15% by weight, about 20% by weight, about 25% by weight, about 29% by weight or about 30% by weight.
在某些情況下,PAOS可移除組份除包含聚氧化烯矽氧以外,亦包含鏈轉移試劑。鏈轉移試劑為促進自由基物質與非自由基物質之間反應的試劑。用於本發明之例示性鏈轉移試劑包括硫醇、二硫醚、有機鹵化物及烯丙氧基化合物。鏈轉移劑之某些說明性實例包括硫醇,諸如丁硫醇、月桂硫醇、硫代乙醇酸辛酯、乙二醇雙(硫代乙醇酸酯)、1,4-丁二醇雙(硫代丙酸酯)、三羥甲基丙烷參(硫代乙醇酸酯)、三羥甲基丙烷參(β-硫代丙酸酯)、異戊四醇肆(β-硫代丙酸酯)及其類似物;二硫醚,諸如二苯基二硫醚;鹵化物,諸如四氯化碳、四溴化碳、氯仿、二氯苯及其類似物;及烯丙氧基化合物,諸如烯丙氧基醇及其類似物。此等鏈轉移劑可個別使用或以任一前述各物之混合物形式使用。較佳用於本發明者為烯丙氧基化合物,亦即包含一或多個烯丙氧基部分之化合物。In some cases, the PAOS removable component also contains a chain transfer reagent in addition to the polyoxyalkylene oxide. The chain transfer reagent is an agent that promotes a reaction between a radical substance and a non-radical substance. Exemplary chain transfer reagents for use in the present invention include thiols, disulfides, organic halides, and allyloxy compounds. Some illustrative examples of chain transfer agents include mercaptans such as butanol, lauryl mercaptan, octyl thioglycolate, ethylene glycol bis(thioglycolate), 1,4-butanediol bis (sulfur) Propionate), trimethylolpropane ginseng (thioglycolate), trimethylolpropane ginseng (β-thiopropionate), isoprene tetraol (β-thiopropionate) And analogs thereof; disulfides such as diphenyl disulfide; halides such as carbon tetrachloride, carbon tetrabromide, chloroform, dichlorobenzene and the like; and allyloxy compounds such as alkenes Propoxyl alcohol and its analogs. These chain transfer agents can be used individually or in the form of a mixture of any of the foregoing. Preferred for use in the present invention are allyloxy compounds, i.e., compounds containing one or more allyloxy moieties.
包含至少一個烯丙氧基部分之化合物具有以下通用結構:
本發明者已發現,視情況向可萃取組份(諸如本文所述之彼等可萃取組份)中添加鏈轉移試劑有效地提供尺寸及物理特性可變性減少之經萃取水合矽氧隱形眼鏡體。因此,添加鏈轉移劑用以"正規化"或"微調"前驅體眼鏡組合物,以使得所得經萃取水合隱形眼鏡群體通常具有小於20%之任一或多種以下特徵之可變性:平衡水含量、透氧性、靜態接觸角、動態接觸角(前進接觸角或後退接觸角)、滯後、折射率、離子流、模數、拉伸強度及其類似特徵。例如,視眼鏡產物之特定特徵而定,任一或多種前述眼鏡特徵之可變性通常均小於約20%,且較佳小於約10%。在一或多個實施例中,眼鏡直徑、平衡水含量及/或離子流中任一或多者之可變性均為約5%或小於5%,更佳為約3%或小於3%,且甚至更佳為約2%或小於2%。眼鏡群體中眼鏡直徑較佳具有小於約1.5%之可變性。The inventors have discovered that the addition of a chain transfer reagent to an extractable component, such as the extractable components described herein, as appropriate, effectively provides an extracted hydrated xenon contact lens body having reduced size and physical property variability. . Thus, a chain transfer agent is added to "normalize" or "fine tune" the precursor lens composition such that the resulting extracted hydrated contact lens population typically has a variability of less than one or more of the following characteristics: equilibrium water content Oxygen permeability, static contact angle, dynamic contact angle (advancing contact angle or receding contact angle), hysteresis, refractive index, ion current, modulus, tensile strength and the like. For example, depending on the particular characteristics of the lens product, the variability of any one or more of the aforementioned lens features is typically less than about 20%, and preferably less than about 10%. In one or more embodiments, the variability of any one or more of the spectacles diameter, the equilibrium water content, and/or the ion current is about 5% or less, more preferably about 3% or less than 3%. And even more preferably about 2% or less than 2%. The diameter of the lens in the lens population preferably has a variability of less than about 1.5%.
如本文所用之批次或群體係指複數個隱形眼鏡。可瞭解,當隱形眼鏡批次或群體中之隱形眼鏡數量足以提供有意義之標準誤差時,達成經改良之統計學數值。在某些情況下,一批隱形眼鏡係指至少10個隱形眼鏡、至少100個隱形眼鏡、至少1000個隱形眼鏡或更多。A batch or group system as used herein refers to a plurality of contact lenses. It can be appreciated that improved statistical values are achieved when the number of contact lenses in a contact lens lot or population is sufficient to provide a meaningful standard error. In some cases, a batch of contact lenses refers to at least 10 contact lenses, at least 100 contact lenses, at least 1000 contact lenses or more.
因此,在一態樣中,本發明提供一種改良聚氧化烯矽氧效能之方法,該方法係藉由向其中添加約0.1重量%至約10重量%之鏈轉移劑,較佳為烯丙氧基化合物,且更佳為烯丙氧基醇,以提供用於製備矽氧水凝膠隱形眼鏡產物之鏈轉移試劑聚氧化烯矽氧。較佳以約0.1重量%至約6重量%範圍內之量添加鏈轉移劑。認為如本文所用之特定批次聚氧化烯矽氧(例如矽油)之"效能"為其在給定濃度(且所有其他因數均相同)下提供具有隱形眼鏡模具之眼鏡形成表面或隱形眼鏡插入物之模具形成表面之外徑約0.90至約1.10倍(諸如約0.95至約1.05倍)範圍內之外徑的最終經萃取水合眼鏡產物之能力。在至少一實施例中,水合眼鏡產物之外徑為所用隱形眼鏡模具或用以形成該隱形眼鏡模具之模具插入物之外徑的約0.98至1.02倍。最終眼鏡產物之眼鏡直徑減小愈大,則聚氧化烯矽氧之"效能"愈大。雖然最終眼鏡直徑為對於鏈轉移劑提供具有如上所述在臨床可接受範圍內之所需特性之矽氧隱形眼鏡產物之能力的一種量測,但在與前驅體組合物之其他組份混合之前向聚氧化烯矽氧中添加鏈轉移劑額外有效地提供最終隱形眼鏡產物之大量可量測特性的更大一致性(亦即可變性減小)。Accordingly, in one aspect, the present invention provides a method for improving the oxygenation efficiency of a polyoxyalkylene by adding thereto from about 0.1% by weight to about 10% by weight of a chain transfer agent, preferably an allylic oxygen. The base compound, and more preferably the allyloxy alcohol, provides a chain transfer reagent polyoxyalkylene oxide for the preparation of a hydroxyl hydrogel contact lens product. The chain transfer agent is preferably added in an amount ranging from about 0.1% by weight to about 6% by weight. The "potency" of a particular batch of polyoxyalkylene oxide (eg, eucalyptus) as used herein is believed to provide a lens forming surface or contact lens insert with a contact lens mold at a given concentration (and all other factors being the same) The mold forms the ability of the final extracted hydrated lens product having an outer diameter in the range of from about 0.90 to about 1.10 times the outer diameter of the mold, such as from about 0.95 to about 1.05 times. In at least one embodiment, the outer diameter of the hydrated lens product is from about 0.98 to 1.02 times the outer diameter of the contact lens mold used or the mold insert used to form the contact lens mold. The greater the reduction in the diameter of the final lens product, the greater the "efficiency" of the polyoxyalkylene. While the final spectacles diameter is a measure of the ability of the chain transfer agent to provide a oxiranium contact lens product having the desired characteristics within the clinically acceptable range as described above, prior to mixing with the other components of the precursor composition The addition of a chain transfer agent to the polyoxyalkylene oxime additionally provides a greater consistency (i.e., reduced denaturation) of the large amount of measurable characteristics of the final contact lens product.
鏈轉移劑及聚氧化烯矽氧之所得混合物較佳將含有約0.1至約5份鏈轉移劑及約99.9至95份聚氧化烯矽氧。亦即,鏈轉移劑-聚氧化烯矽氧之混合物可含有任一以下例示量之鏈轉移劑:0.1、0.2、0.3、0.4、0.5、0.6、0.7、0.8、0.9、1、1.5、2、2.5、3、3.5、4、4.5或5份,及對應份之聚氧化烯矽氧,例如分別為99.9、99.8、99.7、99.6、99.5、99.4、99.3、99.2、99.1、99、98.5、98、97.5、97、96.5、96、95.5或95。The resulting mixture of chain transfer agent and polyoxyalkylene oxime will preferably contain from about 0.1 to about 5 parts chain transfer agent and from about 99.9 to 95 parts polyoxyalkylene oxime. That is, the chain transfer agent-polyoxyalkylene oxide mixture may contain any of the following exemplary amounts of chain transfer agents: 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.5, 2. 2.5, 3, 3.5, 4, 4.5 or 5 parts, and corresponding parts of polyoxyalkylene oxime, for example, 99.9, 99.8, 99.7, 99.6, 99.5, 99.4, 99.3, 99.2, 99.1, 99, 98.5, 98, 97.5, 97, 96.5, 96, 95.5 or 95.
本發明之眼鏡前驅體組合物亦可包括額外組份,例如紫外線(UV)吸收劑或UV輻射或能量吸收劑及/或著色劑。UV吸收劑可為(例如)在約320-380奈米之UV-A範圍內展示相對高之吸收值,但在約380 nm以上相對透明之強UV吸收劑。實例包括光可聚合之羥基二苯甲酮及光可聚合之苯幷三唑,諸如2-羥基-4-丙烯醯氧基乙氧基二苯甲酮(以CYASORBUV416購自Cytec Industries)、2-羥基-4-(2羥基-3-甲基丙烯醯氧基)丙氧基二苯甲酮及光可聚合之苯幷三唑(以NORBLOC7966購自Noramco)。適用於本發明之其他光可聚合UV吸收劑包括可聚合之烯系不飽和三嗪、水楊酸酯、經芳基取代之丙烯酸酯及其混合物。一般而言,UV吸收劑若存在,則以對應於約0.5重量%之前驅體組合物至約1.5重量%之組合物的量提供。尤其較佳者為包括約0.6重量%至約1.0重量% UV吸收劑之組合物。The lens precursor compositions of the present invention may also include additional components such as ultraviolet (UV) absorbers or UV radiation or energy absorbers and/or colorants. The UV absorber can be a relatively strong UV absorber that exhibits relatively high absorbance values, for example, in the UV-A range of about 320-380 nm, but is relatively transparent above about 380 nm. Examples include photopolymerizable hydroxybenzophenones and photopolymerizable benzotriazoles such as 2-hydroxy-4-propenyloxyethoxybenzophenone (with CYASORB) UV416 from Cytec Industries), 2-hydroxy-4-(2-hydroxy-3-methylpropenyloxy)propoxybenzophenone and photopolymerizable benzotriazole (with NORBLOC) 7966 was purchased from Noramco). Other photopolymerizable UV absorbers suitable for use in the present invention include polymerizable ethylenically unsaturated triazines, salicylates, aryl substituted acrylates, and mixtures thereof. In general, the UV absorber, if present, is provided in an amount corresponding to from about 0.5% by weight of the precursor composition to about 1.5% by weight of the composition. Particularly preferred are compositions comprising from about 0.6% to about 1.0% by weight of the UV absorber.
本發明之前驅體組合物亦可包括著色劑,儘管涵蓋彩色眼鏡產物及透明眼鏡產物。著色劑較佳為對所得眼鏡產物有效提供顏色之反應性染料或顏料。反應性染料為與矽氧水凝膠眼鏡物質鍵結且不滲色之彼等染料。例示性著色劑包括以下各物:苯磺酸、4-(4,5-二氫-4-((2-甲氧基-5-甲基-4-((2-(磺氧基)乙基)磺醯基)苯基)偶氮-3-甲基-5-側氧基-1H-吡唑-1-基);[2-萘磺酸,7-(乙醯胺基)-4-羥基-3-((4-((磺氧基乙基)磺醯基)苯基)偶氮)-];[5-((4,6-二氯-1,3,5-三嗪-2-基)胺基-4-羥基-3-((1-磺基-2-萘基)偶氮-2,7-萘-二磺酸,三鈉鹽];[銅,29H,31H-酞菁基(2-)-N29 ,N30 ,N31 ,N32 )-,磺基((4((2-磺氧基)乙基)磺醯基)苯基)胺基)磺醯基衍生物]及[2,7-萘磺酸,4-胺基-5-羥基-3,6-雙((4-((2-(磺氧基)乙基)磺醯基)苯基)偶氮)-四鈉鹽]。The precursor compositions of the present invention may also include colorants, although encompassing colored eyewear products and clear lens products. The colorant is preferably a reactive dye or pigment that effectively provides color to the resulting lens product. The reactive dyes are dyes that bind to the oxygenated hydrogel lens material and do not bleed. Exemplary colorants include the following: benzenesulfonic acid, 4-(4,5-dihydro-4-((2-methoxy-5-methyl-4-((2-(sulfooxy))) (sulfonyl) phenyl) azo-3-methyl-5-sideoxy-1H-pyrazol-1-yl); [2-naphthalenesulfonic acid, 7-(ethinyl)-4 -hydroxy-3-((4-((sulfoethyl)sulfonyl)phenyl)azo)-];[5-((4,6-dichloro-1,3,5-triazine) -2-yl)amino-4-hydroxy-3-((1-sulfo-2-naphthyl)azo-2,7-naphthalene-disulfonic acid, trisodium salt]; [copper, 29H, 31H - phthalocyanine (2-)-N 29 , N 30 , N 31 , N 32 )-, sulfo ((4((2-sulfooxy)ethyl)sulfonyl)phenyl)amino)sulfonate Mercapto derivatives] and [2,7-naphthalenesulfonic acid, 4-amino-5-hydroxy-3,6-bis((4-((2-(sulfooxy)ethyl)sulfonyl)benzene) Base) azo)-tetrasodium salt].
用於本發明之尤其較佳著色劑為酞菁顏料,諸如酞菁藍及酞菁綠、氧化鉻-氧化鋁-氧化亞鈷、氧化鉻及紅色、黃色、棕色及黑色之各種鐵氧化物。亦可併入堵如二氧化鈦之不透明劑。對於某些應用而言,可採用顏色之混合物以更佳模擬自然虹膜之外觀。Particularly preferred colorants for use in the present invention are phthalocyanine pigments such as phthalocyanine blue and phthalocyanine green, chromium oxide-alumina-cobalt oxide, chromium oxide, and various iron oxides of red, yellow, brown, and black. An opacifier such as titanium dioxide can also be incorporated. For some applications, a mixture of colors can be used to better simulate the appearance of a natural iris.
此外,本發明之前驅體組合物可包含一或多種引發劑化合物,亦即能夠引發前驅體組合物聚合之化合物。較佳為熱引發劑,亦即具有"聚合開始"溫度之引發劑。藉由選擇具有較高開始分解溫度之熱引發劑且使用相對低量之引發劑,可能減少本發明眼鏡之離子流,藉此可影響在萃取步驟移除或萃取之可移除物質的量。舉例而言,用於本發明前驅體組合物中之一種例示性熱引發劑為2,2'-偶氮雙(2,4-二甲基戊腈)(VAZO-52)。VAZO-52具有約50℃之開始分解溫度,其為前驅體組合物中之反應性組份開始聚合之溫度。另一適用於本發明組合物之熱引發劑為偶氮二異丁腈(VAZO-88),其具有約90℃之開始分解溫度。亦合適之引發劑為VAZO-64,2,2'-偶氮二異丁腈。本文所述之所有VASO熱引發劑均可購自DuPont(Wilmington,DE)。額外熱引發劑包括腈類,諸如1,1'-偶氮雙(環己腈)及2,2'-偶氮雙(2-甲基丙腈),以及其他類型之引發劑,諸如可購自SigmaAldrich之彼等引發劑。眼睛上相容之矽氧水凝膠隱形眼鏡可自包含約0.2-0.7份VAZO-52(或約0.1至約0.8重量%)或約0.1份至約0.6份VAZO-88(約0.05至約0.5重量%)之前驅體組合物而獲得。Furthermore, the precursor compositions of the present invention may comprise one or more initiator compounds, i.e., compounds capable of initiating polymerization of the precursor composition. A thermal initiator, that is, an initiator having a "polymerization onset" temperature is preferred. By selecting a thermal initiator having a higher onset decomposition temperature and using a relatively low amount of initiator, it is possible to reduce the ion current of the glasses of the present invention, thereby affecting the amount of removable material removed or extracted in the extraction step. For example, one exemplary thermal initiator used in the precursor compositions of the present invention is 2,2'-azobis(2,4-dimethylvaleronitrile) (VAZO) -52). VAZO -52 has an onset decomposition temperature of about 50 ° C which is the temperature at which the reactive component in the precursor composition begins to polymerize. Another thermal initiator suitable for use in the compositions of the present invention is azobisisobutyronitrile (VAZO). -88) which has an initial decomposition temperature of about 90 °C. Also suitable initiator is VAZO -64,2,2'-azobisisobutyronitrile. All of the VASO thermal initiators described herein are available from DuPont (Wilmington, DE). Additional thermal initiators include nitriles such as 1,1'-azobis(cyclohexanecarbonitrile) and 2,2'-azobis(2-methylpropionitrile), as well as other types of initiators such as commercially available Their initiators from Sigma Aldrich. The ophthalmically compatible oxygenated hydrogel contact lens can comprise from about 0.2 to about 0.7 parts of VAZO-52 (or from about 0.1 to about 0.8% by weight) or from about 0.1 parts to about 0.6 parts of VAZO-88 (from about 0.05 to about 0.5). % by weight) obtained from the precursor composition.
本發明之前驅體組合物亦可包含脫模助劑,亦即有效使得固化隱形眼鏡更易於自其模具中移除之一或多種化合物。例示性脫模助劑包括親水性矽氧、聚氧化烯及其組合。The precursor compositions of the present invention may also comprise a release aid, i.e., effective to render the cured contact lens more susceptible to removal of one or more compounds from its mold. Exemplary release aids include hydrophilic oxime, polyoxyalkylenes, and combinations thereof.
前驅體組合物可額外包含選自由以下各物組成之群之稀釋劑:己醇、乙氧基乙醇、異丙醇(IPA)、丙醇、癸醇及其組合。若使用稀釋劑,則其通常以約10%至約30%(重量比)範圍內之量存在。具有相對較高濃度稀釋劑之組合物傾向於(但並非必需)具有較低離子流值、減少之模數及增加之伸長率以及大於20秒之水BUT。The precursor composition may additionally comprise a diluent selected from the group consisting of hexanol, ethoxyethanol, isopropanol (IPA), propanol, decyl alcohol, and combinations thereof. If a diluent is used, it is usually present in an amount ranging from about 10% to about 30% by weight. Compositions having relatively high concentrations of diluent tend to, but are not required to have, lower ion current values, reduced modulus and increased elongation, and water BUTs greater than 20 seconds.
適用於製備矽氧水凝膠隱形眼鏡之其他物質描述於美國專利第6,867,245號中。Other materials suitable for use in the preparation of hydroxyl hydrogel contact lenses are described in U.S. Patent No. 6,867,245.
本申請案內容中之術語"添加劑"係指在本發明之可聚合矽氧水凝膠隱形眼鏡前驅體組合物或預萃取之聚合矽氧水凝膠隱形眼鏡產物中提供但並非製造矽氧水凝膠隱形眼鏡所必需之化合物或任何化學藥劑。雖然對於製備矽氧水凝膠隱形眼鏡而言可能並非必需,但此決不表明由於本發明之組合物中包括一或多種添加劑而不對前驅體組合物或所得眼鏡產物賦予一或多種優勢。舉例而言,包括可移除之添加劑可(例如)便於在製造隱形眼鏡期間對其進行加工,與在無添加劑之情況下自相同前驅體組合物獲得之矽氧水凝膠隱形眼鏡相比可增強矽氧水凝膠隱形眼鏡之一或多種特性,或其組合。如本文所用之添加劑為可自預萃取之聚合矽氧水凝膠隱形眼鏡產物中移除之添加劑。舉例而言,添加劑實質上可為非反應性的或可不與可聚合矽氧水凝膠眼鏡前驅體組合物之其他組份反應,以使得添加劑實質上不成為所得聚合眼鏡產物之共價結合構成部分。視其分子量及形狀而定,大部分(若非全部)添加劑可自聚合矽氧水凝膠隱形眼鏡產物中萃取。因此,在萃取程序期間,本發明組合物中之添加劑可自聚合矽氧水凝膠隱形眼鏡產物中萃取。因此,亦認為如先前描述為可移除或可萃取組份之聚氧化烯矽氧為如本文所用之"添加劑"。The term "additive" in the context of the present application means that the polymerizable silicone hydrogel contact lens precursor composition or the pre-extracted polymeric hydrogel contact lens product of the present invention is provided but not produced. A compound or any chemical necessary for a gel contact lens. While this may not be necessary for the preparation of a silicone hydrogel contact lens, this in no way indicates that one or more advantages are imparted to the precursor composition or the resulting lens product due to the inclusion of one or more additives in the compositions of the present invention. For example, including a removable additive can, for example, facilitate processing of the contact lens during manufacture, as compared to a hydrogel contact lens obtained from the same precursor composition without additives. One or more characteristics of the enhanced hydrogel contact lens, or a combination thereof. The additive as used herein is an additive that can be removed from the pre-extracted polymeric hydrogel hydrogel contact lens product. For example, the additive may be substantially non-reactive or may not react with other components of the polymerizable silicone hydrogel lens precursor composition such that the additive does not substantially constitute a covalent combination of the resulting polymeric lens product. section. Depending on its molecular weight and shape, most, if not all, of the additives may be extracted from the polymerized hydrogel contact lens product. Thus, the additives in the compositions of the present invention can be extracted from the polymerized hydrogel hydrogel contact lens product during the extraction procedure. Accordingly, it is also believed that the polyoxyalkylene oxide as previously described as a removable or extractable component is an "additive" as used herein.
除PAOS可萃取組份以外,添加劑之實例包括(但不限於)硬脂酸乙二醇酯、單月桂酸二乙二醇酯、C2 -C24 醇及/或C2 -C24 胺。添加劑亦可含有一或多種極性或親水性端基,諸如(但不限於)羥基、胺基、硫氫基、磷酸酯基及羧酸基,以便於添加劑與組合物中所存在之其他物質混溶。In addition to the PAOS extractable component, examples of the additive include, but are not limited to, ethylene glycol stearate, diethylene glycol monolaurate, C 2 -C 24 alcohol, and/or C 2 -C 24 amine. The additive may also contain one or more polar or hydrophilic end groups such as, but not limited to, a hydroxyl group, an amine group, a sulfhydryl group, a phosphate group, and a carboxylic acid group to facilitate mixing of the additive with other materials present in the composition. Dissolved.
添加劑可呈液體或固體形式,且包括疏水性或兩親媒性化合物或藥劑。The additive may be in liquid or solid form and includes a hydrophobic or amphiphilic compound or agent.
在某些實施例中,添加劑可稱為稀釋劑,實質上非反應性劑或可萃取劑。除先前所述之PAOS可萃取組份以外,本發明之前驅體組合物亦可含有醇類或非醇類稀釋劑。若使用該等其他稀釋劑,則其通常以在小於約10%(重量比)之量存在。本發明之組合物中所提供之添加劑可提供任一或多種以下功能,例如其可(i)諸如藉由促進形成均質組合物或未經相分離之組合物而有助於形成可聚合之矽氧水凝膠隱形眼鏡前驅體組合物;(ii)諸如藉由促進含有隱形眼鏡產物之隱形眼鏡模具脫模,及/或促進隱形眼鏡產物自隱形眼鏡模具中脫鏡而增強預萃取之聚合矽氧水凝膠隱形眼鏡產物之可加工性;(iii)諸如藉由減少隱形眼鏡群體中(例如不同批次之隱形眼鏡中)隱形眼鏡物理參數之可變性而改良對隱形眼鏡之物理參數的控制;(iv)諸如藉由增強隱形眼鏡表面之可濕性而增強隱形眼鏡之可濕性;(v)諸如藉由視需要減少模數或增加模數而積極影響隱形眼鏡之模數;且(vi)可諸如藉由與自不包括添加劑之眼鏡產物所獲得之隱形眼鏡相比減少隱形眼鏡之離子流而積極影響隱形眼鏡之離子流。因此,本發明組合物中所提供之添加劑可充當相容劑、脫模助劑、脫鏡助劑、物理參數控制劑、可濕性增強劑、模數影響劑、離子流減少劑或前述任一或多者之組合。In certain embodiments, the additive may be referred to as a diluent, substantially a non-reactive agent or an extractable agent. In addition to the PAOS extractable components previously described, the precursor compositions of the present invention may also contain an alcohol or a non-alcohol diluent. If such other diluents are used, they are typically present in an amount of less than about 10% by weight. The additives provided in the compositions of the present invention may provide any one or more of the following functions, for example, they may (i) contribute to the formation of polymerizable hydrazines, such as by promoting the formation of a homogeneous composition or a composition that is not phase separated. An oxygen hydrogel contact lens precursor composition; (ii) enhancing the pre-extracted polymerization, such as by promoting release of a contact lens mold containing a contact lens product, and/or promoting release of the contact lens product from a contact lens mold. Processability of oxygen hydrogel contact lens products; (iii) improved control of physical parameters of contact lenses, such as by reducing the variability of contact lens physical parameters in a contact lens population (eg, in different batches of contact lenses) (iv) enhancing the wettability of the contact lens, such as by enhancing the wettability of the contact lens surface; (v) actively affecting the modulus of the contact lens, such as by reducing the modulus or increasing the modulus as needed; Vi) The ion current of the contact lens can be positively affected, such as by reducing the ion current of the contact lens, as compared to a contact lens obtained from a lens product that does not include an additive. Accordingly, the additive provided in the composition of the present invention can serve as a compatibilizer, a mold release aid, a mirror release aid, a physical parameter control agent, a wettability enhancer, a modulus influencer, an ion flow reducer, or the foregoing. A combination of one or more.
相容劑可改良或增強本發明前驅體組合物之組份的混溶性。舉例而言,與無相容劑之調配物相比,相容劑可減少與含矽聚合物及其他眼鏡形成組份相關之相分離。The compatibilizing agent can improve or enhance the miscibility of the components of the precursor composition of the present invention. For example, a compatibilizer can reduce phase separation associated with cerium-containing polymers and other spectacles forming components as compared to non-compatibilizing formulations.
添加劑較佳均勻分布於整個聚合組合物中且在萃取程序期間自聚合產物中實質性(若非完全)移除。因此,本發明之隱形眼鏡較佳因各批次之間之小的物理或尺寸可變性而產生,藉此改良臨床上可接受之眼睛上相容之矽氧水凝膠隱形眼鏡的產量。The additive is preferably evenly distributed throughout the polymeric composition and is substantially (if not completely) removed from the polymerization product during the extraction procedure. Thus, the contact lenses of the present invention are preferably produced by small physical or dimensional variability between batches, thereby improving the yield of clinically acceptable ocular oxygen-compatible hydrogel contact lenses.
本發明之例示性前驅體組合物於實例1、3及4中提供。Exemplary precursor compositions of the present invention are provided in Examples 1, 3 and 4.
本發明前驅體組合物之某些實施例包括於非極性樹脂隱形眼鏡模具中所提供之可聚合矽氧水凝膠隱形眼鏡前驅體組合物。其他實施例包括在儲存容器(諸如瓶子及其類似物)中或分配裝置(諸如人工或自動移液裝置)中之該等組合物。Certain embodiments of the precursor compositions of the present invention include polymerizable silicone hydrogel contact lens precursor compositions provided in non-polar resin contact lens molds. Other embodiments include such compositions in storage containers such as bottles and the like, or in dispensing devices such as manual or automatic pipetting devices.
一般而言,在產生矽氧水凝膠隱形眼鏡中,將矽氧水凝膠隱形眼鏡前驅體組合物之組份各自稱重且接著組合。接著通常(例如)使用磁力或機械混合來混合所得前驅體組合物,且視情況過濾以移除微粒。In general, in the production of a helium oxygen hydrogel contact lens, the components of the helium oxygen hydrogel contact lens precursor composition are each weighed and then combined. The resulting precursor composition is then typically mixed, for example, using magnetic or mechanical mixing, and optionally filtered to remove particulates.
本發明之眼鏡可(例如)如圖1中所說明來產生。圖1為說明產生矽氧水凝膠隱形眼鏡之方法的方塊圖。特定言之,圖1說明一種澆鑄成型矽氧水凝膠隱形眼鏡之方法。澆鑄成型隱形眼鏡可自身以適於直接置放於人眼上之形式產生,而無需進一步加工來改質眼鏡而使眼鏡適用於眼睛上。使用諸如圖1所說明之程序的澆鑄成型程序而產生的本發明之矽氧水凝膠隱形眼鏡在本文被認為係"澆鑄成型矽氧水凝膠隱形眼鏡"。若不使用加工來改變使眼鏡產物自模具構件脫鏡後之眼鏡設計,則將本發明之眼鏡理解為"完全成型之矽氧水凝膠隱形眼鏡"。The spectacles of the present invention can be produced, for example, as illustrated in FIG. 1 is a block diagram illustrating a method of producing a helium oxygen hydrogel contact lens. In particular, Figure 1 illustrates a method of casting a hydroxyl hydrogel contact lens. The cast contact lens can itself be produced in a form suitable for direct placement on the human eye without further processing to modify the lens to make the lens suitable for use on the eye. The oxygenated hydrogel contact lenses of the present invention produced using a casting process such as the procedure illustrated in Figure 1 are herein considered to be "cast-formed hydroxyl hydrogel contact lenses." The glasses of the present invention are understood to be "fully formed hydroxyl hydrogel contact lenses" if processing is not used to alter the design of the lens that causes the lens product to be removed from the mold member.
用於產生隱形眼鏡(諸如矽氧水凝膠隱形眼鏡)之說明性方法描述於以下專利中:美國專利第4,121,896號、第4,495,313號、第4,565,348號、第4,640,489號、第4,889,664號、第4,985,186號、第5,039,459號、第5,080,839號、第5,094,609號、第5,260,000號、第5,607,518號、第5,760,100號、第5,850,107號、第5,935,492號、第6,099,852號、第6,367,929號、第6,822,016號、第6,867,245號、第6,869,549號、第6,939,487號及美國專利公開案第20030125498號、第20050154080號及第20050191335號。Illustrative methods for producing contact lenses, such as neohydrogenated hydrogel contact lenses, are described in U.S. Patent Nos. 4,121,896, 4,495,313, 4,565,348, 4,640,489, 4,889,664, 4,985,186. , 5,039,459, 5,080,839, 5,094,609, 5,260,000, 5,607,518, 5,760,100, 5,850,107, 5,935,492, 6,099,852, 6,367,929, 6,822,016, 6,867,245, No. 6,869,549, No. 6,939,487, and U.S. Patent Publication Nos. 20030125498, No. 20050154080, and No. 20050191335.
回到圖1,現簡單描述方塊圖中概述之方法。所說明之方法包括步驟102 ,即:將可聚合矽氧水凝膠眼鏡前驅體組合物(202 ,如圖2中所示)置放於隱形眼鏡模具構件上或內部。可聚合矽氧水凝膠眼鏡前驅體組合物係指適於聚合之預聚合或預固化組合物。如本文所用之本發明之可聚合組合物亦可稱為"單體混合物"或"反應混合物"。在組合物固化或聚合之前,可聚合組合物或眼鏡前驅體組合物較佳未經聚合至任何顯著程度。然而,在某些情況下,可聚合組合物或眼鏡前驅體組合物可在經受固化之前部分聚合。Returning to Figure 1, the method outlined in the block diagram will now be briefly described. The illustrated method includes a step 102 of placing a polymerizable silicone hydrogel lens precursor composition ( 202 , as shown in Figure 2) on or in a contact lens mold member. The polymerizable silicone hydrogel lens precursor composition refers to a prepolymerized or precured composition suitable for polymerization. The polymerizable compositions of the invention as used herein may also be referred to as "monomer mixtures" or "reaction mixtures." The polymerizable composition or lens precursor composition is preferably not polymerized to any significant extent prior to curing or polymerization of the composition. However, in some cases, the polymerizable composition or lens precursor composition can be partially polymerized prior to being subjected to curing.
在固化或聚合程序之前,本發明之眼鏡前驅體組合物可提供於容器、分配裝置或隱形眼鏡模具中。Prior to the curing or polymerization procedure, the lens precursor compositions of the present invention can be provided in a container, dispensing device or contact lens mold.
回到圖1步驟102 ,將眼鏡前驅體組合物置放於凹形隱形眼鏡模具構件之眼鏡形成表面上。凹形隱形眼鏡模具構件一般係指第一隱形眼鏡模具構件或前部隱形眼鏡模具構件。舉例而言,凹形隱形眼鏡模具構件具有眼鏡形成表面,該表面界定自隱形眼鏡模具所產生之隱形眼鏡的前表面。Returning to step 102 of Figure 1, the lens precursor composition is placed on the lens forming surface of the concave contact lens mold member. A concave contact lens mold member generally refers to a first contact lens mold member or a front contact lens mold member. For example, a concave contact lens mold member has a lens forming surface that defines a front surface of a contact lens produced from a contact lens mold.
第一隱形眼鏡模具構件與第二隱形眼鏡模具構件接觸置放以形成具有隱形眼鏡狀空腔之隱形眼鏡模具。因此,圖1中所說明之方法包括步驟104 ,即:藉由將兩隱形眼鏡模具構件彼此接觸置放以形成隱形眼鏡狀空腔來封閉隱形眼鏡模具。可聚合矽氧水凝膠眼鏡前驅體組合物202 位於隱形眼鏡狀空腔中。第二隱形眼鏡模具構件係指凸形隱形眼鏡模具構件或後部隱形眼鏡模具構件。舉例而言,第二隱形眼鏡模具構件包括眼鏡形成表面,該表面界定隱形眼鏡模具中所產生之隱形眼鏡的後表面。The first contact lens mold member is placed in contact with the second contact lens mold member to form a contact lens mold having a contact lens shaped cavity. Thus, the method illustrated in Figure 1 includes the step 104 of closing the contact lens mold by placing the two contact lens mold members in contact with one another to form a contact lens shaped cavity. The polymerizable silicone hydrogel lens precursor composition 202 is located in a contact lens shaped cavity. The second contact lens mold member refers to a convex contact lens mold member or a rear contact lens mold member. For example, the second contact lens mold member includes a lens forming surface that defines a rear surface of the contact lens produced in the contact lens mold.
如本文所用之"非極性樹脂隱形眼鏡模具"或"疏水性樹脂隱形眼鏡模具"係指由非極性或疏水性樹脂形成或產生之隱形眼鏡模具。因此,非極性樹脂基隱形眼鏡模具可包含非極性或疏水性樹脂。舉例而言,該等隱形眼鏡模具可包含一或多種聚烯烴,或可由聚烯烴樹脂物質形成。用於本申請案之情形中的非極性樹脂隱形眼鏡模具之實例包括聚乙烯隱形眼鏡模具、聚丙烯隱形眼鏡模具及聚苯乙烯隱形眼鏡模具。非極性樹脂基隱形眼鏡模具通常具有疏水性表面。舉例而言,如使用俘獲氣泡法所測定,非極性樹脂模具或疏水性樹脂模具可具有約90°或更大之靜態接觸角。在該等接觸角下,該等模具中所產生之習知矽氧水凝膠隱形眼鏡具有臨床上不可接受之表面可濕性。As used herein, "non-polar resin contact lens mold" or "hydrophobic resin contact lens mold" refers to a contact lens mold formed or produced from a non-polar or hydrophobic resin. Thus, the non-polar resin based contact lens mold can comprise a non-polar or hydrophobic resin. For example, the contact lens molds can comprise one or more polyolefins or can be formed from a polyolefin resin material. Examples of non-polar resin contact lens molds used in the context of the present application include polyethylene contact lens molds, polypropylene contact lens molds, and polystyrene contact lens molds. Non-polar resin based contact lens molds typically have a hydrophobic surface. For example, the non-polar resin mold or the hydrophobic resin mold may have a static contact angle of about 90 or more as determined using the trapping bubble method. At these contact angles, conventional oxygenated hydrogel contact lenses produced in such molds have clinically unacceptable surface wettability.
該方法進一步包括固化106 可聚合之矽氧水凝膠眼鏡前驅體組合物以形成預萃取之聚合矽氧水凝膠隱形眼鏡產物204 (如圖2中所示)。在固化期間,可聚合矽氧水凝膠眼鏡前驅體組合物之眼鏡形成組份聚合以形成聚合眼鏡產物。因此,固化亦可理解為聚合步驟。固化106 可包括將可聚合之眼鏡前驅體組合物暴露於輻射,諸如熱輻射或任何其他有效聚合眼鏡前驅體組合物之組份的方式。舉例而言,固化106 可包括將可聚合之眼鏡前驅體組合物暴露於聚合量之熱或紫外(UV)光。固化可視情況在無氧環境中進行。舉例而言,固化可在惰性氣氛下(例如在氮、氬或其他惰性氣體下)進行。The method further includes curing 106 a polymerizable silicone hydrogel lens precursor composition to form a pre-extracted polymeric hemohydrogel contact lens product 204 (as shown in Figure 2). During curing, the lens forming components of the polymerizable silicone hydrogel lens precursor composition are polymerized to form a polymeric lens product. Therefore, curing can also be understood as a polymerization step. Curing 106 can include the manner in which the polymerizable lens precursor composition is exposed to radiation, such as heat radiation or any other component of an effective polymeric lens precursor composition. For example, curing 106 can include exposing the polymerizable lens precursor composition to a polymeric amount of heat or ultraviolet (UV) light. Curing can be carried out in an oxygen-free environment as appropriate. For example, curing can be carried out under an inert atmosphere, such as under nitrogen, argon or other inert gases.
預萃取之聚合矽氧水凝膠隱形眼鏡產物204 係指在經受自聚合產物移除實質上所有可移除/可萃取組份之萃取程序之前的聚合產物。在與萃取組合物接觸之前,預萃取之聚合矽氧水凝膠隱形眼鏡產物可提供於隱形眼鏡模具、萃取盤或其他裝置上或內部。舉例而言,在固化程序之後,預萃取之聚合矽氧水凝膠隱形眼鏡產物可提供於隱形眼鏡模具之眼鏡狀空腔中;在隱形眼鏡模具脫模之後,可提供於一種隱形眼鏡模具構件上或內部;或在脫鏡程序之後且在萃取程序之前,可提供於萃取盤或其他裝置上或內部。預萃取之聚合矽氧水凝膠隱形眼鏡產物包括眼鏡形成組份(諸如呈眼鏡狀之含矽聚合網路或基質)及可自眼鏡形成組份移除之可移除組份。可移除組份除PAOS可萃取組份以外亦包括未反應之單體、寡聚物、部分反應之單體或相對於眼鏡形成組份未共價連接或固定之其他藥劑。可移除組份亦可包括一或多種添加劑,包括有機添加劑,包括稀釋劑,其可如先前論述在萃取程序期間自聚合眼鏡產物萃取。因此,可包含可移除組份之物質不僅包括聚氧化烯矽氧可萃取組份,亦可包括相對於鏡體之聚合物主鏈、網路或基質而言未交聯或固定之可萃取物質的線性未交聯、交聯及/或分枝聚合物。The pre-extracted polymeric hydrogel contact lens product 204 refers to a polymeric product prior to undergoing an extraction procedure that removes substantially all of the removable/extractable components from the polymerization product. The pre-extracted polymeric hemohydrogel contact lens product can be provided on or in a contact lens mold, extraction tray or other device prior to contact with the extraction composition. For example, after the curing process, the pre-extracted polymeric hemohydrogel contact lens product can be provided in the lens-like cavity of the contact lens mold; after the contact lens mold is released, it can be provided in a contact lens mold member. Top or inside; or after the stripping procedure and prior to the extraction procedure, may be provided on or in the extraction tray or other device. The pre-extracted polymeric oxygenated hydrogel contact lens product comprises a lens forming component such as a enamel-containing polymeric network or matrix in the form of a spectacles and a removable component removable from the spectacles forming component. The removable component also includes, in addition to the PAOS extractable component, unreacted monomers, oligomers, partially reacted monomers, or other agents that are not covalently attached or immobilized relative to the lens forming component. The removable component can also include one or more additives, including organic additives, including diluents, which can be extracted from the polymeric lens product during the extraction procedure as previously discussed. Thus, the material which may comprise a removable component includes not only the polyoxyalkylene oxime extractable component, but also an extractable or unremovable extractable relative to the polymer backbone, network or matrix of the lens body. Linear uncrosslinked, crosslinked, and/or branched polymers of the material.
此外,可移除組份可包括其他物質,諸如揮發性物質,其可在萃取之前自預萃取之聚合矽氧水凝膠隱形眼鏡產物被動或主動地移除。舉例而言,一部分可移除組份可在脫模步驟與萃取步驟之間蒸發。Additionally, the removable component can include other materials, such as volatile materials, that can be passively or actively removed from the pre-extracted polymeric hydrogel contact lens product prior to extraction. For example, a portion of the removable component can be evaporated between the demolding step and the extraction step.
在固化可聚合之眼鏡前驅體組合物之後,進行隱形眼鏡模具之脫模108 。脫模係指分離含有預萃取之聚合隱形眼鏡產物之模具或聚合裝置的兩個模具構件(諸如凸形及凹形模具構件)之方法。預萃取之聚合矽氧水凝膠隱形眼鏡產物位於經脫模之模具構件之一者上。舉例而言,聚合矽氧水凝膠隱形眼鏡產物可位於凸形模具構件或凹形模具構件上。After curing the polymerizable lens precursor composition, demolding of the contact lens mold 108 is performed . Demolding refers to the method of separating two mold members, such as male and female mold members, of a mold or polymerization device containing a pre-extracted polymeric contact lens product. The pre-extracted polymeric hemohydrogel contact lens product is located on one of the demolded mold members. For example, the polymeric hemohydrogel contact lens product can be located on a male mold member or a female mold member.
接著在脫鏡步驟110 (如圖1所示)期間將預萃取之聚合矽氧水凝膠隱形眼鏡產物204 自其所定位之隱形眼鏡模具構件分離。預萃取之聚合隱形眼鏡產物可自凸形模具構件或凹形模具構件脫鏡,此取決於聚合隱形眼鏡產物在隱形眼鏡模具脫模期間保持黏附之模具構件。The pre-extracted polymeric hemo-hydrogel contact lens product 204 is then separated from the contact lens mold member to which it is positioned during the mirror removal step 110 (shown in Figure 1). The pre-extracted polymeric contact lens product can be removed from the convex mold member or the concave mold member depending on the mold member in which the polymeric contact lens product remains adhered during release of the contact lens mold.
在預萃取之矽氧水凝膠隱形眼鏡產物脫鏡之後,該方法包括自預萃取之矽氧水凝膠隱形眼鏡產物萃取112 可萃取物質。萃取步驟112 導致經萃取之矽氧水凝膠隱形眼鏡產物206 (如圖2所示)。萃取步驟112 係指使預萃取之聚合矽氧水凝膠隱形眼鏡產物與一或多種萃取組合物接觸之程序,且可包括單一萃取步驟或若干次連續萃取。舉例而言,聚合矽氧水凝膠隱形眼鏡產物或一批聚合矽氧水凝膠隱形眼鏡產物與一或多體積之液體萃取介質接觸。萃取介質通常包括一或多種溶劑。舉例而言,萃取介質包括乙醇、甲醇、丙醇及其他醇。萃取介質亦可包括醇類與水之混合物,諸如50%乙醇與50%去離子水之混合物,或70%乙醇與30%去離子水之混合物,或90%乙醇與10%去離子水之混合物。或者,萃取介質可實質上或完全無醇,且可包括一或多種有利於自聚合矽氧水凝膠眼鏡產物移除疏水性未反應組份之藥劑。舉例而言,萃取介質可包含水、緩衝溶液及其類似物、基本上由其組成或完全由其組成。萃取112 可在各種溫度(包括室溫)下進行。舉例而言,萃取可在室溫(例如約20℃)下發生,或其可在高溫(例如約25℃至約100℃)下發生。此外,在某些實施例中,萃取步驟112 可包括使眼鏡產物與醇與水之混合物接觸,在某些情況下,其可包含多步萃取程序之最後一步。After the pre-extracted silicone hydrogel contact lens product is delensed, the method comprising the pre-extraction from silicon hydrogel contact lens product 112 was extracted extractable material. Extraction step 112 results in an extracted hydroxyl hydrogel contact lens product 206 (shown in Figure 2). Extraction step 112 refers to the process of contacting the pre-extracted polymeric hydrogel gel contact lens product with one or more extraction compositions, and may include a single extraction step or several sequential extractions. For example, a polymeric oxygenated hydrogel contact lens product or a batch of polymeric hydroxyl hydrogel contact lens product is contacted with one or more volumes of liquid extraction media. The extraction medium typically includes one or more solvents. For example, the extraction medium includes ethanol, methanol, propanol, and other alcohols. The extraction medium may also comprise a mixture of an alcohol and water, such as a mixture of 50% ethanol and 50% deionized water, or a mixture of 70% ethanol and 30% deionized water, or a mixture of 90% ethanol and 10% deionized water. . Alternatively, the extraction medium can be substantially or completely alcohol free and can include one or more agents that facilitate removal of the hydrophobic unreacted component from the polymerized hydrogel hydrogel lens product. For example, the extraction medium can comprise, consist essentially of, or consist entirely of water, a buffer solution, and the like. Extraction 112 can be carried out at various temperatures, including room temperature. For example, the extraction can occur at room temperature (eg, about 20 °C), or it can occur at elevated temperatures (eg, from about 25 °C to about 100 °C). Moreover, in certain embodiments, the extracting step 112 can include contacting the lens product with a mixture of alcohol and water, which in some cases can include the final step of the multi-step extraction procedure.
在萃取預萃取之聚合矽氧水凝膠隱形眼鏡產物以提供經萃取之聚合矽氧水凝膠隱形眼鏡產物之後,該方法包括水合114 經萃取之聚合矽氧水凝膠隱形眼鏡產物。水合步驟114 例如可包括使經萃取之聚合矽氧水凝膠隱形眼鏡產物或一或多批該等產物與水或水溶液接觸以形成水合矽氧水凝膠隱形眼鏡208 (如圖2中所示)。例如,經萃取之聚合矽氧水凝膠隱形眼鏡產物可藉由置放於兩單獨體積或兩單獨體積以上之水(包括去離子水)中來水合。在某些實施例中,水合步驟114 與萃取步驟112 組合,以使得兩步驟在隱形眼鏡生產線中之單一位置上進行。水合步驟114 可在容器中於室溫或高溫下且必要時在高壓下進行。舉例而言,水合可在約120℃(例如121℃)之溫度及103 kPa(15 psi)之壓力下於水中發生。After the polymerization silicone hydrogel contact lens product to provide a pre-extraction of the extracted polymerized silicone hydrogel contact lens product was extracted, the method comprising the extracted polymerized hydrated 114 of silicon hydrogel contact lens product. The hydrating step 114 can, for example, comprise contacting the extracted polymeric hydrogel hydrogel contact lens product or one or more batches of the product with water or an aqueous solution to form a hydrated hydrogel hydrogel contact lens 208 (shown in Figure 2). ). For example, the extracted polymeric oxygenated hydrogel contact lens product can be hydrated by being placed in two separate volumes or two separate volumes of water, including deionized water. In certain embodiments, the hydrating step 114 is combined with the extraction step 112 such that the two steps are performed at a single location in the contact lens production line. The hydration step 114 can be carried out in a vessel at room temperature or elevated temperature and, if necessary, under high pressure. For example, hydration can occur in water at a temperature of about 120 ° C (eg, 121 ° C) and a pressure of 103 kPa (15 psi).
因此,如由上文顯而易見,認為預萃取之聚合矽氧水凝膠隱形眼鏡產物及經萃取之聚合矽氧水凝膠隱形眼鏡產物為水可膨脹性之產物或元件,且認為水合矽氧水凝膠隱形眼鏡為遇水可膨脹之產物或元件。如本文所用之矽氧水凝膠隱形眼鏡係指已經歷水合步驟之矽氧水凝膠元件。因此,矽氧水凝膠隱形眼鏡可為完全水合之矽氧水凝膠隱形眼鏡、部分水合之矽氧水凝膠隱形眼鏡或脫水之矽氧水凝膠隱形眼鏡。脫水之矽氧水凝膠隱形眼鏡係指已經歷水合程序且隨後經脫水以自眼鏡移除水之隱形眼鏡。Thus, as apparent from the above, it is believed that the pre-extracted polymeric hydrogel contact lens product and the extracted polymeric hydrogel hydrogel contact lens product are products or components of water swellability and are considered to be hydrated hydrophobic water. Gel contact lenses are water swellable products or components. As used herein, a hydroxyl hydrogel contact lens refers to a hydroxyl hydrogel element that has undergone a hydration step. Thus, the helium oxygen hydrogel contact lens can be a fully hydrated neohydrogen hydrogel contact lens, a partially hydrated neohydrogen hydrogel contact lens or a dehydrated hydrogenated hydrogel contact lens. A dehydrated hydrogel contact lens refers to a contact lens that has undergone a hydration procedure and is subsequently dehydrated to remove water from the lens.
在水合經萃取之矽氧水凝膠隱形眼鏡產物以產生矽氧水凝膠隱形眼鏡之後,該方法包括封裝矽氧水凝膠隱形眼鏡208 之步驟116 。舉例而言,矽氧水凝膠隱形眼鏡208 可置放於包括一定體積液體(諸如生理食鹽水溶液,包括經緩衝之生理食鹽水溶液)之發泡包裝或其他合適容器中。適合於本發明眼鏡之液體的實例包括磷酸鹽緩衝生理食鹽水及硼酸鹽緩衝生理食鹽水。如步驟118 所示,接著密封發泡包裝或容器,且隨後殺菌。舉例而言,經封裝之矽氧水凝膠隱形眼鏡可諸如藉由高壓釜處理、γ輻射、電子束輻射或紫外輻射而暴露於殺菌量之輻射,包括熱輻射。After hydrating the extracted oxygenated hydrogel contact lens product to produce a helium oxygen hydrogel contact lens, the method includes the step 116 of encapsulating the helium oxygen hydrogel contact lens 208 . For example, silicone hydrogel contact lens 208 may be placed include a volume of liquid (such as physiological saline solution, including buffered saline solution of physiological and) the blister pack or other suitable container. Examples of liquids suitable for the lenses of the present invention include phosphate buffered saline and borate buffered saline. As shown in step 118 , the blister pack or container is then sealed and subsequently sterilized. For example, encapsulated neohydrogenated hydrogel contact lenses can be exposed to sterilizing amounts of radiation, including thermal radiation, such as by autoclave treatment, gamma radiation, electron beam radiation, or ultraviolet radiation.
如上所論述,本文所提供之組合物及方法提供眼睛上相容之矽氧水凝膠隱形眼鏡。將具有如本文所述之可移除組份的預萃取聚合矽氧水凝膠眼鏡產物萃取且水合以形成具有眼用可接受之表面可濕性的矽氧水凝膠隱形眼鏡。本發明之眼鏡具有透氧性、表面可濕性、模數、水含量、離子流、設計及其組合,其使得本發明之眼鏡適合患者眼睛舒適地配戴延長之時期,諸如至少一天、至少一週、至少兩週或約一個月,而無需自眼睛中移除眼鏡。As discussed above, the compositions and methods provided herein provide an ophthalmically compatible silicone hydrogel contact lens. A pre-extracted polymeric hydrogel lens product having a removable component as described herein is extracted and hydrated to form a hydroxyl hydrogel contact lens having an ophthalmically acceptable surface wettability. The spectacles of the present invention have oxygen permeability, surface wettability, modulus, water content, ion flow, design, and combinations thereof, which make the spectacles of the present invention suitable for comfortable stretching of the patient's eyes, such as at least one day, at least One week, at least two weeks, or about one month, without removing the glasses from your eyes.
如本文所用之"眼睛上相容之矽氧水凝膠隱形眼鏡"係指可配戴於人眼上而人不經歷或報導實質性不適(包括眼睛刺激及類似不適)的矽氧水凝膠隱形眼鏡。眼睛上相容之矽氧水凝膠隱形眼鏡具有眼用可接受之表面可濕性,且通常不引起顯著角膜腫脹、角膜脫水("乾眼病")、上方角膜上皮弓狀病變("SEAL")或其他顯著不適或與該等病狀不相關。具有眼用可接受之表面可濕性之矽氧水凝膠隱形眼鏡係指不會不利影響眼鏡配戴者眼睛之淚膜至導致眼鏡配戴者經歷或報導與眼睛上置放或配戴矽氧水凝膠隱形眼鏡相關之不適之程度的矽氧水凝膠隱形眼鏡。眼睛上相容之矽氧水凝膠隱形眼鏡滿足針對每日配戴或長期配戴隱形眼鏡之臨床上可接受之要求。As used herein, "a compatible oxygenated hydrogel contact lens" refers to a hydroxyl hydrogel that can be worn on the human eye without human experience or substantial discomfort (including eye irritation and similar discomfort). Contact lenses. Eye-compatible, oxygenated hydrogel contact lenses have an ophthalmically acceptable surface wettability and generally do not cause significant corneal swelling, corneal dehydration ("dry eye"), or superior corneal epithelial arch lesion ("SEAL") Or other significant discomfort or unrelated to these conditions. An oxygenated hydrogel contact lens having an ophthalmically acceptable surface wettability means a tear film that does not adversely affect the eye of the wearer of the lens to cause the wearer of the lens to experience or report placement or wear on the eye. Hydroxyl hydrogel contact lenses for the degree of discomfort associated with oxygen hydrogel contact lenses. Eye-compatible, oxygenated hydrogel contact lenses meet the clinically acceptable requirements for daily or long-term wear of contact lenses.
本發明之矽氧水凝膠隱形眼鏡包含鏡體,其具有具眼用可接受之表面可濕性(OASW)的表面,諸如前表面及後表面。可濕性係指隱形眼鏡之一或多個表面的親水性。在一種量測方法中,若眼鏡在如下進行之可濕性檢定中得到3或3以上之評分,則可認為眼鏡表面為可濕性的,或可認為其具有眼用可接受之可濕性。將隱形眼鏡浸入蒸餾水中,自水中移除,且測定水膜自眼鏡表面後退所耗之時間長度(例如水驅散時間(水BUT或WBUT))。檢定提供1-10之線性範圍內的眼鏡等級,其中10分係指其中水滴需20秒或更長時間自眼鏡後退之眼鏡。雖然WBUT之活體外評估僅為對於OASW之一種量測方法或指示,但可認為具有5秒以上(諸如至少10秒或更理想為至少約15秒)水BUT之矽氧水凝膠隱形眼鏡具有眼用可接受之表面可濕性。或者,可在活體內評估OASW。若眼鏡可在患者眼睛上配戴至少6小時而患者未報導不適或刺激,則認為眼鏡具有OASW。The hydroxyl hydrogel contact lenses of the present invention comprise a lens body having an ophthalmically acceptable surface wettability (OASW) surface, such as a front surface and a back surface. Wetability refers to the hydrophilicity of one or more surfaces of a contact lens. In a measurement method, if the glasses obtain a score of 3 or more in the wettability test performed as follows, the surface of the lens may be considered to be wettable, or may be considered to have an ophthalmically acceptable wettability. . The contact lens is immersed in distilled water, removed from the water, and the length of time it takes for the water film to recede from the surface of the lens (eg, water dispersal time (water BUT or WBUT)) is measured. The assay provides a level of eyeglasses in the linear range of 1-10, with 10 points being the glasses in which the water droplets need to recede from the glasses for 20 seconds or more. While the in vitro evaluation of WBUT is only one measurement method or indication for OASW, it can be considered that a helium oxygen hydrogel contact lens having a water BUT of 5 seconds or more (such as at least 10 seconds or more preferably at least about 15 seconds) has An acceptable surface wettability for the eye. Alternatively, OASW can be evaluated in vivo. If the spectacles can be worn on the patient's eyes for at least 6 hours and the patient does not report discomfort or irritation, the spectacles are considered to have OASW.
可濕性亦可藉由量測一或兩個眼鏡表面上之接觸角來測定。接觸角可為動態或靜態接觸角。較低接觸角一般係指隱形眼鏡表面之可濕性增加。舉例而言,矽氧水凝膠隱形眼鏡之可濕性表面可具有小於約120°之接觸角。然而,在本發明眼鏡之某些實施例中,眼鏡具有不大於90°之接觸角,且在其他實施例中,本發明之矽氧水凝膠隱形眼鏡具有小於約80°且甚至更佳小於約75°之前進接觸角。Wettability can also be determined by measuring the contact angle on the surface of one or both of the glasses. The contact angle can be a dynamic or static contact angle. A lower contact angle generally refers to an increase in the wettability of the surface of the contact lens. For example, the wettable surface of the helium oxygen hydrogel contact lens can have a contact angle of less than about 120°. However, in certain embodiments of the spectacles of the present invention, the spectacles have a contact angle of no greater than 90°, and in other embodiments, the oxyahydrogel contact lenses of the present invention have a less than about 80° and even more preferably less than Enter the contact angle before about 75°.
本發明之矽氧水凝膠隱形眼鏡包含具有眼用可接受之表面可濕性的鏡體。舉例而言,本發明之矽氧水凝膠隱形眼鏡之鏡體通常具有前表面及後表面,各表面均具有眼用可接受之表面可濕性。The hydroxyl hydrogel contact lenses of the present invention comprise a lens body having an ophthalmically acceptable surface wettability. For example, the mirror body of the oxygenated hydrogel contact lenses of the present invention typically has a front surface and a back surface, each surface having an ophthalmically acceptable surface wettability.
在一實施例中,矽氧水凝膠隱形眼鏡之鏡體包含矽氧水凝膠物質。鏡體具有不大於萃取前鏡體乾重90%之乾重。舉例而言,預萃取之聚合矽氧水凝膠隱形眼鏡產物之鏡體可具有乾重X。萃取程序之後,經萃取之聚合矽氧水凝膠隱形眼鏡產物之鏡體具有小於或等於0.9X之乾重。如上所論述,在萃取步驟期間,預萃取之聚合矽氧水凝膠隱形眼鏡產物可與大量多種有機溶劑接觸,繼而進行水合步驟以產生矽氧水凝膠隱形眼鏡。接著,將水合矽氧水凝膠隱形眼鏡脫水且稱重以測定矽氧水凝膠隱形眼鏡之鏡體乾重。In one embodiment, the mirror body of the helium oxygen hydrogel contact lens comprises a helium oxygen hydrogel material. The mirror body has a dry weight of no more than 90% of the dry weight of the mirror body before extraction. For example, the mirror body of the pre-extracted polymeric hemohydrogel contact lens product can have a dry weight X. After the extraction procedure, the mirror of the extracted polymeric hydrogel contact lens product has a dry weight of less than or equal to 0.9X. As discussed above, during the extraction step, the pre-extracted polymeric hydrogel gel contact lens product can be contacted with a wide variety of organic solvents, followed by a hydration step to produce a hydroxyl hydrogel contact lens. Next, the hydrated hydrogel hydrogel contact lens was dehydrated and weighed to determine the dry weight of the lens body of the hydroxyl hydrogel contact lens.
舉例而言,在某些方法中,將預萃取之聚合矽氧水凝膠隱形眼鏡產物自隱形眼鏡模具構件脫鏡,且稱重以提供預萃取之聚合矽氧水凝膠隱形眼鏡產物之乾重。接著使預萃取之眼鏡產物與醇接觸約6小時,且接著與水進行水合。接著在約80℃下乾燥水合眼鏡約1小時,且接著在真空下於約80℃下乾燥約2小時。稱重經乾燥之眼鏡以測定矽氧水凝膠隱形眼鏡之鏡體乾重。接著比較該等乾重以確定預萃取之聚合矽氧水凝膠隱形眼鏡產物中所存在之可萃取物質的量。具有約40%可萃取組份含量之預萃取聚合眼鏡產物產生乾重為預萃取眼鏡產物約60%之矽氧水凝膠隱形眼鏡的鏡體。具有約70%可萃取組份含量之預萃取聚合眼鏡產物產生乾重為預萃取眼鏡產物約30%之矽氧水凝膠隱形眼鏡的鏡體,等等。For example, in some methods, the pre-extracted polymeric hemohydrogel contact lens product is removed from the contact lens mold member and weighed to provide a pre-extracted polymeric hydrogel contact lens product. weight. The pre-extracted lens product is then contacted with the alcohol for about 6 hours and then hydrated with water. The hydrated spectacles are then dried at about 80 ° C for about 1 hour and then dried under vacuum at about 80 ° C for about 2 hours. The dried glasses were weighed to determine the dry weight of the lens body of the hydrogenated hydrogel contact lens. The dry weights are then compared to determine the amount of extractable material present in the pre-extracted polymeric hydrogel hydrogel contact lens product. The pre-extracted polymeric lens product having a level of extractable component of about 40% produces a lens body having a dry weight of about 60% of the hydrogel contact lens of the pre-extracted lens product. The pre-extracted polymeric lens product having an extractable component content of about 70% produces a lens body having a dry weight of about 30% of the oxygenated hydrogel contact lens of the pre-extracted lens product, and the like.
預萃取之聚合矽氧水凝膠隱形眼鏡產物中所存在之可萃取物之量或可萃取組份含量可使用以下等式來確定:E=((預萃取眼鏡產物之乾重-經萃取及水合之隱形眼鏡之乾重)/預萃取眼鏡產物之乾重)×100。The amount of extractables or extractable component present in the pre-extracted polymeric hydrogel contact lens product can be determined using the following equation: E = ((dry weight of pre-extracted lens product - extracted and The dry weight of the hydrated contact lens) / the dry weight of the pre-extracted lens product) × 100.
E為預萃取眼鏡產物中所存在之可萃取物的百分比。E is the percentage of extractables present in the pre-extracted lens product.
舉例而言,預萃取之聚合矽氧水凝膠隱形眼鏡產物可具有約20 mg之乾重。若自彼產物所獲得之矽氧水凝膠隱形眼鏡具有約17 mg之乾重,則彼矽氧水凝膠隱形眼鏡包含乾重為預萃取眼鏡產物乾重85%之鏡體。應瞭解,該預萃取眼鏡產物具有約15%(重量比)之可萃取組份含量。作為另一實例,預萃取之聚合矽氧水凝膠隱形眼鏡產物可具有約18 mg之乾重,且若自該眼鏡產物所獲得之經脫水之矽氧水凝膠隱形眼鏡具有約13 mg之乾重,則該矽氧水凝膠隱形眼鏡包含乾重為預萃取之眼鏡產物約72%之鏡體。該預萃取之聚合矽氧水凝膠隱形眼鏡產物具有約28%(重量比)之可萃取組份含量。For example, the pre-extracted polymeric hemohydrogel contact lens product can have a dry weight of about 20 mg. If the oxygenated hydrogel contact lens obtained from the product has a dry weight of about 17 mg, the hydrogenated hydrogel contact lens comprises a lens body having a dry weight of 85% of the dry weight of the pre-extracted lens product. It will be appreciated that the pre-extracted lens product has an extractable component content of about 15% by weight. As another example, the pre-extracted polymeric hydrogel contact lens product can have a dry weight of about 18 mg, and if the dehydrated hydrogel contact lens obtained from the lens product has about 13 mg On dry weight, the helium oxygen hydrogel contact lens comprises a mirror body having a dry weight of about 72% of the pre-extracted lens product. The pre-extracted polymeric hydrogel contact lens product has an extractable component content of about 28% by weight.
在某些實施例中,矽氧水凝膠隱形眼鏡(亦即已經受萃取及水合程序之矽氧水凝膠隱形眼鏡)之鏡體乾重大於鏡體在萃取前之乾重的40%。舉例而言,萃取後之鏡體乾重可為預萃取之鏡體乾重的約40%至約90%。本發明眼鏡之某些實施例包含乾重為預萃取鏡體乾重之約50%至約80%的鏡體。In certain embodiments, the mirror body of the helium-oxygen hydrogel contact lens (i.e., the oxygenated hydrogel contact lens that has been subjected to the extraction and hydration procedure) is substantially more than 40% of the dry weight of the lens body prior to extraction. For example, the dry weight of the lens body after extraction can be from about 40% to about 90% of the dry weight of the pre-extracted lens body. Certain embodiments of the lenses of the present invention comprise a lens body having a dry weight of from about 50% to about 80% of the dry weight of the pre-extracted lens body.
如本文所論述,當預萃取眼鏡產物中之可萃取組份含量(例如未反應之試劑,諸如相對於鏡體之聚合物主鏈、網路或基質未交聯或固定之可萃取物質的線性未交聯、交聯或分枝聚合物)大於10%,諸如至少15%,至少20%,至少25%或更多時,自無聚氧化烯矽氧可萃取組份之眼鏡前驅體組合物或預萃取之矽氧水凝膠隱形眼鏡產物所獲得之矽氧水凝膠隱形眼鏡(例如自"大批調配物"所獲得之眼鏡產物)可具有眼用可接受之表面可濕性。申請者已發現,與大批調配物眼鏡產物相比,前驅體組合物或經聚合之預萃取眼鏡產物中包括一或多種可移除/可萃取添加劑增加可萃取組份之含量,且產生具有眼用可接受之表面可濕性的矽氧水凝膠隱形眼鏡。As discussed herein, the amount of extractable component in the pre-extracted lens product (eg, unreacted reagent, such as linearity of extractable material that is not crosslinked or immobilized relative to the polymer backbone, network, or matrix of the lens body) An optical fiber precursor composition having no polyoxyalkylene oxime extractable component when the uncrosslinked, crosslinked or branched polymer is greater than 10%, such as at least 15%, at least 20%, at least 25% or more The ophthalmic hydrogel contact lenses obtained from the pre-extracted oxygenated hydrogel contact lens products (e.g., the lens products obtained from "mass formulations") may have ophthalmically acceptable surface wettability. Applicants have discovered that one or more removable/extractable additives are included in the precursor composition or the polymerized pre-extracted lens product to increase the content of the extractable component and produce an eye with a larger amount of the formulated lens product. Ophthalmic hydrogel contact lenses with acceptable surface wettability.
雖然本發明之預萃取聚合矽氧水凝膠隱形眼鏡產物具有相對大量之可萃取物質,但本發明之矽氧水凝膠隱形眼鏡之經萃取形式在所得鏡體中具有極少之可萃取物質。在某些實施例中,經萃取之眼鏡中剩餘之可萃取物質的量為約0.1%至約4%,諸如約0.4%至約2%(重量比)。該等額外可萃取物質可藉由使經萃取之隱形眼鏡與額外體積之強溶劑(諸如氯仿)接觸來測定。While the pre-extracted polymeric hydrogel contact lens product of the present invention has a relatively large amount of extractable material, the extracted form of the hydroxyl hydrogel contact lens of the present invention has very little extractable material in the resulting lens body. In certain embodiments, the amount of extractable material remaining in the extracted lens is from about 0.1% to about 4%, such as from about 0.4% to about 2% by weight. The additional extractable material can be determined by contacting the extracted contact lens with an additional volume of a strong solvent such as chloroform.
此外,由於可萃取組份存在且分布在整個可聚合之矽氧水凝膠眼鏡前驅體組合物及預萃取之聚合矽氧水凝膠隱形眼鏡產物中,因此本發明之眼鏡產物及隱形眼鏡可區別於經表面處理之矽氧水凝膠隱形眼鏡。由於可萃取組份可自眼鏡產物萃取且實質上不存在於經水合之隱形眼鏡中,因此本發明之眼鏡產物及隱形眼鏡可區別於具有聚合濕潤劑IPN之矽氧水凝膠隱形眼鏡。In addition, since the extractable component is present and distributed throughout the polymerizable silicone hydrogel lens precursor composition and the pre-extracted polymeric oxygenated hydrogel contact lens product, the lens product and contact lens of the present invention can be Different from surface treated helium hydrogel contact lenses. Since the extractable component can be extracted from the lens product and is substantially absent from the hydrated contact lens, the lens products and contact lenses of the present invention can be distinguished from the oxygenated hydrogel contact lens having the polymeric wetting agent IPN.
本發明之矽氧水凝膠隱形眼鏡可包含自非極性樹脂隱形眼鏡模具所獲得之鏡體,該等鏡體在水合及脫水狀態下檢查時具有實質上相同之表面形態。此外,該等水合鏡體可具有略微小於脫水鏡體之表面粗糙度的表面粗糙度。舉例而言,本發明之眼鏡之鏡體可具有包括奈米大小峰之表面,該等奈米大小峰在分析眼鏡表面之均方根(RMS)粗糙度資料時顯而易見。鏡體可包含在各峰之間差異性隆起之該等峰之間的區域,以提供減少之粗糙度而實質上類似之表面形態。舉例而言,雖然在鏡體水合時峰高可減少,但峰形狀實質上保持相同。The hydroxyl hydrogel contact lenses of the present invention may comprise a lens body obtained from a non-polar resin contact lens mold having substantially the same surface morphology when examined in a hydrated and dehydrated state. Further, the hydrated mirror bodies may have a surface roughness slightly smaller than the surface roughness of the dehydrated mirror body. For example, the lens body of the glasses of the present invention may have a surface comprising a nanometer size peak, which is apparent when analyzing the root mean square (RMS) roughness data of the surface of the lens. The mirror body can include regions between the peaks of the differential ridges between the peaks to provide reduced roughness while substantially similar surface morphology. For example, although the peak height can be reduced when the mirror body is hydrated, the peak shape remains substantially the same.
或者或另外,本發明之經非極性樹脂模製之矽氧水凝膠隱形眼鏡的實施例可包含具有在用電子顯微鏡(諸如掃描電子顯微鏡、透射電子顯微鏡或掃描透射電子顯微鏡)觀察時可視覺辨別之富矽區及貧矽區的鏡體。基於化學分析,可瞭解貧矽區為實質上或完全無矽之眼鏡內區域。貧矽區可能比經表面處理之矽氧水凝膠隱形眼鏡或包含聚合濕潤劑IPN之矽氧水凝膠隱形眼鏡中的該等區大。可使用習知影像分析軟體及裝置(諸如可購自Bioquant(Tennessee)之影像分析系統)測定富矽區、貧矽區或兩者之大小。影像分析軟體系統可用以勾勒出富矽區及貧矽區之邊界輪廓且測定該等區之橫截面積、直徑、體積及其類似物。在某些實施例中,貧矽區具有比其他矽氧水凝膠隱形眼鏡之貧矽區大至少50%、至少60%、至少70%、至少80%或至少90%之橫截面積。Alternatively or additionally, embodiments of the non-polar resin molded oxygenated hydrogel contact lenses of the present invention may comprise visually visible when viewed with an electron microscope such as a scanning electron microscope, a transmission electron microscope, or a scanning transmission electron microscope. Identify the mirrors of the rich and poor areas. Based on chemical analysis, it can be understood that the barren area is a substantially or completely flawless intraocular region. The barren zone may be larger than the surface treated hemohydrogel contact lens or the oxygenated hydrogel contact lens comprising the polymeric wetting agent IPN. The size of the rich zone, the barren zone, or both can be determined using conventional image analysis software and devices, such as image analysis systems available from Bioquant (Tennessee). The image analysis software system can be used to outline the boundary contours of the rich and barren regions and to determine the cross-sectional area, diameter, volume and the like of the regions. In certain embodiments, the barren zone has a cross-sectional area that is at least 50%, at least 60%, at least 70%, at least 80%, or at least 90% greater than the barren zone of other hemihydrate hydrogel contact lenses.
本發明之未經表面處理之鏡體通常提供眼用可接受之表面可濕性。換言之,在一實施例中,本發明之矽氧水凝膠隱形眼鏡之鏡體為未經表面處理之鏡體。換言之,在不進行鏡體之表面處理下產生鏡體以提供眼用可接受之表面可濕性。舉例而言,說明性鏡體不包括用以使鏡體表面在眼睛上更可接受之電漿處理或額外塗層。然而,由於因預萃取之聚合矽氧水凝膠隱形眼鏡產物中所存在之可移除物質之量而使本發明之眼鏡具有眼用可接受之表面可濕性,因此必要時某些實施例可包括表面處理。The untreated surface of the present invention generally provides ophthalmically acceptable surface wettability. In other words, in one embodiment, the mirror body of the helium oxygen hydrogel contact lens of the present invention is a mirror body that has not been surface treated. In other words, the lens body is produced without surface treatment of the lens body to provide an ophthalmically acceptable surface wettability. For example, the illustrative scope does not include a plasma treatment or additional coating to make the surface of the mirror body more acceptable on the eye. However, certain embodiments are necessary if the lenses of the present invention have ophthalmically acceptable surface wettability due to the amount of removable material present in the pre-extracted polymeric hydrogel hydrogel contact lens product. Surface treatment can be included.
本發明之眼鏡之某些實施例包含自非極性樹脂隱形眼鏡模具獲得之澆鑄成型元件鏡體。聚合矽氧水凝膠隱形眼鏡產物係指在非極性樹脂隱形眼鏡模具中聚合或固化之產物。或者,以另一種方式說明,聚合矽氧水凝膠隱形眼鏡產物在非極性樹脂隱形眼鏡模具中產生。如本文所論述,該等隱形眼鏡模具為使用非極性或疏水性樹脂物質或基於非極性或疏水性樹脂物質而產生之模具。該等物質通常在其眼鏡形成表面上具有相對大之接觸角。Certain embodiments of the lenses of the present invention comprise cast molded component mirrors obtained from non-polar resin contact lens molds. The polymeric hemohydrogel contact lens product refers to a product that is polymerized or cured in a non-polar resin contact lens mold. Alternatively, in another manner, the polymeric hemohydrogel contact lens product is produced in a non-polar resin contact lens mold. As discussed herein, the contact lens molds are molds that are produced using non-polar or hydrophobic resinous materials or based on non-polar or hydrophobic resinous materials. These materials typically have a relatively large contact angle on their lens forming surface.
本發明之矽氧水凝膠隱形眼鏡亦可包括一或多種舒適增強劑,其相對於無舒適增強劑之矽氧水凝膠隱形眼鏡增強眼鏡配戴者或眼鏡配戴者群體所感受之隱形眼鏡的舒適度。舒適增強劑之實例包括脫水減少劑、淚膜穩定劑或既減少脫水亦穩定隱形眼鏡所置放之眼睛的淚膜之藥劑。該等舒適增強劑包括對水具有親和力之聚合物質。在某些實施例中,聚合物質包含一或多種兩親媒性基團。適用作舒適增強劑之物質的實例包括可聚合磷脂,諸如包括磷酸膽鹼組份之物質。在某些實施例中,前驅體組合物包含甲基丙烯酸酯磷酸膽鹼單體,以使得在此狀況下兩親媒性物質磷酸膽鹼包括於所得交聯網路中。The silicone hydrogel contact lenses of the present invention may also include one or more comfort enhancers that enhance the invisibility experienced by the wearer or wearer of the eyeglasses relative to the silicone hydrogel contact lens without the comfort enhancer. The comfort of the glasses. Examples of comfort enhancers include dehydration reducing agents, tear film stabilizers, or agents that both reduce dehydration and stabilize the tear film of the eye in which the contact lens is placed. Such comfort enhancers include polymeric materials that have an affinity for water. In certain embodiments, the polymeric material comprises one or more amphiphilic groups. Examples of materials suitable for use as comfort enhancers include polymerizable phospholipids, such as those comprising the choline phosphate component. In certain embodiments, the precursor composition comprises a methacrylate phosphorylcholine monomer such that in this case the amphiphilic material phosphorylcholine is included in the resulting cross-linked network.
如本文所論述,本發明之矽氧水凝膠眼鏡之舒適度亦可藉由在眼鏡前驅體組合物及預萃取之矽氧水凝膠隱形眼鏡產物中包括一或多種可移除之舒適增強劑來增強。舉例而言,本文所述之某些可移除物質包括與自無可移除物質之相同組合物所獲得之眼鏡相比減少本發明之眼鏡的離子流之藥劑。減少眼鏡之離子流可有助於減少眼鏡配戴者之角膜脫水且減少配戴眼鏡所導致之角膜染色。As discussed herein, the comfort of the oxygenated hydrogel lenses of the present invention can also be enhanced by including one or more removable comfort enhancements in the lens precursor composition and the pre-extracted silicone hydrogel contact lens product. Agent to enhance. For example, some of the removable materials described herein include agents that reduce the ion current of the lenses of the present invention as compared to glasses obtained from the same composition of the non-removable material. Reducing the ion flux of the lens can help reduce corneal dehydration of the lens wearer and reduce corneal staining caused by wearing the lens.
如本文所論述,本發明之眼鏡具有允許眼鏡配戴延長時期之特徵及特性。舉例而言,本發明之眼鏡可作為每天配戴眼鏡、每週配戴眼鏡、雙週配戴眼鏡或每月配戴眼鏡來配戴。本發明之眼鏡包含具有有助於眼鏡舒適度及可用性之表面可濕性、模數、離子流、透氧性及水含量的水合鏡體。在某些實施例中,本發明之眼鏡包含具有選自由以下各特徵組成之群之特徵的水合鏡體:小於約95°之前進接觸角、小於約1.6 MPa之拉伸模數、小於約7×10-3 mm2 /min之離子流、至少約70 barrer之透氧性(Dk)、至少約30重量%之水含量及其組合。然而,在其他實施例中,離子流可大於7×10-3 mm2 /min,但仍未引起角膜脫水染色或其他臨床問題。As discussed herein, the spectacles of the present invention have features and characteristics that allow the spectacles to be worn for an extended period of time. For example, the spectacles of the present invention can be worn as wearing glasses every day, wearing glasses every week, wearing bi-weekly glasses, or wearing glasses every month. The spectacles of the present invention comprise a hydrated mirror body having surface wettability, modulus, ion flow, oxygen permeability, and water content that contribute to the comfort and usability of the lens. In certain embodiments, the spectacles of the present invention comprise a hydrated lens body having features selected from the group consisting of: a contact angle of less than about 95°, a tensile modulus of less than about 1.6 MPa, less than about 7 An ion current of ×10 -3 mm 2 /min, an oxygen permeability (Dk) of at least about 70 barrer, a water content of at least about 30% by weight, and combinations thereof. However, in other embodiments, the ion current may be greater than 7 x 10 -3 mm 2 /min, but still does not cause corneal dehydration staining or other clinical problems.
本發明之眼鏡可包含前表面、後表面或前及後表面上之前進接觸角小於120°之水合鏡體。在某些實施例中,鏡體具有小於90°之鏡表面前進接觸角,例如鏡體具有約85°、約80°、約75°、約70°、約65°、約60°、約55°或約50°之鏡表面前進接觸角。鏡體亦可具有小於80°之鏡表面後退接觸角,例如鏡體可具有約75°、約70°、約65°、約60°、約55°、約50°或約45°之鏡表面後退接觸角。作為前進接觸角與後退接觸角之間的差異之滯後可為約5°至約35°。然而,在某些實施例,滯後可大於25°,但仍為臨床上可接受的。The spectacles of the present invention may comprise a hydrated mirror body having a front contact angle of less than 120° on the front surface, the back surface or the front and back surfaces. In certain embodiments, the mirror body has a mirror surface advancing contact angle of less than 90°, such as the mirror body having about 85°, about 80°, about 75°, about 70°, about 65°, about 60°, about 55. ° or about 50° of the mirror surface advancing contact angle. The mirror body may also have a mirror surface receding contact angle of less than 80°, for example, the mirror body may have a mirror surface of about 75°, about 70°, about 65°, about 60°, about 55°, about 50°, or about 45°. Retreat contact angle. The hysteresis as the difference between the advancing contact angle and the receding contact angle may be from about 5° to about 35°. However, in certain embodiments, the hysteresis can be greater than 25°, but is still clinically acceptable.
可使用一般熟習此項技術者已知之常規方法測定前進接觸角。舉例而言,可使用習知液滴形狀法(諸如固著液滴法或俘獲氣泡法)來量測隱形眼鏡之前進接觸角及後退接觸角。矽氧水凝膠隱形眼鏡之前進及後退水接觸角可使用Kruss DSA 100器具(Kruss GmbH,Hamburg)且如D.A.Brandreth:"Dynamic contact angles and contact angle hysteresis",Journal of Colloid and Interface Science,第62卷,1977,第205-212頁及R.Knapikowski,M.Kudra:Kontaktwinkelmessungen nach dem Wilhelmy-Prinzip-Ein statistischer Ansatz zur Fehierbeurteilung",Chem.Technik,第45卷,1993,第179-185頁及美國專利第6,436,481號中所述來測定。The advancing contact angle can be determined using conventional methods known to those skilled in the art. For example, a conventional drop shape method, such as a sessile drop method or a trapped bubble method, can be used to measure the contact angle and the receding contact angle of the contact lens. Kruss DSA 100 appliances (Kruss GmbH, Hamburg) and DABrandreth: "Dynamic contact angles and contact angle hysteresis", Journal of Colloid and Interface Science, No. 62, for the forward and backward water contact angles of the hydrogel contact lenses. Vol., 1977, pp. 205-212 and R. Knapikowski, M. Kudra: Kontaktwinkelmessungen nach dem Wilhelmy-Prinzip-Ein statistischer Ansatz zur Fehierbeurteilung", Chem. Technik, Vol. 45, 1993, pages 179-185 and US patents Measured as described in No. 6,436,481.
例如,前進接觸角及後退接觸角可使用俘獲氣泡法使用磷酸鹽緩衝生理食鹽水(PBS;pH=7.2)來測定。使眼鏡平鋪在石英表面上且在測試之前用PBS再水合10分鐘。使用自動注射系統將氣泡置放於眼鏡表面上。可增加及減小氣泡大小以獲得後退角(當增加氣泡大小時獲得平臺)及前進角(當減小氣泡大小時獲得平臺)。For example, the advancing contact angle and the receding contact angle can be determined using a trapped bubble method using phosphate buffered physiological saline (PBS; pH = 7.2). The glasses were tiled on the quartz surface and rehydrated with PBS for 10 minutes prior to testing. Air bubbles are placed on the surface of the glasses using an automatic injection system. The bubble size can be increased and decreased to obtain a receding angle (a platform is obtained when the bubble size is increased) and an advancing angle (a platform is obtained when the bubble size is reduced).
或者或另外,本發明之眼鏡可包含展示大於5秒之水驅散時間(BUT)的鏡體。舉例而言,包含水BUT為至少15秒(諸如20秒或更長時間)之鏡體的本發明之眼鏡的實施例可具有眼用可接受之表面可濕性。Alternatively or additionally, the spectacles of the present invention may comprise a lens body exhibiting a water dispel time (BUT) of greater than 5 seconds. For example, embodiments of the lenses of the present invention comprising a mirror body having a water BUT of at least 15 seconds (such as 20 seconds or more) may have an ophthalmically acceptable surface wettability.
本發明之眼鏡可包含模數小於1.6 MPa之鏡體。在某些實施例中,鏡體之模數小於1.0 MPa。舉例而言,鏡體可具有約0.9 MPa、約0.8 MPa、約0.7 MPa、約0.6 MPa、約0.5 MPa、約0.4 MPa或約0.3 MPa之模數。本發明之鏡體之模數較佳為約0.4至約0.8 MPa,且甚至更佳在約0.4與約0.6 MPa之間。在一實施例中,鏡體具有約0.4與0.5 MPa之間的模數。選擇鏡體模數以提供當置放於眼睛上時舒適之眼鏡且使眼鏡配戴者可適應眼鏡之操作。The spectacles of the present invention may comprise a lens body having a modulus of less than 1.6 MPa. In some embodiments, the mirror has a modulus of less than 1.0 MPa. For example, the mirror body can have a modulus of about 0.9 MPa, about 0.8 MPa, about 0.7 MPa, about 0.6 MPa, about 0.5 MPa, about 0.4 MPa, or about 0.3 MPa. The modulus of the mirror body of the present invention is preferably from about 0.4 to about 0.8 MPa, and even more preferably between about 0.4 and about 0.6 MPa. In an embodiment, the mirror body has a modulus between about 0.4 and 0.5 MPa. The mirror body modulus is selected to provide a comfortable eyeglass when placed on the eye and to allow the eyewear wearer to adapt to the operation of the eyewear.
可使用一般熟習此項技術者已知之常規方法測定鏡體之模數。舉例而言,寬度約4 mm之隱形眼鏡片可自眼鏡中心部分切割,且拉伸模數(單位:MPa)可自藉由使用Instron 3342(Instron Corporation)在25℃下在至少75%濕度之空氣中以10 mm/min之速率進行拉伸測試所獲得之應力應變曲線的初始斜率來測定。The modulus of the mirror body can be determined using conventional methods known to those skilled in the art. For example, a contact lens having a width of about 4 mm can be cut from the center portion of the lens, and the tensile modulus (unit: MPa) can be at least 75% humidity at 25 ° C by using Instron 3342 (Instron Corporation). The initial slope of the stress-strain curve obtained by tensile testing at a rate of 10 mm/min in air was measured.
本發明之眼鏡之鏡體的離子流通常小於約5×10-3 mm2 /min。雖然某些本發明之眼鏡的鏡體可具有高達約7×10-3 mm2 /min之離子流,但咸信當離子流小於約5×10-3 mm2 /min,且當隱形眼鏡不包括MPC時,可減少角膜脫水染色。在某些實施例中,鏡體之離子流為約4.5×10-3 mm2 /min、約4×10-3 mm2 /min、約3.5×10-3 mm2 /min、約3×10-3 mm2 /min或更少。然而,如本文所述,離子流可大於7×10-3 mm2 /min,但仍未引起角膜脫水染色或其他臨床問題。The ion current of the lens body of the glasses of the present invention is typically less than about 5 x 10 -3 mm 2 /min. While some of the scopes of the lenses of the present invention may have an ion current of up to about 7 x 10 -3 mm 2 /min, the ion current is less than about 5 x 10 -3 mm 2 /min, and when the contact lens is not Corneal dehydration staining can be reduced when MPC is included. In some embodiments, the ion current of the mirror body is about 4.5 x 10 -3 mm 2 /min, about 4 x 10 -3 mm 2 /min, about 3.5 x 10 -3 mm 2 /min, about 3 x 10 -3 mm 2 /min or less. However, as described herein, the ion current can be greater than 7 x 10 -3 mm 2 /min, but still does not cause corneal dehydration staining or other clinical problems.
本發明之眼鏡之鏡體的離子流可使用一般熟習此項技術者已知之常規方法來測定。舉例而言,隱形眼鏡或鏡體之離子流可使用實質上類似於美國專利第5,849,811號中所述之"Ionoflux Technique"的技術來量測。舉例而言,待量測之眼鏡可置放在保留眼鏡之裝置中的凸形與凹形部分之間。凸形及凹形部分包括位於眼鏡與各凸形或凹形部分之間的可撓性密封環。在將眼鏡定位於保留眼鏡之裝置中之後,將保留眼鏡之裝置置放於帶螺紋之蓋中。將蓋擰至玻璃管上以界定原料物質腔室。原料物質腔室中可填充有16 ml 0.1莫耳濃度之NaCl溶液。接收腔室可填充有80 ml去離子水。將電導計之導線浸入接收腔室之去離子水中,且將攪拌棒添加至接收腔室中。將接收腔室置放在恆溫箱中,且將溫度保持在約35℃。最後,將原料物質腔室浸入接收腔室中。可在將原料物質腔室浸入接收腔室後10分鐘開始,每隔兩分鐘進行電導率之量測,歷時約20分鐘。電導率與時間之關係資料應實質上呈線性。The ion current of the lens body of the glasses of the present invention can be determined using conventional methods known to those skilled in the art. For example, the ion current of the contact lens or lens body can be measured using a technique substantially similar to the "Ionoflux Technique" described in U.S. Patent No. 5,849,811. For example, the spectacles to be measured can be placed between the convex and concave portions of the device that retains the spectacles. The male and female portions include a flexible sealing ring between the eyeglasses and each of the male or female portions. After positioning the glasses in the device that holds the glasses, the device that retains the glasses is placed in a threaded cover. Screw the cover onto the glass tube to define the material chamber. The raw material chamber can be filled with 16 ml of a 0.1 molar concentration of NaCl solution. The receiving chamber can be filled with 80 ml of deionized water. The wire of the conductivity meter is immersed in deionized water in the receiving chamber and a stir bar is added to the receiving chamber. The receiving chamber was placed in an incubator and the temperature was maintained at approximately 35 °C. Finally, the material substance chamber is immersed in the receiving chamber. The conductivity measurement can be performed every two minutes starting from 10 minutes after the raw material chamber is immersed in the receiving chamber for about 20 minutes. The relationship between conductivity and time should be substantially linear.
本發明之眼鏡之鏡體通常具有高透氧性。舉例而言,鏡體具有Dk不小於60 barrer之透氧性。本發明之眼鏡的實施例包含Dk為約80 barrer、約90 barrer、約100 barrer、約110 barrer、約120 barrer、約130 barrer、約140 barrer或更大之鏡體。The lens body of the glasses of the present invention generally has high oxygen permeability. For example, the mirror body has an oxygen permeability of Dk of not less than 60 barrer. Embodiments of the spectacles of the present invention comprise a lens body having a Dk of about 80 barrer, about 90 barrer, about 100 barrer, about 110 barrer, about 120 barrer, about 130 barrer, about 140 barrer or greater.
可使用一般熟習此項技術者已知之常規方法來測定本發明之眼鏡之Dk。舉例而言,Dk值可使用如美國專利第5,817,924號中所述之Mocon方法來測定。Dk值可使用型號名稱為Mocon Ox-Tran System之市售器具來測定。The Dk of the glasses of the present invention can be determined using conventional methods generally known to those skilled in the art. For example, the Dk value can be determined using the Mocon method as described in U.S. Patent No. 5,817,924. The Dk value can be determined using a commercially available instrument of the Mocon Ox-Tran System model name.
本發明之眼鏡亦包含具有眼用可接受之水含量的鏡體。舉例而言,本發明之眼鏡之實施例包含水含量不小於30%之鏡體。在某些實施例中,鏡體具有約35%、約40%、約45%、約50%、約55%、約60%或約65%之水含量。The spectacles of the present invention also comprise a lens body having an ophthalmically acceptable water content. For example, embodiments of the glasses of the present invention comprise a lens body having a water content of not less than 30%. In certain embodiments, the mirror body has a water content of about 35%, about 40%, about 45%, about 50%, about 55%, about 60%, or about 65%.
可使用一般熟習此項技術者已知之常規方法來測定本發明之眼鏡之水含量。舉例而言,水合矽氧水凝膠隱形眼鏡可自水性液體中移除,擦拭以移除過量表面水,且稱重。接著可將經稱重之眼鏡在烘箱中於80℃真空中乾燥,且接著可稱重經乾燥之眼鏡。藉由自水合眼鏡重量減去乾燥眼鏡重量來測定重量差。水含量(%)為(重量差/水合重量)×100。The water content of the lenses of the present invention can be determined using conventional methods generally known to those skilled in the art. For example, a hydrated hydrogel hydrogel contact lens can be removed from an aqueous liquid, wiped to remove excess surface water, and weighed. The weighed glasses can then be dried in an oven at 80 ° C in vacuum and the dried glasses can then be weighed. The weight difference was determined by subtracting the weight of the dry glasses from the weight of the hydrated glasses. The water content (%) is (weight difference / hydration weight) × 100.
除上文所確定之特定值以外,本發明之眼鏡可具有在上文所確定之特定值之任何組合之間範圍內之值。舉例而言,本發明之隱形眼鏡可具有約45%至約55%之水含量,約3至約4之離子流值,約35°至約45°之靜態接觸角,約55°至約80°之前進接觸角,約47°至約55°之後退接觸角,約11°至約25°之滯後,約0.47 MPa至約0.51 MPa之楊氏模數(Young's moduli)、約140%至約245%之伸長率及其組合。The spectacles of the present invention may have values in the range between any combination of the specific values determined above, in addition to the specific values determined above. For example, the contact lenses of the present invention can have a water content of from about 45% to about 55%, an ion current value of from about 3 to about 4, a static contact angle of from about 35 to about 45, from about 55 to about 80. °Advance contact angle, about 47° to about 55° receding contact angle, lag of about 11° to about 25°, Young's moduli of about 0.47 MPa to about 0.51 MPa, about 140% to about 245% elongation and combinations thereof.
在本發明之矽氧水凝膠隱形眼鏡之某些特定實施例中,鏡體具有小於0.5 MPa之模數,小於4之離子流及約42-46%之水含量。In certain particular embodiments of the helium oxygen hydrogel contact lenses of the present invention, the lens body has a modulus of less than 0.5 MPa, an ion current of less than 4, and a water content of about 42-46%.
本發明之矽氧水凝膠隱形眼鏡為矯正視力或增強視力之隱形眼鏡。眼鏡可為球面眼鏡或非球面眼鏡。眼鏡可為單焦點眼鏡或多焦點眼鏡,包括雙焦點眼鏡。在某些實施例中,本發明之眼鏡為旋轉穩定眼鏡,諸如旋轉穩定複曲面隱形眼鏡。旋轉穩定隱形眼鏡可為包含包括壓載物之鏡體的隱形眼鏡。舉例而言,鏡體可具有稜鏡壓載物、周圍壓載物及/或一或多個薄化上方及下方區域。The oxygenated hydrogel contact lens of the present invention is a contact lens for correcting vision or enhancing vision. The glasses can be spherical or aspherical. The glasses can be single focus glasses or multifocal glasses, including bifocal glasses. In certain embodiments, the spectacles of the present invention are rotationally stable spectacles, such as rotationally stable toric contact lenses. The rotationally stable contact lens can be a contact lens comprising a mirror body comprising a ballast. For example, the mirror body can have a ballast, a surrounding ballast, and/or one or more thinned upper and lower regions.
本發明之眼鏡亦包含包括外周邊緣區域之鏡體。外周邊緣區域可包括圓形部分。舉例而言,外周邊緣區域可包含圓形後邊緣表面、圓形前邊緣表面或其組合。在某些實施例中,外周邊緣自前表面至後表面完全成圓形。因此,可瞭解本發明之眼鏡之鏡體可包含圓形外周邊緣。The spectacles of the present invention also include a scope comprising a peripheral edge region. The peripheral edge region may include a circular portion. For example, the peripheral edge region can comprise a rounded trailing edge surface, a rounded leading edge surface, or a combination thereof. In some embodiments, the peripheral edge is completely rounded from the front surface to the back surface. Thus, it will be appreciated that the scope of the eyeglasses of the present invention can comprise a rounded peripheral edge.
本發明之眼鏡可包含其厚度分布解決與現有矽氧水凝膠隱形眼鏡相關之問題但對眼鏡配戴者而言仍舒適之鏡體。藉由改變鏡體厚度及鏡體模數,可控制鏡體之硬度。舉例而言,隱形眼鏡之一區域的硬度可定義為眼鏡之楊氏模數與指定區域之眼鏡厚度平方的乘積。因此,本發明之眼鏡之某些實施例可包含中心硬度(例如眼鏡中心或視區中心之硬度)小於約0.007 MPa-mm2 、眼鏡接面硬度小於約0.03 MPa-mm2 或其組合之鏡體。眼鏡接面可定義為眼鏡區與斜面或(對於無斜面之眼鏡而言)距離眼鏡邊緣約1.2 mm之點的接面(參見美國專利第6,849,671號)。在其他實施例中,本發明之眼鏡可包含中心硬度大於0.007 MPa-mm2 、眼鏡接面硬度大於約0.03 MPa-mm2 或其組合之鏡體。The spectacles of the present invention may comprise a lens body whose thickness profile solves the problems associated with prior oxyhydrogel contact lenses but is still comfortable for the lens wearer. The hardness of the mirror body can be controlled by changing the thickness of the mirror body and the modulus of the mirror body. For example, the hardness of a region of a contact lens can be defined as the product of the Young's modulus of the eyeglass and the square of the eyeglass thickness of the designated area. Thus, certain embodiments of the glasses of the present invention may comprise a mirror having a central hardness (e.g., a center of the eyeglass or a center of the viewing zone) of less than about 0.007 MPa-mm 2 , a lens joint hardness of less than about 0.03 MPa-mm 2 , or a combination thereof. body. The spectacles junction can be defined as the junction of the spectacles and bevels or (for slanted glasses) at a point of about 1.2 mm from the edge of the spectacles (see U.S. Patent No. 6,849,671). In other embodiments, the spectacles of the present invention may comprise a lens body having a center hardness greater than 0.007 MPa-mm 2 and a lens joint hardness greater than about 0.03 MPa-mm 2 or a combination thereof.
理想的是,在眼鏡或大批眼鏡中,本發明之矽氧水凝膠隱形眼鏡之物理參數(諸如物理尺寸及其類似物)具有小的可變性。舉例而言,在某些實施例中,將諸如鏈轉移劑之添加劑添加至可聚合矽氧水凝膠隱形眼鏡前驅體組合物中以減少眼鏡物理屬性之可變性。使用該等控制物理參數之添加劑,任兩批眼鏡之間的可變性較佳小於2%。舉例而言,一或多批本發明之眼鏡之可變性可為約0.5%至約1.9%。舉例而言,本發明之眼鏡之直徑及基礎曲線可控制在預定值之1.6%內。更特定言之,若目標隱形眼鏡直徑為14.0 mm,且若一批隱形眼鏡中隱形眼鏡之實際直徑在約13.6 mm至約14.4 mm之間變化,則可在隱形眼鏡產生期間使用一或多種添加劑以減少可變性,且產生直徑在約13.8 mm至約14.2 mm範圍內之隱形眼鏡。可提供類似控制以減少眼鏡厚度、徑向深度、基礎曲率及其類似物之變化。Desirably, the physical parameters of the oxygenated hydrogel contact lenses of the present invention, such as physical dimensions and the like, have little variability in spectacles or bulk glasses. For example, in certain embodiments, an additive such as a chain transfer agent is added to the polymerizable silicone hydrogel contact lens precursor composition to reduce the variability in the physical properties of the lens. The variability between any two batches of glasses is preferably less than 2% using such additives that control physical parameters. For example, one or more batches of the lenses of the present invention may have a variability of from about 0.5% to about 1.9%. For example, the diameter and base curve of the glasses of the present invention can be controlled to within 1.6% of the predetermined value. More specifically, if the target contact lens diameter is 14.0 mm, and if the actual diameter of the contact lens in a batch of contact lenses varies from about 13.6 mm to about 14.4 mm, one or more additives may be used during contact lens production. To reduce variability and to produce contact lenses having a diameter ranging from about 13.8 mm to about 14.2 mm. Similar controls can be provided to reduce variations in spectacles thickness, radial depth, base curvature, and the like.
本發明之矽氧水凝膠隱形眼鏡可提供於密封包裝中。舉例而言,本發明之矽氧水凝膠隱形眼鏡可提供於密封發泡包裝或適於傳遞給眼鏡配戴者之其他類似容器中。眼鏡可儲存在包裝內之水溶液中,諸如生理食鹽水溶液。某些合適溶液包括磷酸鹽緩衝生理食鹽水溶液及硼酸鹽緩衝溶液。必要時,溶液可包括消毒劑或可無消毒劑或防腐劑。必要時,溶液亦可包括界面活性劑,諸如泊洛沙姆(poloxamer)及其類似物。The oxygenated hydrogel contact lenses of the present invention can be provided in a sealed package. For example, the oxygenated hydrogel contact lenses of the present invention can be provided in a sealed blister pack or other similar container suitable for delivery to a spectacles wearer. The spectacles can be stored in an aqueous solution within the package, such as a physiological saline solution. Some suitable solutions include phosphate buffered physiological saline solutions and borate buffer solutions. The solution may or may not include a disinfectant or a preservative if necessary. If necessary, the solution may also include a surfactant such as poloxamer and the like.
密封包裝內之眼鏡較佳無菌。舉例而言,眼鏡可在密封包裝之前殺菌或可在密封包裝內殺菌。經殺菌之眼鏡可為已暴露於殺菌量之輻射之眼鏡。舉例而言,眼鏡可為經高壓釜處理之眼鏡、經γ輻射之眼鏡、經紫外輻射暴露之眼鏡及其類似物。The lenses in the sealed package are preferably sterile. For example, the spectacles can be sterilized prior to sealing the package or can be sterilized within the sealed package. The sterilized spectacles may be spectacles that have been exposed to sterilizing radiation. For example, the glasses can be autoclaved glasses, gamma irradiated glasses, ultraviolet radiation exposed glasses, and the like.
以下實例說明本發明之某些態樣及優勢,然而絕不認為本發明限於以下所述之特定實施例。The following examples illustrate some aspects and advantages of the invention, but the invention is not to be considered as limited to the specific embodiments described below.
除非另外指出,否則本發明之實踐將採用此項技術技能範圍內之聚合物合成、水凝膠形成及其類似物之習知技術。該等技術在文獻中充分說明。除非相反特定說明,否則試劑及物質為市售的。The practice of the present invention will employ, unless otherwise indicated, conventional techniques of polymer synthesis, hydrogel formation, and the like within the skill of the art. These techniques are fully described in the literature. Reagents and materials are commercially available unless specifically stated to the contrary.
製備隱形眼鏡(例如矽氧水凝膠隱形眼鏡)之方法描述於以下專利中:美國專利第4,121,896號、第4,495,313號、第4,565,348號、第4,640,489號、第4,889,664號、第4,985,186號、第5,039,459號、第5,080,839號、第5,094,609號、第5,260,000號、第5,607,518號、第5,760,100號、第5,850,107號、第5,935,492號、第6,099,852號、第6,367,929號、第6,822,016號、第6,867,245號、第6,869,549號、第6,939,487號及美國專利公開案第20030125498號、第20050154080號及第20050191335號。Methods of making contact lenses, such as neohydrogenated hydrogel contact lenses, are described in U.S. Patent Nos. 4,121,896, 4,495,313, 4,565,348, 4,640,489, 4,889,664, 4,985,186, 5,039,459. , Nos. 5,080,839, 5,094,609, 5,260,000, 5,607,518, 5,760,100, 5,850,107, 5,935,492, 6,099,852, 6,367,929, 6,822,016, 6,867,245, 6,869,549, No. 6,939,487 and U.S. Patent Publication Nos. 20030125498, No. 20050154080, and No. 20050191335.
在以下實例中,雖然已努力確保與所用數字(例如量、溫度等)相關之精確性,但仍應解決某些實驗誤差及偏差。除非另外指出,否則溫度以℃計,且壓力在海平面下為大氣壓力或接近大氣壓力。In the following examples, while efforts have been made to ensure accuracy with respect to the numbers used (eg, amount, temperature, etc.), certain experimental errors and deviations should still be addressed. Unless otherwise indicated, the temperature is in °C and the pressure is at or near atmospheric pressure at sea level.
以下熟知之化學物質在實例中提及,且在某些情況下,由其如下提出之縮寫提及。The following well-known chemical substances are mentioned in the examples, and in some cases, are mentioned by the abbreviations proposed below.
縮寫 AE:烯丙氧基乙醇DI:去離子化HEMA:甲基丙烯酸2-羥乙酯IPA:異丙醇MMA:甲基丙烯酸甲酯M3U:M3-U;α-ω-雙(甲基丙烯醯氧基乙基亞胺基羧基乙氧基丙基)-聚(二甲基矽氧烷)-聚(三氟丙基甲基矽氧烷)-聚(ω-甲氧基-聚(乙二醇)丙基甲基矽氧烷;含二甲基丙烯醯基矽氧大分子單體 Abbreviation AE: allyloxyethanol DI: deionized HEMA: 2-hydroxyethyl methacrylate IPA: isopropanol MMA: methyl methacrylate M3U: M3-U; α-ω-bis (methacryl醯Ethoxyethyliminocarboxycarbonylpropyl)-poly(dimethyloxane)-poly(trifluoropropylmethyloxirane)-poly(ω-methoxy-poly(B) Glycol) propylmethyl decane; dimethyl methacrylate oxime macromonomer
以下實例中所用之M3U由下式表示,其中n為121,m為7.6,h為4.4,p為7.4,且Mn=12,800,且Mw=16,200(Asahikasei Aime Co.,Ltd.,Japan)。The M3U used in the following examples is represented by the following formula, wherein n is 121, m is 7.6, h is 4.4, p is 7.4, and Mn = 12,800, and Mw = 16,200 (Asahikasei Aime Co., Ltd., Japan).
M3U著色:β銅酞菁於M3U中之分散液(重量%)。銅酞菁可自BASF以Heliogen Blue K7090獲得。N,N-DMF:DMF;N,N-二甲基甲醯胺NVP:1-乙烯基-2-吡咯啶酮(在真空下新鮮蒸餾)PDMS:聚二甲基矽氧烷PDMS-共-PEG:聚二甲基矽氧烷與PEG之嵌段共聚物,其含有75% PEG且MW為600(來自Gelest之DBE712)PEG:聚乙二醇PP:丙基丙烯Pr:丙醇TEGDMA:二甲基丙烯酸三乙二醇酯TEGDVE:三乙二醇二乙烯醚TPO:聯苯基(2,4,6-三甲基苯甲醯基)氧化膦TPTMA:三羥甲基丙烷三甲基丙烯酸酯UV416:丙烯酸2-(4-苯甲醯基-3-羥基苯氧基)乙酯Vazo-52:2,2'-偶氮雙(2,4-二甲基戊腈)(V-52;熱引發劑)Vazo-64:偶氮二異丁腈(V-64;熱引發劑)VMA:N-乙烯基-N-甲基乙醯胺(在真空下新鮮蒸餾)VM:甲基丙烯酸乙烯酯M3U coloring: dispersion of β copper phthalocyanine in M3U (% by weight). Copper phthalocyanine is available from BASF as Heliogen Blue K7090. N,N-DMF:DMF; N,N-dimethylformamide NVP: 1-vinyl-2-pyrrolidone (fresh distillation under vacuum) PDMS: polydimethyloxane PDMS-total PEG: block copolymer of polydimethylsiloxane and PEG, which contains 75% PEG and MW 600 (DBE712 from Gelest) PEG: polyethylene glycol PP: propyl propylene Pr: propanol TEGDMA: two Triethylene glycol methacrylate TEGDVE: triethylene glycol divinyl ether TPO: biphenyl (2,4,6-trimethyl benzhydryl) phosphine oxide TPTMA: trimethylolpropane trimethacrylic acid Ester UV416: 2-(4-Benzylmercapto-3-hydroxyphenoxy)ethyl acrylate Vazo-52: 2,2'-azobis(2,4-dimethylvaleronitrile) (V-52 ; thermal initiator) Vazo-64: azobisisobutyronitrile (V-64; thermal initiator) VMA: N-vinyl-N-methylacetamide (fresh distillation under vacuum) VM: methacrylic acid Vinyl ester
前進接觸角/後退接觸角 可使用一般熟習此項技術者已知之常規方法測定前進接觸角。舉例而言,可使用習知液滴形狀法(諸如固著液滴法或俘獲氣泡法)來量測本文所提供之隱形眼鏡之前進接觸角及後退接觸角。矽氧水凝膠隱形眼鏡之前進及後退水接觸角可使用Kruss DSA 100器具(Kruss GmbH,Hamburg)且如D.A.Brandreth:"Dynamic contact angles and contact angle hysteresis",Journal of Colloid and Interface Science,第62卷,1977,第205-212頁及R.Knapikowski,M.Kudra:Kontaktwinkelmessungen nach dem Wilhelmy-Prinzip-Ein statistischer Ansatz zur Fehierbeurteilung",Chem.Technik,第45卷,1993,第179-185頁及美國專利第6,436,481號中所述來測定。 Advancing contact angle/reverse contact angle The advancing contact angle can be determined using conventional methods known to those skilled in the art. For example, a conventional drop shape method, such as a sessile drop method or a trapped bubble method, can be used to measure the anterior contact angle and receding contact angle of the contact lenses provided herein. The Kruss DSA 100 appliance (Kruss GmbH, Hamburg) can be used for the front and back water contact angles of the deoxygenated hydrogel contact lenses and as DABrandreth: "Dynamic contact angles and contact angle hysteresis", Journal of Colloid and Interface Science, Vol. 62 , 1977, pp. 205-212 and R. Knapikowski, M. Kudra: Kontaktwinkelmessungen nach dem Wilhelmy-Prinzip-Ein statistischer Ansatz zur Fehierbeurteilung", Chem. Technik, Vol. 45, 1993, pp. 179-185 and US Patent Measured as described in 6,436,481.
例如,前進接觸角及後退接觸角可使用俘獲氣泡法使用磷酸鹽緩衝生理食鹽水(PBS;pH=7.2)來測定。使眼鏡平鋪在石英表面上且在測試之前用PBS再水合10分鐘。使用自動注射系統將氣泡置放於眼鏡表面上。可增加及減小氣泡大小以獲得後退角(當增加氣泡大小時獲得平臺)及前進角(當減小氣泡大小時獲得平臺)。For example, the advancing contact angle and the receding contact angle can be determined using a trapped bubble method using phosphate buffered physiological saline (PBS; pH = 7.2). The glasses were tiled on the quartz surface and rehydrated with PBS for 10 minutes prior to testing. Air bubbles are placed on the surface of the glasses using an automatic injection system. The bubble size can be increased and decreased to obtain a receding angle (a platform is obtained when the bubble size is increased) and an advancing angle (a platform is obtained when the bubble size is reduced).
模數 可使用一般熟習此項技術者已知之常規方法測定鏡體之模數。舉例而言,寬度約4 mm之隱形眼鏡片可自眼鏡中心部分切割,且拉伸模數(單位:MPa)可自藉由使用Instron 3342(Instron Corporation)在25℃下在至少75%濕度之空氣中以10 mm/min之速率進行拉伸測試所獲得之應力應變曲線的初始斜率來測定。 Modulus The modulus of the mirror body can be determined using conventional methods known to those skilled in the art. For example, a contact lens having a width of about 4 mm can be cut from the center portion of the lens, and the tensile modulus (unit: MPa) can be at least 75% humidity at 25 ° C by using Instron 3342 (Instron Corporation). The initial slope of the stress-strain curve obtained by tensile testing at a rate of 10 mm/min in air was measured.
離子流 本發明之眼鏡之鏡體的離子流可使用一般熟習此項技術者已知之常規方法來測定。舉例而言,隱形眼鏡或鏡體之離子流可使用實質上類似於美國專利第5,849,811號中所述之"Ionoflux Technique"的技術來量測。舉例而言,待量測之眼鏡可置放在保留眼鏡之裝置中的凸形與凹形部分之間。凸形及凹形部分包括位於眼鏡與各凸形或凹形部分之間的可撓性密封環。在將眼鏡定位於保留眼鏡之裝置中之後,將保留眼鏡之裝置置放於帶螺紋之蓋中。將蓋擰至玻璃管上以界定原料物質腔室。原料物質腔室中可填充有16 ml 0.1莫耳濃度之NaCl溶液。接收腔室可填充有80 ml去離子水。將電導計之導線浸入接收腔室之去離子水中,且將攪拌棒添加至接收腔室中。將接收腔室置放在恆溫箱中,且將溫度保持在約35℃。最後,將原料物質腔室浸入接收腔室中。可在將原料物質腔室浸入接收腔室後10分鐘開始,每隔兩分鐘進行電導率之量測,歷時約20分鐘。電導率與時間之關係資料應實質上呈線性。 Ion Current The ion current of the lens body of the glasses of the present invention can be determined using conventional methods known to those skilled in the art. For example, the ion current of the contact lens or lens body can be measured using a technique substantially similar to the "Ionoflux Technique" described in U.S. Patent No. 5,849,811. For example, the spectacles to be measured can be placed between the convex and concave portions of the device that retains the spectacles. The male and female portions include a flexible sealing ring between the eyeglasses and each of the male or female portions. After positioning the glasses in the device that holds the glasses, the device that retains the glasses is placed in a threaded cover. Screw the cover onto the glass tube to define the material chamber. The raw material chamber can be filled with 16 ml of a 0.1 molar concentration of NaCl solution. The receiving chamber can be filled with 80 ml of deionized water. The wire of the conductivity meter is immersed in deionized water in the receiving chamber and a stir bar is added to the receiving chamber. The receiving chamber was placed in an incubator and the temperature was maintained at approximately 35 °C. Finally, the material substance chamber is immersed in the receiving chamber. The conductivity measurement can be performed every two minutes starting from 10 minutes after the raw material chamber is immersed in the receiving chamber for about 20 minutes. The relationship between conductivity and time should be substantially linear.
透氧性 可使用一般熟習此項技術者已知之常規方法來測定本發明之眼鏡之Dk。舉例而言,Dk值可使用如美國專利第5,817,924號中所述之Mocon方法來測定。Dk值可使用型號名稱為Mocon Ox-Tran System之市售器具來測定。 Oxygen Permeability The Dk of the lenses of the present invention can be determined using conventional methods generally known to those skilled in the art. For example, the Dk value can be determined using the Mocon method as described in U.S. Patent No. 5,817,924. The Dk value can be determined using a commercially available instrument of the Mocon Ox-Tran System model name.
平衡水含量 可使用一般熟習此項技術者已知之常規方法來測定本發明之眼鏡之水含量。舉例而言,水合矽氧水凝膠隱形眼鏡可自水性液體中移除,擦拭以移除過量表面水,且稱重。接著可將經稱重之眼鏡在烘箱中於80℃真空中乾燥,且接著可稱重經乾燥之眼鏡。藉由自水合眼鏡重量減去乾燥眼鏡重量來測定重量差。水含量(%)為(重量差/水合重量)×100。 Equilibrium Water Content The water content of the lenses of the present invention can be determined using conventional methods generally known to those skilled in the art. For example, a hydrated hydrogel hydrogel contact lens can be removed from an aqueous liquid, wiped to remove excess surface water, and weighed. The weighed glasses can then be dried in an oven at 80 ° C in vacuum and the dried glasses can then be weighed. The weight difference was determined by subtracting the weight of the dry glasses from the weight of the hydrated glasses. The water content (%) is (weight difference / hydration weight) × 100.
使用以下指定之試劑及相對量來製備可聚合矽氧水凝膠隱形眼鏡前驅體組合物。歸因於所得水合隱形眼鏡產物之低模數,此調配物在本文稱為"低模數調配物"或"LMF"。The polymerizable silicone hydrogel contact lens precursor composition was prepared using the reagents and relative amounts specified below. Due to the low modulus of the resulting hydrated contact lens product, this formulation is referred to herein as a "low modulus formulation" or "LMF."
稱重表1中之組份且混合以形成混合物。經由0.2-20.0微米注射過濾器將混合物過濾至瓶中,且儲存長達約2週。(此混合物在本文稱為可聚合矽氧水凝膠隱形眼鏡前驅體組合物)。在表1中,除各自重量百分比(以重量/重量表示;重量比)以外,提供單位量之各化合物。The components in Table 1 were weighed and mixed to form a mixture. The mixture was filtered into vials via a 0.2-20.0 micron syringe filter and stored for up to about 2 weeks. (This mixture is referred to herein as a polymerizable silicone hydrogel contact lens precursor composition). In Table 1, each unit amount of each compound is provided in addition to the respective weight percentages (expressed by weight/weight; weight ratio).
在最終之矽氧水凝膠隱形眼鏡中,各化學組份之百分比與組合物中所存在之單位量而非相應重量百分比更密切相關。In the final oxime hydrogel contact lens, the percentage of each chemical component is more closely related to the unit amount present in the composition than the corresponding weight percentage.
使用重複真空/氮沖洗程序使來自實例1之大量前驅體組合物脫氣。接著將經脫氣之前驅體組合物置放至凹形非極性樹脂模具構件中。接著藉由在達成緊密配合所需之壓力下與非極性樹脂凸形模具構件接觸置放來封閉經填充之凹形模具構件。接著在氮批料烘箱中以如下循環進行固化:室溫下30 min N2 淨化,55℃下30 min及80℃下60 min。藉由敲擊隱形眼鏡模具之凹形模具構件進行脫模,以使得凸形模具構件自其釋放,其中聚合矽氧水凝膠隱形眼鏡產物黏附於凸形模具構件。藉由浮離法或使用機械脫鏡設備進行脫鏡。浮離法包括將含有乾燥眼鏡之凸形模具構件浸泡於一桶水中。眼鏡通常在約10分鐘內離開模具。藉由壓縮及旋轉聚合矽氧水凝膠隱形眼鏡產物黏附至其之凸形模具構件,引導氣體介於隱形眼鏡產物與旋轉凸形模具構件之間,且對隱形眼鏡產物之暴露表面施加真空來進行機械脫鏡。接著將經分離之眼鏡負載至塑料盤上以進行萃取及水合。A large number of precursor compositions from Example 1 were degassed using a repeated vacuum/nitrogen rinse procedure. The degassed precursor composition is then placed into a concave non-polar resin mold member. The filled female mold member is then closed by contact with a non-polar resin male mold member under the pressure required to achieve a tight fit. The curing was then carried out in a nitrogen batch oven in the following cycle: 30 min N 2 purification at room temperature, 30 min at 55 ° C and 60 min at 80 ° C. Demolding is performed by tapping a concave mold member of the contact lens mold such that the male mold member is released therefrom, wherein the polymeric oxygenated hydrogel contact lens product adheres to the male mold member. The mirror is removed by a floatation method or using a mechanical lens removal device. The floatation method involves soaking a convex mold member containing dry glasses in a bucket of water. The glasses typically leave the mold in about 10 minutes. The compressed gas is interposed between the contact lens product and the rotating male mold member by compressing and rotating the polymeric oxygenated hydrogel contact lens product to which the convex mold member is adhered, and applying a vacuum to the exposed surface of the contact lens product Perform mechanical removal. The separated spectacles are then loaded onto a plastic tray for extraction and hydration.
於室溫下,將含有聚合矽氧水凝膠隱形眼鏡產物之眼鏡盤浸入溶劑液體(諸如含有95%乙醇及5%甲醇之工業甲基化酒精(IMS))中歷時45 min。接著排出溶劑且用新鮮IMS代替,且用IMS(3次)、1:1醇/水(3次)及DI水(3次)重複該方法。The spectacles containing the polymerized hydrogel contact lens product were immersed in a solvent liquid (such as industrial methylated spirit (IMS) containing 95% ethanol and 5% methanol) for 45 min at room temperature. The solvent was then drained and replaced with fresh IMS and the procedure was repeated with IMS (3 times), 1:1 alcohol/water (3 times) and DI water (3 times).
將水合眼鏡儲存於含有DI水之玻璃小瓶或發泡包裝中或儲存於pH為7.1-7.5之磷酸鹽緩衝生理食鹽水中。在121℃下將密封容器高壓釜處理30 min。在高壓釜處理24 h後,進行眼鏡量測。The hydrated spectacles are stored in a glass vial or blister pack containing DI water or stored in phosphate buffered physiological saline at a pH of 7.1-7.5. The sealed vessel autoclave was treated at 121 ° C for 30 min. After 24 hours of autoclaving, glasses were measured.
稱重所得水合矽氧水凝膠隱形眼鏡,且接著在烘箱中脫水,且再次稱重以測定經脫水之矽氧水凝膠隱形眼鏡之乾重。The resulting hydrated hydrogel hydrogel contact lenses were weighed and then dehydrated in an oven and weighed again to determine the dry weight of the dehydrated hydrogel hydrogel contact lens.
如本文所述,測定眼鏡特性,諸如接觸角(包括動態接觸角及靜態接觸角)、透氧性、離子流、模數、伸長率、拉伸強度、水含量及其類似特性。水合矽氧水凝膠隱形眼鏡之可濕性亦藉由量測眼鏡之水驅散時間來檢測。Spectacle characteristics such as contact angle (including dynamic contact angle and static contact angle), oxygen permeability, ion current, modulus, elongation, tensile strength, water content, and the like are determined as described herein. The wettability of the hydrated hydrogel hydrogel contact lens is also detected by measuring the water dispersing time of the glasses.
在分配研究期間,進一步檢測眼睛相容性,其中將隱形眼鏡置放於人眼上歷時1小時、3小時或6小時或更長時間,且接著進行臨床評估。Eye compatibility was further tested during the dispensing study, where the contact lenses were placed on the human eye for 1 hour, 3 hours, or 6 hours or longer, and then clinical evaluation was performed.
由本發明之調配物所產生之矽氧水凝膠隱形眼鏡具有眼用可接受之表面可濕性。該等矽氧水凝膠隱形眼鏡具有44+/-2%之平衡水濃度(EWC),且經測定具有48.9+/-0.7%之可萃取物含量。The oxygenated hydrogel contact lenses produced from the formulations of the present invention have an ophthalmically acceptable surface wettability. The hydroxyl hydrogel contact lenses have an equilibrium water concentration (EWC) of 44 +/- 2% and have been determined to have an extractables content of 48.9 +/- 0.7%.
所得水合隱形眼鏡具有以下特性:
在最終之眼鏡中,在萃取程序後,將大部分(若非所有)矽油與未反應之單體或線性聚合物組份一起萃取。在本實例中,萃取後未偵測到矽油。In the final glasses, after the extraction procedure, most, if not all, of the eucalyptus oil is extracted with the unreacted monomer or linear polymer component. In this example, no eucalyptus oil was detected after extraction.
製備一系列數批眼鏡以用於臨床評估。自如實例1中所述之前驅體組合物製備眼鏡。該數批眼鏡經表徵且具有以下特性。A series of lenses were prepared for clinical evaluation. Spectacles were prepared from the precursor composition as described in Example 1. The batch of glasses was characterized and had the following characteristics.
在上述各表中,GPC值為萃取及水合後殘餘可移除物含量之相對讀數。使用氯仿作為用以接觸先前萃取之隱形眼鏡的最終萃取溶劑,萃取及水合後之總殘餘/可萃取物含量在約0.4%至2%之範圍內。對各組眼鏡而言,量測3至5個重複樣品。In each of the above tables, the GPC value is the relative reading of the residual removable content after extraction and hydration. Chloroform was used as the final extraction solvent to contact the previously extracted contact lenses, and the total residual/extractable content after extraction and hydration was in the range of about 0.4% to 2%. For each set of glasses, 3 to 5 replicate samples were measured.
使用以下指定之試劑及量來製備可聚合矽氧水凝膠隱形眼鏡前驅體組合物。歸因於所得水合矽氧水凝膠隱形眼鏡產物中之低模數及低批次間變化,此調配物在本文中稱為"微調低模數調配物"或"MLMF"。The polymerizable silicone hydrogel contact lens precursor composition was prepared using the reagents and amounts specified below. This formulation is referred to herein as a "fine-tuned low modulus formulation" or "MLMF" due to the low modulus and low batch-to-batch variation in the resulting hydrated hydrogel hydrogel contact lens product.
稱重上表4中之組份且混合以形成混合物。經由0.2-5.0微米注射過濾器將混合物過濾至瓶中,且儲存長達約2週。The components in Table 4 above were weighed and mixed to form a mixture. The mixture was filtered into a vial via a 0.2-5.0 micron syringe filter and stored for up to about 2 weeks.
前驅體組合物與實例1中所述之前驅體組合物的不同之處在於矽油組份中包括AE。將AE添加至矽油中,之後將矽油與前驅體調配物中所含之其他化學試劑混合,且有利地用以減少所得水合隱形眼鏡產物之尺寸及物理特性的可變性。The precursor composition differs from the precursor composition described in Example 1 in that AE is included in the oyster oil component. The AE is added to the eucalyptus oil, after which the eucalyptus oil is mixed with other chemical agents contained in the precursor formulation, and is advantageously used to reduce the variability in the size and physical properties of the resulting hydrated contact lens product.
基本上如以上實例2中所述進行隱形眼鏡之調配。所得水合隱形眼鏡具有類似於實例2中所述眼鏡之物理特性,其具有以下有利之例外情況-眼鏡直徑、EWC及離子流之任一或多者的可變性通常低於在AE不存在下所製備之調配物中之彼等的可變性。The dispensing of the contact lenses was carried out essentially as described in Example 2 above. The resulting hydrated contact lens has physical properties similar to those described in Example 2, with the following advantageous exceptions - the variability of either or both of the spectacles diameter, EWC, and ion current is generally lower than in the absence of AE Their variability in the formulations prepared.
進行以下實驗以進一步研究向矽油中添加不同量之烯丙氧基乙醇以藉此減少最終經萃取水合隱形眼鏡產物中之尺寸及物理特性之批次變化的作用。The following experiment was conducted to further investigate the effect of adding varying amounts of allyloxyethanol to the eucalyptus oil to thereby reduce batch variations in size and physical properties in the final extracted hydrated contact lens product.
如實例1及3中所述來製備單體混合物(可聚合矽氧水凝膠前驅體組合物)。調配物組份與以上實例1中所述者相同,其中例外為可萃取之矽油組份在矽油中視情況含有各種量之烯丙氧基乙醇:0、2、4及6%。調配物詳情提供於下表4及5中。將各種量之烯丙氧基醇添加至三種不同貨號之矽油(Gelest)的每一者中。A monomer mixture (polymerizable hydroxyl hydrogel precursor composition) was prepared as described in Examples 1 and 3. The formulation components were the same as those described in Example 1 above, with the exception that the extractable emu oil component contained various amounts of allyloxyethanol in the emu oil as appropriate: 0, 2, 4 and 6%. Details of the formulations are provided in Tables 4 and 5 below. Various amounts of allyloxy alcohol were added to each of the three different grades of Gelest.
將單體混合物過濾且脫氣,分散於凹形聚丙烯隱形眼鏡模具構件之眼鏡形成表面上,且將凸形模具構件與凹形模具構件嚙合以形成在隱形眼鏡狀腔室中含有單體混合物之隱形眼鏡模具。工具之EF(膨脹係數)為約1.1%或鋼質隱形眼鏡模具插入物之外徑為約14.3 mm。在分批烘箱中在N2 下進行固化。通常將經填充之模具置放於N2 批料烘箱內,且用N2 淨化30 min以將氧含量減少至小於1000 ppm,繼而第一次加熱至55℃歷時30 min,繼而加熱至80℃歷時60 min。The monomer mixture is filtered and degassed, dispersed on the lens forming surface of the concave polypropylene contact lens mold member, and the male mold member is engaged with the female mold member to form a monomer mixture in the contact lens-like chamber Contact lens mold. The tool has an EF (expansion coefficient) of about 1.1% or an outer diameter of the steel contact lens mold insert of about 14.3 mm. Curing was carried out under N 2 in a batch oven. The filled mold is typically placed in a N 2 batch oven and purged with N 2 for 30 min to reduce the oxygen content to less than 1000 ppm, followed by the first heating to 55 ° C for 30 min, followed by heating to 80 ° C. It lasted 60 minutes.
固化後,在臺式脫模機上進行脫模及脫鏡。所有調配物之眼鏡均顯示良好之脫模/脫鏡特徵。After curing, demolding and mirror removal were performed on a benchtop stripper. All formulations of the glasses showed good release/off mirror characteristics.
將乾燥眼鏡負載於聚丙烯盤中,且相繼使用乙醇、乙醇-水及水各自循環洗滌約30分鐘來萃取及水合,且與熱水接觸。接著將經萃取及水合之眼鏡置放於含有pH 7.2 PBS緩衝液(含有界面活性劑)之小瓶中且經高壓釜處理。The dry glasses were loaded in a polypropylene pan, and successively washed with ethanol, ethanol-water and water for about 30 minutes to extract and hydrate, and contacted with hot water. The extracted and hydrated lenses were then placed in vials containing pH 7.2 PBS buffer (containing surfactant) and autoclaved.
量測眼鏡且在高壓釜處理後1天進行檢查。僅量測未變形眼鏡之尺寸及物理特性,包括直徑、基礎曲線、平衡水含量、靜態及動態接觸角、拉伸特性(模數、拉伸強度及伸長率)及離子流。The glasses were measured and inspected one day after the autoclave treatment. Only the dimensions and physical properties of undeformed glasses are measured, including diameter, base curve, equilibrium water content, static and dynamic contact angles, tensile properties (modulus, tensile strength and elongation), and ion current.
研究向矽油中添加各種量之烯丙氧基乙醇為一種(i)減少所得經萃取/水合矽氧水凝膠隱形眼鏡產物中各批次之間的差異,及(ii)提供具有所需尺寸及物理特性之隱形眼鏡的方式。Studying the addition of various amounts of allyloxyethanol to eucalyptus oil as one (i) reducing the difference between batches in the resulting extracted/hydrated hydrogel hydrogel contact lens product, and (ii) providing the desired size And the way physical contact lenses are used.
經萃取水合隱形眼鏡之高壓釜處理後的直徑及物理特性提供於表7中。直徑、平衡水含量及離子流與烯丙氧基乙醇含量之關係分別顯示於圖4、5及6中。The diameter and physical properties of the autoclave after extraction of the hydrated contact lenses are provided in Table 7. The relationship between diameter, equilibrium water content, and ion current and allyloxyethanol content are shown in Figures 4, 5 and 6, respectively.
如圖3中所示,在所有三種調配物(系列A1、B1及C1)中均使用25份矽油/AE混合物;眼鏡直徑隨混合物中AE含量增加而減少。各系列對應於由給定貨號之矽油所製備之隱形眼鏡,其中用於各系列A1、B1及C1之矽油均不同。As shown in Figure 3, 25 parts of the eucalyptus/AE mixture were used in all three formulations (Series A1, B1 and C1); the diameter of the spectacles decreased as the AE content in the mixture increased. Each series corresponds to a contact lens prepared from a given article of eucalyptus oil, wherein the eucalyptus oils used in each series A1, B1 and C1 are different.
A系列產生之眼鏡比系列B或C產生之眼鏡大。早期使用未添加有AE之系列A矽油製得25C眼鏡之臨床試驗導致眼鏡具有相對較高之脫水染色速率,而由系列C矽油製得之眼鏡具有更令人滿意(較低)之脫水染色速率。因此,理想的是,確定應增加系列A貨號矽油之效能以達成甚至更為所需之眼鏡臨床特性。(認為特定批次之聚氧化烯矽氧(例如矽油)之效能為其在給定濃度下產生具有自所用之隱形眼鏡模具直徑減小之直徑的最終經萃取水合眼鏡產物之能力。最終眼鏡產物之眼鏡直徑減小愈大,聚氧化烯矽氧之效能則愈大。尤其較佳者為產生具有所用隱形眼鏡模具直徑0.98至1.02倍範圍內之直徑的最終眼鏡產物之矽油)。舉例而言,參看圖3,向系列A矽油貨號中添加4% AE產生基本上與在添加烯丙氧基乙醇之前由系列C矽油貨號產生之眼鏡直徑相同的眼鏡直徑。Glasses produced in Series A are larger than those produced in Series B or C. Early clinical trials using 25A glasses without the addition of AE's Series A enamel resulted in glasses with relatively high rates of dehydration staining, while glasses made from Series C oysters had a more satisfactory (lower) dehydration dyeing rate. . Therefore, it is desirable to determine that the efficacy of Series A No. 矽 oil should be increased to achieve even more desirable spectacles clinical characteristics. (It is believed that the potency of a particular batch of polyoxyalkylene oxime (e.g., eucalyptus) is its ability to produce a final extracted hydrated spectacles product having a reduced diameter from the contact lens mold used at a given concentration. Final spectacles product The greater the reduction in the diameter of the lens, the greater the effectiveness of the polyoxyalkylene oxime. Especially preferred is the enamel which produces the final spectacles product having a diameter in the range of 0.98 to 1.02 times the diameter of the contact lens mold used. For example, referring to Figure 3, the addition of 4% AE to the Series A oil number produces a lens diameter substantially the same as the diameter of the glasses produced by the Series C oil number prior to the addition of allyloxyethanol.
如表6中所示及圖4及圖5中分別圖示說明,觀測到諸如EWC%及離子流之特性的類似趨勢。As shown in Table 6, and illustrated in Figures 4 and 5, respectively, similar trends such as EWC% and ion flow characteristics were observed.
因此,向聚氧化烯矽氧可萃取組份中添加鏈轉移試劑(諸如本實例中所用之例示性烯丙氧基乙醇)有效地細微調節或"微調"前驅體組合物提供具有類似有益物理特性之最終矽氧隱形眼鏡產物之能力。尤其較佳者為平衡水含量在約40-50%之範圍內、離子流在約2至約5之範圍內且模數小於約1.2 Mpa之經萃取水合隱形眼鏡。Thus, the addition of a chain transfer agent, such as the exemplary allyloxyethanol used in this example, to the polyoxyalkylene oxime extractable component effectively fine-tunes or "fine-tunes" the precursor composition to provide similar beneficial physical properties. The ability to ultimately oxidize contact lens products. Particularly preferred are extracted hydrated contact lenses having an equilibrium water content in the range of from about 40% to about 50%, an ion current in the range of from about 2 to about 5, and a modulus of less than about 1.2 MPa.
如早期所示,可藉由添加4% AE來調節5 L批次之SO。如對於SO批次10627及11038而言,其已具有高效能,且因此僅添加0.1%之AE來用於微調。為進一步證實此微調概念,將4%AE添加至SO 5L批次中,且將0.1%之AE添加至SO 10627批次中。兩批M3U用以製成具有20、23、26及29份微調SO(或SO/AE混合物)之25C眼鏡,如表5中所列。眼鏡特性列於表8中。As indicated earlier, the SO of the 5 L batch can be adjusted by adding 4% AE. As for SO batches 10627 and 11038, it already has high performance, and therefore only 0.1% of AE is added for fine tuning. To further confirm this fine tuning concept, 4% AE was added to the SO 5L batch and 0.1% AE was added to the SO 10627 batch. Two batches of M3U were used to make 25C glasses with 20, 23, 26 and 29 parts of fine-tuned SO (or SO/AE mixture) as listed in Table 5. The characteristics of the glasses are listed in Table 8.
眼鏡直徑與SO含量之關係顯示於圖6及7中。眼鏡直徑隨SO負載增加而減少,此主要歸因於SO之稀釋作用。稀釋劑負載愈高,萃取後所移除之物質的量則愈大,且因此,最終眼鏡之直徑則愈小。基於矽油負載含量為20%及29%之直徑資料,可見兩種微調矽油之效能近乎相同。該等結果證實向矽油可萃取組份中添加4% AE有效地"微調"或細微調節例示性可萃取組份SO 5L以匹配僅含0.1% AE之SO 10627的效能。The relationship between the diameter of the glasses and the SO content is shown in Figures 6 and 7. The diameter of the glasses decreases as the SO load increases, which is mainly due to the dilution effect of SO. The higher the diluent loading, the greater the amount of material removed after extraction and, therefore, the smaller the diameter of the final lens. Based on the diameter data of 20% and 29% of the eucalyptus oil load, it can be seen that the performance of the two fine-tuning oyster sauces is almost the same. These results demonstrate that the addition of 4% AE to the emu oil extractable component effectively "fine tune" or fine tune the exemplary extractable component SO 5L to match the efficacy of SO 10627 containing only 0.1% AE.
現轉向例示性含氟二甲基丙烯醯基矽氧大分子單體M3U,資料表明對於不同批次之M3U而言,眼鏡直徑在約0.2 mm內變化。如圖6及7中可見,D對%SO之斜率為約-0.06 mm/%SO。由此資料外推,為了提供具有類似直徑之眼鏡,選擇約25%±4%之SO(預調節)含量。Turning now to the exemplary fluorine-containing dimethyl methacryloyloxyl macromonomer M3U, the data indicates that for different batches of M3U, the diameter of the spectacles varies within about 0.2 mm. As can be seen in Figures 6 and 7, the slope of D versus %SO is about -0.06 mm/% SO. With the extrapolation of this data, in order to provide glasses with similar diameters, an SO (preconditioning) content of about 25% ± 4% is selected.
表6中所列之所有25C調配物的直徑及離子流與平衡水含量之一般關係圖示於圖8中。參看圖8,可見直徑與水含量之間存在強相關性,且離子流與水含量之間亦存在強相關性。因此,基於此圖,顯然離子流一般可基於平衡水含量來預測。The general relationship between the diameter and ion current and equilibrium water content of all 25C formulations listed in Table 6 is shown in Figure 8. Referring to Figure 8, there is a strong correlation between diameter and water content, and there is also a strong correlation between ion current and water content. Therefore, based on this figure, it is apparent that the ion current can generally be predicted based on the equilibrium water content.
熟習本發明所屬領域之技術者將瞭解,本發明之多種修改及其他實施例具有前述描述中呈現之教示的益處。因此,應瞭解本發明不限於本文所揭示之特定實施例,如藉助於實例所呈現之該等實施例。雖然論述例示性實施例,但應理解前述實施方式之目的在於覆蓋實施例之所有修改、替代及等效物,如其他揭示案所定義可屬於本發明之精神及範疇內。雖然本文採用特定術語,但其僅以通用及描述性意義使用且非限制目的。It will be appreciated by those skilled in the art <RTIgt;a</RTI> that the various modifications and other embodiments of the present invention have the benefit of the teachings presented in the foregoing description. Therefore, it is understood that the invention is not limited to the specific embodiments disclosed herein, such as the embodiments presented by the examples. The exemplified embodiments are to be considered as illustrative of the embodiments of the invention. Although specific terms are employed herein, they are used in a generic and descriptive sense only and not limiting.
已在上文引用大量公開案及專利。所引用之公開案及專利各自以全文引用的方式併入本文中。A large number of publications and patents have been cited above. The cited publications and patents are each incorporated herein by reference in their entirety.
102...置放102. . . Place
104...封閉104. . . Closed
106...固化106. . . Curing
108...脫模108. . . Demolding
110...脫鏡110. . . Mirror
112...萃取112. . . extraction
114...水合114. . . Hydration
116...封裝116. . . Package
118...密封及殺菌118. . . Sealing and sterilization
202...可聚合矽氧水凝膠眼鏡前驅體組合物202. . . Polymerizable silicone hydrogel lens precursor composition
204...預萃取之聚合矽氧水凝膠隱形眼鏡產物204. . . Pre-extracted polymeric helium hydrogel contact lens product
206...經萃取之矽氧水凝膠隱形眼鏡產物206. . . Extracted Hydrogen Hydrogel Contact Lens Products
208...水合矽氧水凝膠隱形眼鏡208. . . Hydrated helium hydrogel contact lens
圖1 為說明產生矽氧水凝膠隱形眼鏡之例示性方法的方塊圖。 1 is a block diagram illustrating an exemplary method of producing a helium oxygen hydrogel contact lens.
圖2 為說明本發明之組合物、眼鏡產物及隱形眼鏡的方塊圖。 2 is a block diagram illustrating the composition, lens product, and contact lens of the present invention.
圖3 為表明在用作用以形成矽氧水凝膠隱形眼鏡之可萃取組份的聚氧化烯矽氧中增加烯丙氧基乙醇含量之作用與如實例4所述之所得經萃取水合高壓釜處理後之隱形眼鏡產物之直徑的關係曲線圖。 Figure 3 is a graph showing the effect of increasing the allyloxyethanol content in the polyoxyalkylene oxide used as the extractable component for forming a helium oxygen hydrogel contact lens and the resulting extracted hydration autoclave as described in Example 4. A graph of the relationship of the diameter of the contact lens product after treatment.
圖4 為表明在用作用以形成矽氧水凝膠隱形眼鏡之可萃取組份的聚氧化烯矽氧中增加烯丙氧基乙醇含量之作用與如實例4所述之所得經萃取水合高壓釜處理後之隱形眼鏡產物之平衡水含量的關係曲線圖。 Figure 4 is a graph showing the effect of increasing the allyloxyethanol content in the polyoxyalkylene oxide used as the extractable component for forming a helium oxygen hydrogel contact lens and the obtained extracted hydration autoclave as described in Example 4. A graph of the equilibrium water content of the contact lens product after treatment.
圖5 為表明在用作用以形成矽氧水凝膠隱形眼鏡之可萃取組份的聚氧化烯矽氧中增加烯丙氧基乙醇含量之作用與如實例4所述之所得經萃取水合高壓釜處理後之隱形眼鏡產物之離子流的關係曲線圖。 Figure 5 is a graph showing the effect of increasing the allyloxyethanol content in the polyoxyalkylene oxide used as the extractable component for forming a helium oxygen hydrogel contact lens and the resulting extracted hydration autoclave as described in Example 4. A graph of the ion flux of the contact lens product after treatment.
圖6 為表明經萃取水合隱形眼鏡之直徑(mm)與如實例4所述之使用特定含氟二甲基丙烯醯基矽氧大分子單體(存放期3MU)之可聚合前驅體組合物中例示性聚氧化烯矽氧/烯丙氧基乙醇可萃取組份百分比的關係曲線圖。 Figure 6 is a graph showing the diameter (mm) of the extracted hydrated contact lens and the polymerizable precursor composition using a specific fluorine-containing dimethyl propylene fluorenyloxyl macromonomer (storage period 3 MU) as described in Example 4. A graph of the relationship between the exemplary polyoxyalkylene oxime/allyloxyethanol extractable components.
圖7 表明經萃取水合隱形眼鏡之直徑(mm)與如實例4所述之使用特定含氟二甲基丙烯醯基矽氧大分子單體(黃色M3U)之可聚合前驅體組合物中例示性聚氧化烯矽氧/烯丙氧基乙醇可萃取組份百分比的關係。 Figure 7 shows the exemplification of the diameter (mm) of the extracted hydrated contact lens and the polymerizable precursor composition using a specific fluorine-containing dimethyl propylene fluorenyloxyl macromonomer (yellow M3U) as described in Example 4. The relationship between the percentage of extractable components of polyoxyalkylene oxime/allyloxyethanol.
圖8 為表明平衡水含量分別與自聚氧化烯矽氧/烯丙氧基乙醇可萃取組份百分比變化之各種可聚合前驅體組合物產生的最終經萃取水合隱形眼鏡產物之直徑及離子流各自的一般關係曲線。 Figure 8 is a graph showing the diameter and ion current of the final extracted hydrated contact lens product produced by various polymerizable precursor compositions having an equilibrium water content and a percentage change from the polyoxyalkylene oxime/allyloxyethanol extractable component, respectively. General relationship curve.
102...置放102. . . Place
104...封閉104. . . Closed
106...固化106. . . Curing
108...脫模108. . . Demolding
110...脫鏡110. . . Mirror
112...萃取112. . . extraction
114...水合114. . . Hydration
116...封裝116. . . Package
118...密封及殺菌118. . . Sealing and sterilization
Claims (38)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80491106P | 2006-06-15 | 2006-06-15 | |
US88751307P | 2007-01-31 | 2007-01-31 | |
US89460907P | 2007-03-13 | 2007-03-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200813102A TW200813102A (en) | 2008-03-16 |
TWI443116B true TWI443116B (en) | 2014-07-01 |
Family
ID=39007968
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW96121939A TWI443116B (en) | 2006-06-15 | 2007-06-15 | Wettable silicone hydrogel contact lenses and related compositions and methods |
TW96121908A TWI444408B (en) | 2006-06-15 | 2007-06-15 | Wettable silicone hydrogel contact lenses and related compositions and methods |
TW103118502A TWI512017B (en) | 2006-06-15 | 2007-06-15 | Wettable silicone hydrogel contact lenses and related compositions and methods |
TW96121940A TWI429713B (en) | 2006-06-15 | 2007-06-15 | Wettable silicone hydrogel contact lenses and related compositions and methods |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW96121908A TWI444408B (en) | 2006-06-15 | 2007-06-15 | Wettable silicone hydrogel contact lenses and related compositions and methods |
TW103118502A TWI512017B (en) | 2006-06-15 | 2007-06-15 | Wettable silicone hydrogel contact lenses and related compositions and methods |
TW96121940A TWI429713B (en) | 2006-06-15 | 2007-06-15 | Wettable silicone hydrogel contact lenses and related compositions and methods |
Country Status (2)
Country | Link |
---|---|
JP (4) | JP5224090B2 (en) |
TW (4) | TWI443116B (en) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101918865B (en) * | 2008-01-14 | 2012-12-26 | 库柏维景国际控股公司 | Polymerizable contact lens formulations and contact lenses obtained therefrom |
WO2011041523A2 (en) * | 2009-10-01 | 2011-04-07 | Coopervision International Holding Company, Lp | Silicone hydrogel contact lenses and methods of making silicone hydrogel contact lenses |
BR112012027065B1 (en) * | 2010-04-23 | 2018-09-04 | Johnson & Johnson Vision Care | method for improving the rotational properties of a stabilized ophthalmic lens |
HUE034946T2 (en) | 2010-07-09 | 2018-03-28 | Coopervision Int Holding Co Lp | Ophthalmic lens molds with low levels of uv light transmittance, ophthalmic lenses molded therein, and related methods |
MX2013001189A (en) * | 2010-07-30 | 2013-02-21 | Novartis Ag | Silicone hydrogel lenses with water-rich surfaces. |
EP2598321B1 (en) * | 2010-07-30 | 2016-10-26 | CooperVision International Holding Company, LP | Ophthalmic lens molds, ophthalmic lenses molded therein, and related methods |
ES2533693T3 (en) * | 2011-02-28 | 2015-04-14 | Coopervision International Holding Company, Lp | Hydrogel contact lenses containing phosphine |
ES2449709T3 (en) * | 2011-02-28 | 2014-03-20 | Coopervision International Holding Company, Lp | Silicone Hydrogel Contact Lenses |
JP6130793B2 (en) * | 2011-02-28 | 2017-05-17 | クーパーヴィジョン インターナショナル ホウルディング カンパニー リミテッド パートナーシップ | Silicone hydrogel contact lens |
US9057822B2 (en) * | 2011-02-28 | 2015-06-16 | Coopervision International Holding Company, Lp | Silicone hydrogel contact lenses |
MX2013009217A (en) | 2011-02-28 | 2014-09-08 | Coopervision Int Holding Co Lp | Silicone hydrogel contact lenses having acceptable levels of energy loss. |
JP5980626B2 (en) * | 2011-08-31 | 2016-08-31 | 三洋化成工業株式会社 | Active energy ray-curable resin composition |
US9588258B2 (en) | 2011-12-23 | 2017-03-07 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogels formed from zero diluent reactive mixtures |
US9156934B2 (en) | 2011-12-23 | 2015-10-13 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogels comprising n-vinyl amides and hydroxyalkyl (meth)acrylates or (meth)acrylamides |
US8937110B2 (en) | 2011-12-23 | 2015-01-20 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogels having a structure formed via controlled reaction kinetics |
US9140825B2 (en) | 2011-12-23 | 2015-09-22 | Johnson & Johnson Vision Care, Inc. | Ionic silicone hydrogels |
US8937111B2 (en) | 2011-12-23 | 2015-01-20 | Johnson & Johnson Vision Care, Inc. | Silicone hydrogels comprising desirable water content and oxygen permeability |
TWI496838B (en) * | 2012-11-30 | 2015-08-21 | Pegavision Corp | Silicone hydrogel composition and silicone hydrogel contact lenses made of the composition |
US9161598B2 (en) * | 2012-12-21 | 2015-10-20 | Coopervision International Holding Company, Lp | Ophthalmic devices for delivery of beneficial agents |
JP2016524178A (en) * | 2013-04-30 | 2016-08-12 | クーパーヴィジョン インターナショナル ホウルディング カンパニー リミテッド パートナーシップ | Primary amine-containing silicone hydrogel contact lenses and related compositions and methods |
JP5452756B1 (en) | 2013-07-02 | 2014-03-26 | Hoya株式会社 | Method for producing silicone-containing copolymer molded article having hydrophilic surface and silicone hydrogel contact lens having hydrophilic surface |
JP6329005B2 (en) * | 2014-06-05 | 2018-05-23 | 株式会社メニコン | Ophthalmic lens |
TWI571670B (en) * | 2015-01-09 | 2017-02-21 | Composite contact lenses | |
KR101786302B1 (en) * | 2016-03-03 | 2017-10-17 | (주)메디오스 | The method for producing blue light blocking soft contact lens |
JP6859432B2 (en) * | 2016-10-11 | 2021-04-14 | アルコン インク. | Chain Extension Polydimethylsiloxane Vinyl Crosslinker and Its Use |
RU2766412C2 (en) * | 2017-06-07 | 2022-03-15 | Алькон Инк. | Silicone hydrogel contact lenses |
RU2022108168A (en) * | 2017-06-07 | 2022-04-08 | Алькон Инк. | SILICONE HYDROGEL CONTACT LENSES |
JP6907845B2 (en) * | 2017-09-13 | 2021-07-21 | 日油株式会社 | Monomer composition for contact lenses, polymers for contact lenses and methods for producing them, and contact lenses and methods for producing them. |
CA3097124A1 (en) * | 2018-05-15 | 2019-11-21 | Bausch & Lomb Incorporated | Water extractable ophthalmic devices |
US11767401B2 (en) | 2018-06-27 | 2023-09-26 | Sumitomo Chemical Company, Limited | Gel containing condensation product of reactive silicon compound |
CN112513681B (en) * | 2018-07-03 | 2024-07-26 | 鲍希与洛姆伯股份有限公司 | Water extraction ophthalmic device |
JP7243731B2 (en) | 2018-09-14 | 2023-03-22 | 日油株式会社 | Monomer composition for contact lens, polymer thereof, contact lens and method for producing the same |
CN114867769B (en) | 2019-12-27 | 2023-07-18 | 日油株式会社 | Polysiloxane monomer containing phosphorylcholine base |
TWI779275B (en) * | 2020-03-31 | 2022-10-01 | 望隼科技股份有限公司 | Anti-blue light contact lens, composition and manufacturing method thereof |
CN116997846A (en) | 2021-04-21 | 2023-11-03 | 日油株式会社 | Monomer composition for contact lens, polymer thereof, contact lens and method for producing same |
WO2024143214A1 (en) * | 2022-12-27 | 2024-07-04 | 三菱ケミカル株式会社 | Curable composition, molded body, silicone hydrogel, and method for producing silicone hydrogel |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4678838A (en) * | 1986-08-04 | 1987-07-07 | Ciba-Geigy Corporation | Particulate hydroperoxidized poly-N-vinyl lactam, its preparation and use thereof |
CA2009668A1 (en) * | 1989-02-16 | 1990-08-16 | Ashok R. Thakrar | Colored contact lenses and method of making same |
US5310779A (en) * | 1991-11-05 | 1994-05-10 | Bausch & Lomb Incorporated | UV curable crosslinking agents useful in copolymerization |
US5760100B1 (en) * | 1994-09-06 | 2000-11-14 | Ciba Vision Corp | Extended wear ophthalmic lens |
JPH10195324A (en) * | 1997-01-16 | 1998-07-28 | Hoya Corp | Yellow reactive dye and spectacle lens containing the same |
US6367929B1 (en) * | 1998-03-02 | 2002-04-09 | Johnson & Johnson Vision Care, Inc. | Hydrogel with internal wetting agent |
US7052131B2 (en) * | 2001-09-10 | 2006-05-30 | J&J Vision Care, Inc. | Biomedical devices containing internal wetting agents |
US6359024B2 (en) * | 1998-05-15 | 2002-03-19 | Bausch & Lomb Incorporated | Method for polymerizing contact lenses |
DE60043907D1 (en) * | 1999-10-07 | 2010-04-08 | Johnson & Johnson Vision Care | Soft contact lenses |
CN100374881C (en) * | 1999-12-16 | 2008-03-12 | 旭化成爱美株式会社 | Soft contact lens capable of being worn for long period |
JP2001201723A (en) * | 2000-01-18 | 2001-07-27 | Asahi Kasei Aimii Kk | Soft contact lens for continuous wearing |
JP4438162B2 (en) * | 2000-02-24 | 2010-03-24 | 東レ株式会社 | Method for producing polymer for ophthalmic lens and ophthalmic lens |
JP4441998B2 (en) * | 2000-07-14 | 2010-03-31 | 日油株式会社 | Contact lens material, contact lens and manufacturing method thereof |
US7879267B2 (en) * | 2001-08-02 | 2011-02-01 | J&J Vision Care, Inc. | Method for coating articles by mold transfer |
JP2004085655A (en) * | 2002-08-23 | 2004-03-18 | Asahi Kasei Aimii Kk | Fouling resistant hydrous soft contact lens |
CN100529842C (en) * | 2003-01-10 | 2009-08-19 | 株式会社美你康 | Highly safe silicone-containing material for ocular lens and process for producing the same |
ES2732439T3 (en) * | 2004-08-27 | 2019-11-22 | Coopervision Int Holding Co Lp | Silicone Hydrogel Contact Lenses |
US7249848B2 (en) * | 2004-09-30 | 2007-07-31 | Johnson & Johnson Vision Care, Inc. | Wettable hydrogels comprising reactive, hydrophilic, polymeric internal wetting agents |
JP2007183697A (en) * | 2005-12-31 | 2007-07-19 | Mitsuyo Nakagami | Portable medical chart display device, portable medical chart display program and computer-readable recording medium |
-
2007
- 2007-06-15 TW TW96121939A patent/TWI443116B/en active
- 2007-06-15 JP JP2007183696A patent/JP5224090B2/en active Active
- 2007-06-15 TW TW96121908A patent/TWI444408B/en active
- 2007-06-15 TW TW103118502A patent/TWI512017B/en active
- 2007-06-15 JP JP2007183697A patent/JP2008020918A/en active Pending
- 2007-06-15 JP JP2007183695A patent/JP5024702B2/en active Active
- 2007-06-15 TW TW96121940A patent/TWI429713B/en active
-
2014
- 2014-01-22 JP JP2014009742A patent/JP5982684B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
TW201434885A (en) | 2014-09-16 |
TWI444408B (en) | 2014-07-11 |
JP2008003612A (en) | 2008-01-10 |
JP5982684B2 (en) | 2016-08-31 |
TWI429713B (en) | 2014-03-11 |
JP5024702B2 (en) | 2012-09-12 |
JP5224090B2 (en) | 2013-07-03 |
TW200817471A (en) | 2008-04-16 |
TW200813102A (en) | 2008-03-16 |
TWI512017B (en) | 2015-12-11 |
JP2014089477A (en) | 2014-05-15 |
JP2008020918A (en) | 2008-01-31 |
JP2008050576A (en) | 2008-03-06 |
TW200815501A (en) | 2008-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI443116B (en) | Wettable silicone hydrogel contact lenses and related compositions and methods | |
EP1870735B1 (en) | Wettable silicone hydrogel contact lenses and related compositions and methods | |
US7540609B2 (en) | Wettable silicone hydrogel contact lenses and related compositions and methods | |
US9804417B2 (en) | Wettable silicone hydrogel contact lenses and related compositions and methods | |
US8672475B2 (en) | Silicone hydrogel contact lenses and methods of making silicone hydrogel contact lenses | |
TWI531826B (en) | Dimensionally stable silicone hydrogel contact lenses and method of manufacturing the same | |
KR20140012104A (en) | Silicone hydrogel contact lenses | |
CN101467094B (en) | Wettable silicone hydrogel contact lenses and related compositions and methods | |
KR20140009401A (en) | Wettable silicone hydrogel contact lenses | |
KR20140009400A (en) | Silicone hydrogel contact lenses |